TWI835878B - Water treatment device, and water treatment method - Google Patents
Water treatment device, and water treatment method Download PDFInfo
- Publication number
- TWI835878B TWI835878B TW108135957A TW108135957A TWI835878B TW I835878 B TWI835878 B TW I835878B TW 108135957 A TW108135957 A TW 108135957A TW 108135957 A TW108135957 A TW 108135957A TW I835878 B TWI835878 B TW I835878B
- Authority
- TW
- Taiwan
- Prior art keywords
- osmosis membrane
- water
- forward osmosis
- treatment
- treatment device
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 741
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 541
- 238000000034 method Methods 0.000 title claims abstract description 113
- 239000012528 membrane Substances 0.000 claims abstract description 740
- 238000009292 forward osmosis Methods 0.000 claims abstract description 466
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 219
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 134
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 108
- 238000002203 pretreatment Methods 0.000 claims abstract description 93
- 239000012141 concentrate Substances 0.000 claims abstract description 13
- 239000000243 solution Substances 0.000 claims description 292
- 239000007864 aqueous solution Substances 0.000 claims description 99
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 66
- 159000000003 magnesium salts Chemical group 0.000 claims description 52
- 239000002253 acid Substances 0.000 claims description 35
- 239000011780 sodium chloride Substances 0.000 claims description 33
- 239000012266 salt solution Substances 0.000 claims description 9
- 239000011260 aqueous acid Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 description 90
- 230000000844 anti-bacterial effect Effects 0.000 description 86
- 239000003899 bactericide agent Substances 0.000 description 79
- -1 hydrogen peroxide Chemical compound 0.000 description 77
- 239000007800 oxidant agent Substances 0.000 description 70
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 63
- 239000000203 mixture Substances 0.000 description 63
- 229910052794 bromium Inorganic materials 0.000 description 60
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 59
- 238000006243 chemical reaction Methods 0.000 description 59
- 239000000460 chlorine Substances 0.000 description 54
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 53
- 229910052801 chlorine Inorganic materials 0.000 description 53
- 238000000926 separation method Methods 0.000 description 41
- 239000003513 alkali Substances 0.000 description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 239000000701 coagulant Substances 0.000 description 31
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 27
- 238000005342 ion exchange Methods 0.000 description 27
- 238000005345 coagulation Methods 0.000 description 26
- 230000015271 coagulation Effects 0.000 description 26
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 25
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 24
- 239000003456 ion exchange resin Substances 0.000 description 23
- 229920003303 ion-exchange polymer Polymers 0.000 description 23
- 230000001590 oxidative effect Effects 0.000 description 21
- 239000003795 chemical substances by application Substances 0.000 description 20
- 239000011777 magnesium Substances 0.000 description 20
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 19
- 229910052749 magnesium Inorganic materials 0.000 description 19
- 239000007795 chemical reaction product Substances 0.000 description 18
- 239000000645 desinfectant Substances 0.000 description 18
- 230000008929 regeneration Effects 0.000 description 18
- 238000011069 regeneration method Methods 0.000 description 18
- 239000011347 resin Substances 0.000 description 18
- 229920005989 resin Polymers 0.000 description 18
- 230000003204 osmotic effect Effects 0.000 description 17
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 15
- 230000002776 aggregation Effects 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 15
- 238000000108 ultra-filtration Methods 0.000 description 15
- 238000010586 diagram Methods 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000003085 diluting agent Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 11
- 235000011941 Tilia x europaea Nutrition 0.000 description 11
- 238000004220 aggregation Methods 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 239000004571 lime Substances 0.000 description 11
- 235000012239 silicon dioxide Nutrition 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 10
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 10
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000005189 flocculation Methods 0.000 description 9
- 230000016615 flocculation Effects 0.000 description 9
- 239000013535 sea water Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000008394 flocculating agent Substances 0.000 description 8
- 239000002351 wastewater Substances 0.000 description 8
- 239000002270 dispersing agent Substances 0.000 description 7
- 239000000417 fungicide Substances 0.000 description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000010802 sludge Substances 0.000 description 7
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000004520 agglutination Effects 0.000 description 6
- 239000001099 ammonium carbonate Substances 0.000 description 6
- 235000012501 ammonium carbonate Nutrition 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 6
- 239000000347 magnesium hydroxide Substances 0.000 description 6
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 6
- 238000001728 nano-filtration Methods 0.000 description 6
- 239000012466 permeate Substances 0.000 description 6
- 229920002647 polyamide Polymers 0.000 description 6
- 229940124530 sulfonamide Drugs 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 229920006318 anionic polymer Polymers 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229920002301 cellulose acetate Polymers 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000008235 industrial water Substances 0.000 description 5
- 239000011261 inert gas Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000005708 Sodium hypochlorite Substances 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical compound BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000010612 desalination reaction Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000005188 flotation Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000005374 membrane filtration Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920005597 polymer membrane Polymers 0.000 description 4
- 238000003672 processing method Methods 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000004760 aramid Substances 0.000 description 3
- 229920003235 aromatic polyamide Polymers 0.000 description 3
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000909 electrodialysis Methods 0.000 description 3
- 239000003673 groundwater Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229910010272 inorganic material Inorganic materials 0.000 description 3
- 239000011147 inorganic material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000002352 surface water Substances 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- QNGVNLMMEQUVQK-UHFFFAOYSA-N 4-n,4-n-diethylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C=C1 QNGVNLMMEQUVQK-UHFFFAOYSA-N 0.000 description 2
- 102000010637 Aquaporins Human genes 0.000 description 2
- 108010063290 Aquaporins Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 2
- 229940005991 chloric acid Drugs 0.000 description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002608 ionic liquid Substances 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- GVWISOJSERXQBM-UHFFFAOYSA-N n-methylpropan-1-amine Chemical compound CCCNC GVWISOJSERXQBM-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000005373 pervaporation Methods 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 239000012492 regenerant Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical class N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- JBQDKODJUQXMPD-UHFFFAOYSA-N [Au+3].[O-]Cl.[O-]Cl.[O-]Cl Chemical class [Au+3].[O-]Cl.[O-]Cl.[O-]Cl JBQDKODJUQXMPD-UHFFFAOYSA-N 0.000 description 1
- WOHVONCNVLIHKY-UHFFFAOYSA-L [Ba+2].[O-]Cl=O.[O-]Cl=O Chemical compound [Ba+2].[O-]Cl=O.[O-]Cl=O WOHVONCNVLIHKY-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- KHPLPBHMTCTCHA-UHFFFAOYSA-N ammonium chlorate Chemical compound N.OCl(=O)=O KHPLPBHMTCTCHA-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- ISFLYIRWQDJPDR-UHFFFAOYSA-L barium chlorate Chemical compound [Ba+2].[O-]Cl(=O)=O.[O-]Cl(=O)=O ISFLYIRWQDJPDR-UHFFFAOYSA-L 0.000 description 1
- HPEWZLCIOKVLBZ-UHFFFAOYSA-N barium hypochlorite Chemical class [Ba+2].Cl[O-].Cl[O-] HPEWZLCIOKVLBZ-UHFFFAOYSA-N 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- YALMXYPQBUJUME-UHFFFAOYSA-L calcium chlorate Chemical compound [Ca+2].[O-]Cl(=O)=O.[O-]Cl(=O)=O YALMXYPQBUJUME-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003657 drainage water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000001614 effect on membrane Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
- SIVVHUQWDOGLJN-UHFFFAOYSA-N ethylsulfamic acid Chemical group CCNS(O)(=O)=O SIVVHUQWDOGLJN-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 description 1
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 description 1
- 235000014824 magnesium bicarbonate Nutrition 0.000 description 1
- 239000002370 magnesium bicarbonate Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000009285 membrane fouling Methods 0.000 description 1
- MYMDOKBFMTVEGE-UHFFFAOYSA-N methylsulfamic acid Chemical group CNS(O)(=O)=O MYMDOKBFMTVEGE-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- AMULHDKUJWPBKU-UHFFFAOYSA-L nickel(2+);dichlorite Chemical compound [Ni+2].[O-]Cl=O.[O-]Cl=O AMULHDKUJWPBKU-UHFFFAOYSA-L 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001470 polyketone Polymers 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- SATVIFGJTRRDQU-UHFFFAOYSA-N potassium hypochlorite Chemical compound [K+].Cl[O-] SATVIFGJTRRDQU-UHFFFAOYSA-N 0.000 description 1
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 239000008400 supply water Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
- B01D61/04—Feed pretreatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/28—Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/58—Multistep processes
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/42—Treatment of water, waste water, or sewage by ion-exchange
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/58—Treatment of water, waste water, or sewage by removing specified dissolved compounds
- C02F1/60—Silicon compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A20/00—Water conservation; Efficient water supply; Efficient water use
- Y02A20/124—Water desalination
- Y02A20/131—Reverse-osmosis
Landscapes
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
本發明係關於進行包含溶解性二氧化矽及硬度成分中之至少一者之被處理水的處理的水處理裝置及水處理方法。此外,本發明係關於正滲透膜處理方法、正滲透膜處理系統及使用該正滲透膜處理方法、正滲透膜處理系統的水處理方法、水處理系統。 The present invention relates to a water treatment device and a water treatment method for treating water to be treated that contains at least one of soluble silica and hardness components. In addition, the present invention relates to a forward osmosis membrane treatment method, a forward osmosis membrane treatment system, and a water treatment method and a water treatment system using the forward osmosis membrane treatment method and the forward osmosis membrane treatment system.
為了減少排水之放流對環境之影響,在進行排水淨化及減容化等之處理後,才進行放流、廢棄之動作。排水處理使用固液分離、膜分離、減壓濃縮等,但排水中含有之溶解性二氧化矽及鈣等之硬度成分不溶化而附著在用於排水處理之配管及裝置等上,發生所謂結垢,因此系統之性能降低是習知的。為了進行有效率之排水處理,必須去除排水中之溶解性二氧化矽及硬度成分等。 In order to reduce the impact of drainage on the environment, drainage and volume reduction are carried out before drainage and disposal. Drainage treatment uses solid-liquid separation, membrane separation, vacuum concentration, etc. However, hard components such as soluble silica and calcium contained in the drainage do not dissolve and adhere to the pipes and equipment used for drainage treatment, causing so-called scaling. , so system performance degradation is common. In order to carry out efficient drainage treatment, soluble silica and hardness components in the drainage must be removed.
例如,專利文獻1記載對含有溶解性二氧化矽之排水,在鹼性條件下添加鎂鹽以使溶解性二氧化矽不溶化後固液分離,接著逆滲透膜處理或正滲透膜處理製得之處理水,由排水回收淡水的方法。 For example, Patent Document 1 describes a process in which wastewater containing soluble silica is added with magnesium salt under alkaline conditions to insolubilize the soluble silica, followed by solid-liquid separation, followed by reverse osmosis membrane treatment or forward osmosis membrane treatment. A method of treating water and recovering fresh water from drainage.
正滲透膜處理係透過正滲透膜使供給水及吸引溶液存在,藉此即使未加壓時亦可利用滲透壓使水移動至吸引溶液。接著藉由例如加溫等之手段使稀釋之吸引溶液相變化,藉此可一面取得淡水,一面再利用吸引溶液。 Forward osmosis membrane treatment allows supply water and suction solution to exist through the forward osmosis membrane, whereby osmotic pressure can be used to move water to the suction solution even when no pressure is applied. Then, the phase of the diluted suction solution is changed by means such as heating, so that fresh water can be obtained and the suction solution can be reused.
正滲透膜處理之吸引溶液可使用碳酸銨水溶液、及無機鹽與溫度感應性藥劑之混合物等(請參照專利文獻2)。 The suction solution for forward osmosis membrane treatment can use ammonium carbonate aqueous solution, a mixture of inorganic salts and temperature-sensitive chemicals, etc. (please refer to Patent Document 2).
為了再利用吸引溶液必須施加加溫等以外的能量,且必須追加地具有用以再利用吸引溶液之裝置(請參照圖10),因此造成整體系統之成本增加。 In order to reuse the suction solution, energy other than heating must be applied, and an additional device for reusing the suction solution must be provided (see Figure 10), which increases the cost of the entire system.
專利文獻3記載添加鹼劑於含有硬度成分之排水中使其析出(所謂石灰軟化法)、凝集、過濾處理後逆滲透膜處理過濾水的方法,作為硬度成分之去除方法。此外,專利文獻4記載使用離子交換樹脂吸附去除硬度成分之方法(樹脂軟化法)。 Patent document 3 describes a method of adding an alkali to drainage containing hardness components to cause precipitation (so-called lime softening method), coagulating, filtering, and then treating the filtered water with a reverse osmosis membrane as a method for removing hardness components. In addition, patent document 4 describes a method of removing hardness components by adsorption using an ion exchange resin (resin softening method).
但是,在石灰軟化法中必須添加鹼劑,且在樹脂軟化法中為了再生吸附硬度成分之離子交換樹脂,必須通入高濃度鹽水(氯化鈉水溶液),因此需要降低藥品成本。 However, in the lime softening method, an alkali agent must be added, and in the resin softening method, in order to regenerate the ion exchange resin that absorbs hardness components, high-concentration brine (sodium chloride aqueous solution) must be passed through, so it is necessary to reduce drug costs.
另一方面,在藉由透過正滲透膜使被處理水與濃度比被處理水高之吸引溶液接觸而製得濃縮水及稀薄吸引溶液的正滲透(FO)膜處理系統中,膜之積垢控制是重要的課題。正滲透膜處理系統之殺菌方法使用次氯酸及氯胺等之氯系殺菌劑、過氧化氫等之氧化劑、或5-氯-2-甲基-4-異噻唑啉-3-酮等之有機系殺菌劑(例如,請參照專利文獻5、6)。 On the other hand, in a forward osmosis (FO) membrane treatment system that produces concentrated water and a dilute draw solution by bringing the treated water into contact with a draw solution having a higher concentration than the treated water through a forward osmosis membrane, membrane fouling control is an important issue. The sterilization method of the forward osmosis membrane treatment system uses chlorine-based disinfectants such as hypochlorous acid and chloramine, oxidants such as hydrogen peroxide, or organic disinfectants such as 5-chloro-2-methyl-4-isothiazoline-3-one (for example, see patent documents 5 and 6).
但是,因為該等殺菌劑(氯系殺菌劑、氧化劑、有機系殺菌劑)會透過正滲透膜,所以殺菌劑之殺菌成分未充分地擴散到正滲透膜處理裝置之出口側,因此產生無法將正滲透膜充分地殺菌之問題。此外,有機系殺菌劑特別會對生物、環境等產生影響。特別在藉由加熱等處理由稀薄吸引溶液中分離生產水並加以利用時,若生產水中含有有機系殺菌劑,則會顯著地限制對工業用途、食品用途、飲用用途等之用途適用性。另外,為了將包含透過正滲透膜之殺菌劑的稀薄吸引溶液的一部份或全部排出至系外,必須去除稀薄吸引溶液的一部份或全部。此外,氯系殺菌劑及氧化劑等使正滲透膜,特別是聚醯胺系逆滲透膜之性能降低,因此藉由逆滲透膜再處理稀薄吸引溶液之一部份或全部時,恐有該等殺菌劑使逆滲透膜之性能降低之虞。 However, since these bactericides (chlorine-based bactericides, oxidants, organic bactericides) pass through the forward osmosis membrane, the bactericidal components of the bactericide are not fully diffused to the outlet side of the forward osmosis membrane treatment device, resulting in the inability to The problem of sufficient sterilization of forward osmosis membrane. In addition, organic fungicides in particular have an impact on organisms, the environment, etc. Especially when the production water is separated from a dilute suction solution by heating or other treatment and used, if the production water contains organic fungicides, the suitability for industrial use, food use, drinking use, etc. will be significantly limited. In addition, in order to discharge part or all of the dilute suction solution including the bactericide that has passed through the forward osmosis membrane to the outside of the system, it is necessary to remove part or all of the dilute suction solution. In addition, chlorine-based bactericides and oxidants reduce the performance of forward osmosis membranes, especially polyamide-based reverse osmosis membranes. Therefore, when part or all of the dilute suction solution is reprocessed through the reverse osmosis membrane, these may occur. Bactericides may reduce the performance of reverse osmosis membranes.
[先前技術文獻] [Prior Art Literature]
[專利文獻] [Patent Literature]
專利文獻1:國際專利申請公開2013/153587號說明書 Patent Document 1: International Patent Application Publication No. 2013/153587 Specification
專利文獻2:日本特開2017-056424號公報 Patent Document 2: Japanese Patent Application Publication No. 2017-056424
專利文獻3:日本特開2017-170275號公報 Patent document 3: Japanese Patent Publication No. 2017-170275
專利文獻4:日本特開2014-231039號公報 Patent Document 4: Japanese Patent Application Publication No. 2014-231039
專利文獻5:日本特開2015-188787號公報 Patent Document 5: Japanese Patent Application Publication No. 2015-188787
專利文獻6:日本特開2018-015684號公報 Patent Document 6: Japanese Patent Application Publication No. 2018-015684
本發明之目的在於提供一種可用低成本處理包含溶解性二氧化矽及硬度成分中之至少一者的被處理水的水處理裝置及水處理方法。 An object of the present invention is to provide a water treatment device and a water treatment method that can treat water to be treated containing at least one of soluble silica and hardness components at low cost.
此外,本發明之目的在於提供一種抑制殺菌劑透過正滲透膜且可再利用稀薄吸引溶液之正滲透膜處理方法、正滲透膜處理系統及使用該正滲透膜處理方法、正滲透膜處理系統的水處理方法、水處理系統。 In addition, the purpose of the present invention is to provide a forward osmosis membrane treatment method and a forward osmosis membrane treatment system that inhibit the passage of a bactericidal agent through a forward osmosis membrane and can reuse a dilute attracting solution, and a water treatment method and a water treatment system using the forward osmosis membrane treatment method and the forward osmosis membrane treatment system.
本發明係一種水處理裝置,其進行包含溶解性二氧化矽及硬度成分中之至少一者之被處理水的處理,且具有:前處理設備,其具有溶解性二氧化矽去除設備及硬度成分去除設備中之任一者;濃縮處理設備,其濃縮處理藉由前述前處理設備製得之前處理水;及正滲透膜處理設備,其正滲透膜處理藉由前述濃縮處理設備製得之濃縮水,前述前處理設備中使用前述正滲透膜處理設備中使用之稀薄吸引溶液。 The present invention is a water treatment device that processes water to be treated containing at least one of soluble silica and hardness components, and has: a pre-treatment device having a soluble silica removal device and a hardness component. Any of the removal equipment; the concentration treatment equipment, which concentrates the pre-treated water produced by the aforementioned pre-treatment equipment; and the forward osmosis membrane treatment equipment, whose forward osmosis membrane treats the concentrated water produced by the aforementioned concentration treatment equipment. , the thin suction solution used in the aforementioned forward osmosis membrane treatment equipment is used in the aforementioned pretreatment equipment.
較佳地,在前述水處理裝置中,前述濃縮處理設備係逆滲透膜處理設備。 Preferably, in the aforementioned water treatment device, the aforementioned concentration treatment equipment is a reverse osmosis membrane treatment equipment.
本發明係一種水處理裝置,其進行包含溶解性二氧化矽及硬度成分中之至少一者之被處理水的處理,且具有:前處理設備,其具有溶解性二氧化矽去除設備及硬度成分去除設備中之任一者;第一濃縮處理設備,其濃縮處理藉由前述前處理設備製得之前處理水;正滲透膜處理設備,其正滲透膜處理藉由前述第一濃縮處理設備製得之濃縮水;及第二濃縮處理設備,其濃縮處理前述正滲透膜處理設備中使用之稀薄吸引溶液的一部份,前述前處理設備中使用前述正滲透膜處理設備中使用之稀薄吸引溶液的一部份,且再度使用藉由前述第二濃縮處理設備濃縮之濃縮吸引溶液作為前述正滲透膜處理設備中之吸引溶液。 The present invention is a water treatment device that processes water to be treated containing at least one of soluble silica and hardness components, and has: a pre-treatment device having a soluble silica removal device and a hardness component. Any of the removal equipment; the first concentration treatment equipment, the concentration treatment of which is obtained by the aforementioned pre-treatment equipment; the forward osmosis membrane treatment equipment, whose forward osmosis membrane treatment is obtained by the aforementioned first concentration treatment equipment Concentrated water; and a second concentration treatment device that concentrates and processes a part of the dilute suction solution used in the aforementioned forward osmosis membrane treatment equipment, and the aforementioned pre-treatment equipment uses the dilute suction solution used in the aforementioned forward osmosis membrane treatment equipment. A part of the concentrated suction solution concentrated by the second concentration treatment equipment is used again as the suction solution in the forward osmosis membrane treatment equipment.
較佳地,在前述水處理裝置中,前述第二濃縮處理設備係使用半透膜之濃縮設備。 Preferably, in the aforementioned water treatment device, the aforementioned second concentration treatment equipment is a concentration equipment using a semipermeable membrane.
較佳地,在前述水處理裝置中,前述第一濃縮處理設備係逆滲透膜處理設備。 Preferably, in the aforementioned water treatment device, the aforementioned first concentration treatment equipment is a reverse osmosis membrane treatment equipment.
較佳地,在前述水處理裝置中,前述正滲透膜處理設備中使用之吸引溶液係鎂鹽水溶液,且前述溶解性二氧化矽去除設備中使用前述正滲透膜處理設備中使用之鎂鹽稀薄水溶液。 Preferably, in the aforementioned water treatment device, the draw solution used in the aforementioned forward osmosis membrane treatment device is a magnesium salt aqueous solution, and the aforementioned soluble silica removal device uses a dilute magnesium salt aqueous solution used in the aforementioned forward osmosis membrane treatment device.
較佳地,在前述水處理裝置中,更具有調製設備,該調製設備混合氫氧化鎂及酸且在pH7以下使其反應,藉此調製作為前述正滲透膜處理設備中使用之吸引溶液使用的鎂鹽水溶液。 Preferably, the water treatment device further includes a preparation device that mixes magnesium hydroxide and acid and reacts them at a pH of 7 or less, thereby preparing the suction solution used in the forward osmosis membrane treatment device. Magnesium salt solution.
較佳地,在前述水處理裝置中,前述正滲透膜處理設備中使用之吸引溶液係鹼劑水溶液,且前述硬度成分去除設備中使用前述正滲透膜處理設備中使用之鹼劑稀薄水溶液。 Preferably, in the water treatment device, the suction solution used in the forward osmosis membrane treatment equipment is an alkali aqueous solution, and the hardness component removal equipment uses a dilute alkali aqueous solution used in the forward osmosis membrane treatment equipment.
較佳地,在前述水處理裝置中,前述正滲透膜處理設備中使用之吸引溶液係酸水溶液或氯化鈉水溶液,且前述硬度成分去除設備中使用前述正滲透膜處理設備中使用之酸稀薄水溶液或氯化鈉稀薄水溶液。 Preferably, in the aforementioned water treatment device, the attracting solution used in the aforementioned forward osmosis membrane treatment equipment is an acid aqueous solution or a sodium chloride aqueous solution, and the aforementioned hardness component removal equipment uses the acid dilute aqueous solution or the sodium chloride dilute aqueous solution used in the aforementioned forward osmosis membrane treatment equipment.
此外,本發明係一種水處理方法,其進行包含溶解性二氧化矽及硬度成分中之至少一者之被處理水的處理,且包含以下步驟:前處理步驟,其包含溶解性二氧化矽去除步驟及硬度成分去除步驟中之任一者;濃縮處理步驟,濃縮處理藉由前述前處理步驟製得之前處理水;及正滲透膜處理步驟,正滲透膜處理藉由前述濃縮處理步驟製得之濃縮水,在前述前處理步驟中使用前述正滲透膜處理步驟中使用之稀薄吸引溶液。 In addition, the present invention is a water treatment method, which treats water to be treated containing at least one of soluble silica and hardness components, and includes the following steps: a pretreatment step, which includes removing soluble silica Any one of the steps and the hardness component removal step; the concentration treatment step, the concentration treatment is to obtain pre-treated water through the aforementioned pre-treatment step; and the forward osmosis membrane treatment step, the forward osmosis membrane treatment is obtained through the aforementioned concentration treatment step. Concentrated water, in the aforementioned pretreatment step, use the thin suction solution used in the aforementioned forward osmosis membrane treatment step.
較佳地,在前述水處理方法中,前述濃縮處理步驟係逆滲透膜處理步驟。 Preferably, in the aforementioned water treatment method, the aforementioned concentration treatment step is a reverse osmosis membrane treatment step.
本發明係一種水處理方法,其進行包含溶解性二氧化矽及硬度成分中之至少一者之被處理水的處理,且包含以下步驟:前處理步驟,其包含溶解性二氧化矽去除步驟及硬度成分去除步驟中之任一者;第一濃縮處理步驟,濃縮處理藉由前述前處理步驟製得之前處理水;正滲透膜處理步驟,正滲透膜處理藉由前述第一濃縮處理步驟製得之濃縮水;及第二濃縮處理步驟,濃縮處理前述正滲透膜處理步驟中使用之稀薄吸引溶液的一部份,在前述前處理步驟中使用前述正滲透膜處理步驟中使用之稀薄吸引溶液的一部份,且再度使用藉由前述第二濃縮處理步驟濃縮之濃縮吸引溶液作為前述正滲透膜處理步驟中之吸引溶液。 The present invention is a water treatment method, which treats water to be treated containing at least one of soluble silica and hardness components, and comprises the following steps: a pre-treatment step, which comprises either a soluble silica removal step or a hardness component removal step; a first concentration treatment step, in which the pre-treated water is concentrated by the pre-treatment step; a forward osmosis membrane treatment step, in which the forward osmosis membrane treatment is carried out by the pre-treatment step; The concentrated water obtained in the first concentration treatment step; and the second concentration treatment step, concentration treatment of a portion of the dilute attracting solution used in the aforementioned forward osmosis membrane treatment step, using a portion of the dilute attracting solution used in the aforementioned forward osmosis membrane treatment step in the aforementioned pre-treatment step, and reusing the concentrated attracting solution concentrated by the aforementioned second concentration treatment step as the attracting solution in the aforementioned forward osmosis membrane treatment step.
較佳地,在前述水處理方法中,前述第二濃縮處理步驟係使用半透膜之濃縮步驟。 Preferably, in the aforementioned water treatment method, the aforementioned second concentration treatment step is a concentration step using a semipermeable membrane.
較佳地,在前述水處理方法中,前述第一濃縮處理步驟係逆滲透膜處理步驟。 Preferably, in the aforementioned water treatment method, the aforementioned first concentration treatment step is a reverse osmosis membrane treatment step.
較佳地,在前述水處理方法中,前述正滲透膜處理步驟中使用之吸引溶液係鎂鹽水溶液,且在前述溶解性二氧化矽去除步驟中使用前述正滲透膜處理步驟中使用之鎂鹽稀薄水溶液。 Preferably, in the aforementioned water treatment method, the attracting solution used in the aforementioned forward osmosis membrane treatment step is an aqueous solution of a magnesium salt, and the aforementioned soluble silica removal step uses the dilute aqueous solution of a magnesium salt used in the aforementioned forward osmosis membrane treatment step.
較佳地,在前述水處理方法中,更具有調製步驟,該調製步驟混合氫氧化鎂及酸且在pH7以下使其反應,藉此調製作為前述正滲透膜處理步驟中使用之吸引溶液使用的鎂鹽水溶液。 Preferably, the aforementioned water treatment method further comprises a preparation step, wherein magnesium hydroxide and an acid are mixed and reacted at a pH below 7 to prepare an aqueous solution of magnesium salt to be used as an attracting solution in the aforementioned forward osmosis membrane treatment step.
較佳地,在前述水處理方法中,前述正滲透膜處理步驟中使用之吸引溶液係鹼劑水溶液,且在前述硬度成分去除步驟中使用前述正滲透膜處理步驟中使用之鹼劑稀薄水溶液。 Preferably, in the aforementioned water treatment method, the attracting solution used in the aforementioned forward osmosis membrane treatment step is an alkaline aqueous solution, and the aforementioned hardness component removal step uses the alkaline dilute aqueous solution used in the aforementioned forward osmosis membrane treatment step.
較佳地,在前述水處理方法中,前述正滲透膜處理步驟中使用之吸引溶液係酸水溶液或氯化鈉水溶液,且在前述硬度成分去除步驟中使用前述正滲透膜處理步驟中使用之酸稀薄水溶液或氯化鈉稀薄水溶液。 Preferably, in the aforementioned water treatment method, the suction solution used in the aforementioned forward osmosis membrane treatment step is an acid aqueous solution or a sodium chloride aqueous solution, and the acid used in the aforementioned forward osmosis membrane treatment step is used in the aforementioned hardness component removal step. Thin aqueous solution or sodium chloride solution.
本發明係一種正滲透膜處理方法,其包含:藉由透過正滲透膜使被處理水及濃度比前述被處理水高之吸引溶液接觸,製得濃縮水及稀薄吸引溶液的正滲透膜處理步驟,且使包含溴系氧化劑或氯系氧化劑及磺醯胺酸化合物之殺菌劑存在前述被處理水中。 The present invention is a forward osmosis membrane treatment method, which includes: a forward osmosis membrane treatment step of producing concentrated water and a dilute suction solution by contacting water to be treated with a suction solution having a higher concentration than the water to be treated through a forward osmosis membrane. , and a bactericide containing a bromine-based oxidizing agent or a chlorine-based oxidizing agent and a sulfonamide compound is allowed to exist in the aforementioned water to be treated.
本發明係一種正滲透膜處理方法,其包含:藉由透過正滲透膜使被處理水及濃度比前述被處理水高之吸引溶液接觸,製得濃縮水及稀薄吸引溶液的正滲透膜處理步驟,且使包含溴系氧化劑及磺醯胺酸化合物之殺菌劑存在前述被處理水中。 The present invention is a forward osmosis membrane treatment method, which includes: a forward osmosis membrane treatment step of producing concentrated water and a dilute suction solution by contacting water to be treated with a suction solution having a higher concentration than the water to be treated through a forward osmosis membrane. , and a bactericide containing a brominated oxidizing agent and a sulfonamide compound is allowed to exist in the aforementioned water to be treated.
本發明係一種正滲透膜處理方法,其包含:藉由透過正滲透膜使被處理水及濃度比前述被處理水高之吸引溶液接觸,製得濃縮水及稀薄吸引溶液的正滲透膜處理步驟,且使包含溴及磺醯胺酸化合物之殺菌劑存在前述被處理水中。 The present invention is a forward osmosis membrane treatment method, which includes: a forward osmosis membrane treatment step of producing concentrated water and a dilute suction solution by contacting water to be treated with a suction solution having a higher concentration than the water to be treated through a forward osmosis membrane. , and a bactericide containing bromine and a sulfonamide compound is allowed to exist in the aforementioned water to be treated.
本發明係一種水處理方法,其包含前述正滲透膜處理方法,且在前述正滲透膜處理步驟之前段中包含前處理步驟及逆滲透膜處理步驟,並且在前述前處理步驟中使用藉由前述正滲透膜處理步驟製得之稀薄吸引溶液。 The present invention is a water treatment method, which includes the aforementioned forward osmosis membrane treatment method, and includes a pre-treatment step and a reverse osmosis membrane treatment step in the preceding stage of the aforementioned forward osmosis membrane treatment step, and the dilute attracting solution obtained by the aforementioned forward osmosis membrane treatment step is used in the aforementioned pre-treatment step.
本發明係一種正滲透膜處理系統,其具有:藉由透過正滲透膜使被處理水及濃度比前述被處理水高之吸引溶液接觸,製得濃縮水及稀薄吸引溶液的正滲透膜處理設備,且使包含溴系氧化劑或氯系氧化劑及磺醯胺酸化合物之殺菌劑存在前述被處理水中。 The present invention is a forward osmosis membrane treatment system, which has: forward osmosis membrane treatment equipment that makes concentrated water and a dilute suction solution by contacting water to be treated with a suction solution having a higher concentration than the water to be treated through a forward osmosis membrane. , and a bactericide containing a bromine-based oxidizing agent or a chlorine-based oxidizing agent and a sulfonamide compound is allowed to exist in the aforementioned water to be treated.
本發明係一種正滲透膜處理系統,其具有:藉由透過正滲透膜使被處理水及濃度比前述被處理水高之吸引溶液接觸,製得濃縮水及稀薄吸引溶液的正滲透膜處理設備,且使包含溴系氧化劑及磺醯胺酸化合物之殺菌劑存在前述被處理水中。 The present invention is a forward osmosis membrane treatment system, which has: forward osmosis membrane treatment equipment that makes concentrated water and a dilute suction solution by contacting water to be treated with a suction solution having a higher concentration than the water to be treated through a forward osmosis membrane. , and a bactericide containing a brominated oxidizing agent and a sulfonamide compound is allowed to exist in the aforementioned water to be treated.
本發明係一種正滲透膜處理系統,其具有:藉由透過正滲透膜使被處理水及濃度比前述被處理水高之吸引溶液接觸,製得濃縮水及稀薄吸引溶液的正滲透膜處理設備,且使包含溴及磺醯胺酸化合物之殺菌劑存在前述被處理水中。 The present invention is a forward osmosis membrane treatment system, which has: forward osmosis membrane treatment equipment that makes concentrated water and a dilute suction solution by contacting water to be treated with a suction solution having a higher concentration than the water to be treated through a forward osmosis membrane. , and a bactericide containing bromine and a sulfonamide compound is allowed to exist in the aforementioned water to be treated.
本發明係一種水處理系統,其具有前述正滲透膜處理系統,且在前述正滲透膜處理設備之前段中具有前處理設備及逆滲透膜處理設備,並且前述前處理設備中使用藉由前述正滲透膜處理設備製得之稀薄吸引溶液。 The present invention is a water treatment system, which has the aforementioned forward osmosis membrane treatment system, and has a pre-treatment device and a reverse osmosis membrane treatment device in the front section of the aforementioned forward osmosis membrane treatment device, and the aforementioned pre-treatment device uses a dilute suction solution prepared by the aforementioned forward osmosis membrane treatment device.
藉由本發明,可用低成本處理包含溶解性二氧化矽及硬度成分中之至少一者的被處理水。 According to the present invention, water to be treated containing at least one of soluble silica and hardness components can be treated at low cost.
此外,藉由本發明,可提供抑制殺菌劑透過正滲透膜且可再利用稀薄吸引溶液之正滲透膜處理方法、正滲透膜處理系統及使用該正滲透膜處理方法、正滲透膜處理系統的水處理方法、水處理系統。 In addition, the present invention can provide a forward osmosis membrane treatment method, a forward osmosis membrane treatment system that inhibits the penetration of a bactericide through a forward osmosis membrane and can reuse a dilute suction solution, and water using the forward osmosis membrane treatment method and forward osmosis membrane treatment system. Treatment methods, water treatment systems.
1,3,5,7:水處理裝置 1,3,5,7:Water treatment device
8:正滲透膜處理系統 8: Forward osmosis membrane treatment system
9:水處理系統 9:Water treatment system
10,114:前處理裝置 10,114: Pre-processing device
12,118:逆滲透膜處理裝置 12,118:Reverse osmosis membrane treatment device
14:滲透膜處理裝置 14:Permeable membrane treatment device
16,120:被處理水配管 16,120: Treated water piping
18:前處理水配管 18: Pre-treatment water piping
20:濃縮水配管 20:Concentrated water piping
22:透過水配管 22: Through water piping
24,32:吸引溶液配管 24,32:Suction solution piping
26,36:稀薄吸引溶液配管 26,36: Thin suction solution piping
28:FO濃縮水配管 28:FO concentrated water piping
30:吸引溶液調製槽 30: Suction solution preparation tank
34,340,342,344,346,348,350:濃縮裝置 34,340,342,344,346,348,350: Concentrator
38:濃縮吸引溶液配管 38: Piping for concentrated suction solution
40:稀釋液配管 40: diluent piping
42,78:第一段半透膜處理裝置 42,78: The first section of semi-permeable membrane treatment device
44,80:第二段半透膜處理裝置 44,80: Second stage semipermeable membrane treatment device
46,82:第三段半透膜處理裝置 46,82: The third semipermeable membrane treatment device
48,84:一次側(第一空間) 48,84: First side (first space)
50,86:二次側(第二空間) 50,86: Secondary side (second space)
52,88:半透膜 52,88: Semipermeable membrane
54,56,58,60,62,64,66,68,90,92,94,96,98,100,102,104,122,124:配管 54,56,58,60,62,64,66,68,90,92,94,96,98,100,102,104,122,124:Piping
70,72,74,106:泵 70,72,74,106: Pump
110:正滲透膜 110:Forward osmosis membrane
112:殺菌劑添加配管 112: Disinfectant adding piping
116:濁質去除裝置 116: Fouling removal device
126:RO透過水配管 126:RO through water piping
128:逆洗排水配管 128: Backwash drainage piping
[圖1]係顯示本發明實施形態之一水處理裝置例的概略結構圖。 [Figure 1] is a schematic structural diagram showing an example of a water treatment device in one embodiment of the present invention.
[圖2]係顯示本發明實施形態之另一水處理裝置例的概略結構圖。 [Fig. 2] is a schematic structural diagram showing another example of a water treatment device according to an embodiment of the present invention.
[圖3]係顯示本發明實施形態之另一水處理裝置例的概略結構圖。 [Figure 3] is a schematic structural diagram showing another example of a water treatment device according to the embodiment of the present invention.
[圖4]係顯示本發明實施形態之水處理裝置的一濃縮裝置例的概略結構圖。 [Fig. 4] is a schematic structural diagram showing an example of a concentration device of the water treatment device according to the embodiment of the present invention.
[圖5]係顯示本發明實施形態之水處理裝置的另一濃縮裝置例的概略結構圖。 [Figure 5] is a schematic structural diagram showing another example of a concentration device of a water treatment device in an embodiment of the present invention.
[圖6]係顯示本發明實施形態之水處理裝置的另一濃縮裝置例的概略結構圖。 [Fig. 6] is a schematic structural diagram showing another example of a concentration device of the water treatment device according to the embodiment of the present invention.
[圖7]係顯示本發明實施形態之水處理裝置的另一濃縮裝置例的概略結構圖。 [Fig. 7] is a schematic structural diagram showing another example of a concentration device of the water treatment device according to the embodiment of the present invention.
[圖8]係顯示本發明實施形態之水處理裝置的另一濃縮裝置例的概略結構圖。 [Fig. 8] is a schematic structural diagram showing another example of the concentration device of the water treatment device according to the embodiment of the present invention.
[圖9]係顯示本發明實施形態之水處理裝置的另一濃縮裝置例的概略結構圖。 [Fig. 9] is a schematic structural diagram showing another example of the concentration device of the water treatment device according to the embodiment of the present invention.
[圖10]係顯示習知水處理裝置的概略結構圖。 [Figure 10] is a schematic diagram showing the structure of a conventional water treatment device.
[圖11]係顯示本發明實施形態之一正滲透膜處理系統例的概略結構圖。 [Fig. 11] is a schematic structural diagram showing an example of a forward osmosis membrane treatment system according to an embodiment of the present invention.
[圖12]係顯示本發明實施形態之一水處理系統例的概略結構圖。 [Figure 12] is a schematic diagram showing an example of a water treatment system in one embodiment of the present invention.
以下說明本發明之實施形態。本實施形態係實施本發明之一例,且本發明不限於本實施形態。 Embodiments of the present invention will be described below. This embodiment is an example of implementing the present invention, and the present invention is not limited to this embodiment.
以下在圖1中顯示本發明實施形態之一水處理裝置例的概略,且說明其結構。 The following is a schematic diagram of an example of a water treatment device in accordance with an embodiment of the present invention shown in FIG1, and its structure is described.
水處理裝置1具有:前處理裝置10,其作為具有溶解性二氧化矽去除設備及硬度成分去除設備中之至少一者的前處理設備;逆滲透膜處理裝置12,其作為濃縮處理藉由前處理裝置10製得之前處理水的濃縮處理設備;及正滲透膜處理 裝置14,其作為正滲透膜處理藉由逆滲透膜處理裝置12製得之濃縮水的正滲透膜處理設備。 The water treatment device 1 comprises: a pre-treatment device 10, which is a pre-treatment device having at least one of a soluble silica removal device and a hardness component removal device; a reverse osmosis membrane treatment device 12, which is a concentration treatment device for concentrating the previously treated water obtained by the pre-treatment device 10; and a forward osmosis membrane treatment device 14, which is a forward osmosis membrane treatment device for forward osmosis membrane treatment of the concentrated water obtained by the reverse osmosis membrane treatment device 12.
圖1之水處理裝置1中,被處理水配管16連接於前處理裝置10之被處理水入口,且前處理裝置10之出口及逆滲透膜處理裝置12之入口藉由前處理水配管18連接。逆滲透膜處理裝置12之濃縮水出口及正滲透膜處理裝置14之濃縮水入口藉由濃縮水配管20連接,且透過水配管22連接於逆滲透膜處理裝置12之透過水出口。吸引溶液配管24連接於正滲透膜處理裝置14之吸引溶液入口,且正滲透膜處理裝置14之稀薄吸引溶液出口及前處理裝置10之稀薄吸引溶液入口藉由稀薄吸引溶液配管26連接,並且FO濃縮水配管28連接於正滲透膜處理裝置14之FO濃縮水出口。 In the water treatment device 1 of FIG. 1 , the treated water pipe 16 is connected to the treated water inlet of the pre-treatment device 10, and the outlet of the pre-treatment device 10 and the inlet of the reverse osmosis membrane treatment device 12 are connected by the pre-treatment water pipe 18. The concentrated water outlet of the reverse osmosis membrane treatment device 12 and the concentrated water inlet of the forward osmosis membrane treatment device 14 are connected by the concentrated water pipe 20, and the permeated water pipe 22 is connected to the permeated water outlet of the reverse osmosis membrane treatment device 12. The suction solution piping 24 is connected to the suction solution inlet of the forward osmosis membrane treatment device 14, and the dilute suction solution outlet of the forward osmosis membrane treatment device 14 and the dilute suction solution inlet of the pre-treatment device 10 are connected via the dilute suction solution piping 26, and the FO concentrated water piping 28 is connected to the FO concentrated water outlet of the forward osmosis membrane treatment device 14.
以下說明本實施形態之水處理方法及水處理裝置1的動作。 The following describes the water treatment method and the operation of the water treatment device 1 of this embodiment.
包含溶解性二氧化矽及硬度成分中之至少一者的被處理水通過被處理水配管16輸送至前處理裝置10。在前處理裝置10中,進行溶解性二氧化矽及硬度成分中之至少一者的去除處理(前處理步驟)。 The treated water containing at least one of soluble silica and hardness components is transported to the pre-treatment device 10 through the treated water pipe 16. In the pre-treatment device 10, at least one of the soluble silica and hardness components is removed (pre-treatment step).
被處理水包含溶解性二氧化矽時,前處理裝置10具有:鎂反應設備,其將鎂鹽添加至被處理水中使其反應,使溶解性二氧化矽不溶化;凝集處理設備,其將凝集劑添加至反應後之被處理水中使其凝集;及固液分離設備,其由凝集處理後之被處理水分離凝集物。前處理裝置10中,在例如鹼條件(例如,pH10 至12)下將鎂鹽添加至被處理水中,使溶解性二氧化矽不溶化(鎂反應步驟)。然後,依需要添加凝集劑以進行凝集處理(凝集處理步驟),使凝集物固液分離(固液分離步驟)。接著將藉由固液分離製得之前處理水通過前處理水配管18輸送至逆滲透膜處理裝置12。 When the water to be treated contains soluble silica, the pretreatment device 10 includes: a magnesium reaction device that adds a magnesium salt to the water to be treated and reacts it to insolubilize the soluble silica; and a coagulation treatment device that adds a coagulant to the water to be treated. Adding to the treated water after the reaction to cause agglomeration; and a solid-liquid separation device that separates the agglomerate from the treated water after the agglutination treatment. In the pretreatment device 10, for example, under alkaline conditions (for example, pH 10 Add magnesium salt to the water to be treated under 12) to insolubilize the soluble silica (magnesium reaction step). Then, if necessary, a coagulant is added to perform aggregation treatment (aggregation treatment step), and the aggregated product is solid-liquid separated (solid-liquid separation step). Then, the pre-treated water produced by solid-liquid separation is transported to the reverse osmosis membrane treatment device 12 through the pre-treated water pipe 18 .
被處理水包含硬度成分,且藉由石灰軟化法進行硬度成分之去除時,前處理裝置10具有例如:鹼劑反應設備,其將鹼劑添加至被處理水中使其反應,使硬度成分不溶化;凝集處理設備,其依需要將凝集劑添加至反應後之被處理水中使其凝集;及固液分離設備,其由凝集處理後之被處理水分離凝集物。前處理裝置10中,例如將鹼劑添加至被處理水中,使硬度成分不溶化(鹼劑反應步驟)。然後,添加凝集劑以進行凝集處理(凝集處理步驟),使凝集物固液分離(固液分離步驟)。接著將藉由固液分離製得之前處理水通過前處理水配管18輸送至逆滲透膜處理裝置12。 When the water to be treated contains a hardness component and the hardness component is removed by lime softening, the pretreatment device 10 has, for example: an alkali reaction device, which adds an alkali agent to the water to be treated to react and insolubilize the hardness component; A coagulation treatment equipment, which adds a coagulant to the water to be treated after the reaction to agglomerate it as necessary; and a solid-liquid separation equipment, which separates agglomerates from the water to be treated after the coagulation treatment. In the pretreatment device 10, for example, an alkaline agent is added to the water to be treated to insolubilize the hardness component (alkali agent reaction step). Then, a coagulant is added to perform aggregation treatment (aggregation treatment step), and the aggregate is solid-liquid separated (solid-liquid separation step). Then, the pre-treated water produced by solid-liquid separation is transported to the reverse osmosis membrane treatment device 12 through the pre-treated water pipe 18 .
被處理水包含硬度成分,且藉由樹脂軟化法進行硬度成分之去除時,前處理裝置10具有例如使用離子交換樹脂等進行離子交換處理之離子交換處理設備。前處理裝置10中,例如將被處理水通至填充離子交換樹脂作為離子交換處理設備之離子交換塔,並吸附去除硬度成分(離子交換步驟)。接著將藉由離子交換處理製得之前處理水通過前處理水配管18輸送至逆滲透膜處理裝置12。離子交換樹脂需要再生時,藉由通過再生劑再生離子交換樹脂。 When the water to be treated contains a hardness component and the hardness component is removed by a resin softening method, the pretreatment device 10 has, for example, an ion exchange treatment device that performs ion exchange treatment using an ion exchange resin or the like. In the pretreatment device 10, for example, the water to be treated is passed to an ion exchange tower filled with ion exchange resin as an ion exchange treatment device, and the hardness component is adsorbed and removed (ion exchange step). Then, the pre-treated water produced by the ion exchange treatment is transported to the reverse osmosis membrane treatment device 12 through the pre-treated water pipe 18 . When the ion exchange resin needs to be regenerated, the ion exchange resin is regenerated by using a regenerant.
接著,在逆滲透膜處理裝置12中濃縮處理藉由前處理步驟製得之前處理水(濃縮處理步驟)。藉由逆滲透膜處理製得之濃縮水通過濃縮水配管20輸送至正滲透膜處理裝置14,且透過水通過透過水配管22排出。 Next, the pre-treatment step is concentrated in the reverse osmosis membrane treatment device 12 to obtain pre-treated water (concentration treatment step). The concentrated water obtained by the reverse osmosis membrane treatment is transported to the forward osmosis membrane treatment device 14 through the concentrated water pipe 20, and the permeated water is discharged through the permeated water pipe 22.
在正滲透膜處理裝置14中正滲透膜處理藉由逆滲透膜處理製得之濃縮水(正滲透膜處理步驟)。在正滲透膜處理裝置14中,吸引溶液通過吸引溶液配管24輸送至正滲透膜之二次側,接著透過正滲透膜,使濃縮水及吸引溶液存在,藉此利用滲透壓使水移動至吸引溶液。 In the forward osmosis membrane treatment device 14, the forward osmosis membrane processes the concentrated water produced by the reverse osmosis membrane treatment (forward osmosis membrane treatment step). In the forward osmosis membrane treatment device 14, the suction solution is transported to the secondary side of the forward osmosis membrane through the suction solution pipe 24, and then passes through the forward osmosis membrane to allow concentrated water and the suction solution to exist, thereby moving the water to the suction side using osmotic pressure. solution.
正滲透膜處理步驟中使用之稀薄吸引溶液通過稀薄吸引溶液配管26輸送至前處理裝置10,並在前處理裝置10中在前處理步驟中使用。接著通過FO濃縮水配管28排出藉由正滲透膜處理步驟製得之FO濃縮水。FO濃縮水可回收、再利用。 The dilute suction solution used in the forward osmosis membrane treatment step is transported to the pretreatment device 10 through the dilute suction solution pipe 26, and is used in the pretreatment device 10 in the pretreatment step. Then, the FO concentrated water produced by the forward osmosis membrane treatment step is discharged through the FO concentrated water pipe 28. FO concentrated water can be recycled and reused.
前處理裝置10包含進行溶解性二氧化矽去除之裝置時,例如,可使用鎂鹽水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(鎂鹽稀薄水溶液)可作為在前處理裝置10中添加之鎂鹽使用。 When the pretreatment device 10 includes a device for removing soluble silica, for example, a magnesium salt aqueous solution can be used as the suction solution in the forward osmosis membrane treatment device 14, and the dilute suction solution (magnesium) used in the forward osmosis membrane treatment device 14 Salt dilute aqueous solution) can be used as the magnesium salt added in the pretreatment device 10.
前處理裝置10包含藉由石灰軟化法進行硬度成分之去除的裝置時,可使用例如鹼劑水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(鹼劑稀薄水溶液)可作為在前處理裝置10中添加之鹼劑使用。 When the pretreatment device 10 includes a device for removing hardness components by lime softening, an alkaline aqueous solution, for example, can be used as the draw solution in the forward osmosis membrane treatment device 14, and the dilute draw solution (alkaline dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be used as the alkali added to the pretreatment device 10.
前處理裝置10包含藉由樹脂軟化法進行硬度成分之去除的裝置時,例如,可使用酸水溶液或氯化鈉水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(酸稀薄水溶液或氯化鈉稀薄水溶液)可在前處理裝置10中作為離子交換樹脂之再生劑使用。 When the pretreatment device 10 includes a device for removing hardness components by a resin softening method, for example, an acid aqueous solution or a sodium chloride aqueous solution can be used as the suction solution in the forward osmosis membrane treatment device 14, and the forward osmosis membrane treatment device 14 The dilute suction solution (a dilute aqueous acid solution or a dilute sodium chloride aqueous solution) used can be used as a regeneration agent for the ion exchange resin in the pretreatment device 10 .
藉由本實施形態之水處理方法及水處理裝置,可用低成本處理包含溶解性二氧化矽及硬度成分中之至少一者的被處理水。 With the water treatment method and water treatment device of this embodiment, water to be treated containing at least one of soluble silica and hardness components can be treated at low cost.
因為在前處理步驟中使用藉由正滲透膜處理稀釋之稀薄吸引溶液,所以可減少本來需要之再利用吸引溶液的必要成本且不需要再生設備。因為稀薄吸引溶液只是稀釋前處理步驟中本來使用之吸引溶液,所以幾乎不產生追加之成本。 Since the dilute suction solution diluted by the positive osmosis membrane treatment is used in the pre-treatment step, the necessary cost of reusing the suction solution that is originally required can be reduced and no regeneration equipment is required. Since the dilute suction solution is only used to dilute the suction solution originally used in the pre-treatment step, there is almost no additional cost.
以下在圖3中顯示本發明實施形態之另一水處理裝置例的概略,且說明其結構。 FIG3 shows an overview of another water treatment device according to the present invention and explains its structure.
水處理裝置5具有:前處理裝置10,其作為具有溶解性二氧化矽去除設備及硬度成分去除設備中之至少一者的前處理設備;逆滲透膜處理裝置12,其作為濃縮處理藉由前處理裝置10製得之前處理水的第一濃縮處理設備;正滲透膜處理裝置14,其作為正滲透膜處理藉由逆滲透膜處理裝置12製得之濃縮水的正滲透膜處理設備;及濃縮裝置34,其作為濃縮處理正滲透膜處理裝置14使用之稀薄吸引溶液之一部份的第二濃縮處理設備。 The water treatment device 5 has: a pretreatment device 10 as a pretreatment device having at least one of a soluble silica removal device and a hardness component removal device; and a reverse osmosis membrane treatment device 12 as a concentration treatment by pretreatment. The treatment device 10 produces a first concentration treatment device for previously treated water; a forward osmosis membrane treatment device 14, which serves as a forward osmosis membrane treatment device for treating concentrated water produced by the reverse osmosis membrane treatment device 12; and concentration Device 34 is a second concentration treatment device that serves as a part of the dilute suction solution used by the forward osmosis membrane treatment device 14 for concentration treatment.
圖3之水處理裝置5中,被處理水配管16連接於前處理裝置10之被處理水入口,且前處理裝置10之出口及逆滲透膜處理裝置12之入口藉由前處理水配管18連接。逆滲透膜處理裝置12之濃縮水出口及正滲透膜處理裝置14之濃縮水入口藉由濃縮水配管20連接,且透過水配管22連接於逆滲透膜處理裝置12之透過水出口。吸引溶液配管24連接於正滲透膜處理裝置14之吸引溶液入口,且正滲透膜處理裝置14之稀薄吸引溶液出口及前處理裝置10之稀薄吸引溶液入口藉由稀薄吸引溶液配管26連接,並且FO濃縮水配管28連接於正滲透膜處理裝置14之FO濃縮水出口。由稀薄吸引溶液配管26分歧之稀薄吸引溶液配管36連接於濃縮裝置34之入口,且濃縮裝置34之濃縮吸引溶液出口與吸引溶液配管24之中途藉由濃縮吸引溶液配管38連接。稀釋液配管40連接於濃縮裝置34之稀釋液出口。 In the water treatment device 5 of Figure 3 , the treated water pipe 16 is connected to the treated water inlet of the pre-treatment device 10 , and the outlet of the pre-treatment device 10 and the inlet of the reverse osmosis membrane treatment device 12 are connected by the pre-treated water pipe 18 . The concentrated water outlet of the reverse osmosis membrane treatment device 12 and the concentrated water inlet of the forward osmosis membrane treatment device 14 are connected by a concentrated water pipe 20 , and the permeated water pipe 22 is connected to the permeated water outlet of the reverse osmosis membrane treatment device 12 . The suction solution pipe 24 is connected to the suction solution inlet of the forward osmosis membrane treatment device 14, and the dilute suction solution outlet of the forward osmosis membrane treatment device 14 and the dilute suction solution inlet of the pretreatment device 10 are connected by the dilute suction solution pipe 26, and FO The concentrated water pipe 28 is connected to the FO concentrated water outlet of the forward osmosis membrane treatment device 14 . The thin suction solution pipe 36 branched from the thin suction solution pipe 26 is connected to the inlet of the concentration device 34 , and the concentrated suction solution outlet of the concentration device 34 and the suction solution pipe 24 are connected by the concentrated suction solution pipe 38 . The diluent pipe 40 is connected to the diluent outlet of the concentration device 34 .
以下說明本實施形態之水處理方法及水處理裝置5的動作。 The following describes the water treatment method and the operation of the water treatment device 5 of this embodiment.
包含溶解性二氧化矽及硬度成分中之至少一者的被處理水通過被處理水配管16輸送至前處理裝置10。在前處理裝置10中,進行溶解性二氧化矽及硬度成分中之至少一者的去除處理(前處理步驟)。 The water to be treated containing at least one of soluble silica and hardness components is transported to the pretreatment device 10 through the water to be treated pipe 16 . In the pretreatment device 10, at least one of soluble silica and hardness components is removed (pretreatment step).
被處理水包含溶解性二氧化矽時,前處理裝置10具有例如:鎂反應設備,其將鎂鹽添加至被處理水中使其反應,使溶解性二氧化矽不溶化;凝集處理設備,其將凝集劑添加至反應後之被處理水中使其凝集;及固液分離設備,其由凝集處理後之被處理水分離凝集物。前處理裝置10中,在例如鹼條件(例如,pH10 至12)下將鎂鹽添加至被處理水中,使溶解性二氧化矽不溶化(鎂反應步驟)。然後,依需要添加凝集劑以進行凝集處理(凝集處理步驟),使凝集物固液分離(固液分離步驟)。接著將藉由固液分離製得之前處理水通過前處理水配管18輸送至逆滲透膜處理裝置12。 When the treated water contains soluble silica, the pre-treatment device 10 has, for example, a magnesium reaction device, which adds magnesium salt to the treated water to react and insolubilize the soluble silica; a coagulation treatment device, which adds a coagulant to the treated water after the reaction to coagulate it; and a solid-liquid separation device, which separates the coagulant from the treated water after the coagulation treatment. In the pre-treatment device 10, magnesium salt is added to the treated water under alkaline conditions (e.g., pH 10 to 12) to insolubilize the soluble silica (magnesium reaction step). Then, a coagulant is added as needed to perform coagulation treatment (coagulation treatment step) to separate the coagulant into solid and liquid (solid-liquid separation step). Then, the pre-treated water obtained by solid-liquid separation is transported to the reverse osmosis membrane treatment device 12 through the pre-treated water pipe 18.
被處理水包含硬度成分,且藉由石灰軟化法進行硬度成分之去除時,前處理裝置10具有例如:鹼劑反應設備,其將鹼劑添加至被處理水中使其反應,使硬度成分不溶化;凝集處理設備,其依需要將凝集劑添加至反應後之被處理水中使其凝集;及固液分離設備,其由凝集處理後之被處理水分離凝集物。前處理裝置10中,例如將鹼劑添加至被處理水中,使硬度成分不溶化(鹼劑反應步驟)。然後,添加凝集劑以進行凝集處理(凝集處理步驟),使凝集物固液分離(固液分離步驟)。接著將藉由固液分離製得之前處理水通過前處理水配管18輸送至逆滲透膜處理裝置12。 When the water to be treated contains a hardness component and the hardness component is removed by lime softening, the pretreatment device 10 has, for example: an alkali reaction device, which adds an alkali agent to the water to be treated to react and insolubilize the hardness component; A coagulation treatment equipment, which adds a coagulant to the water to be treated after the reaction to agglomerate it as necessary; and a solid-liquid separation equipment, which separates agglomerates from the water to be treated after the coagulation treatment. In the pretreatment device 10, for example, an alkaline agent is added to the water to be treated to insolubilize the hardness component (alkali agent reaction step). Then, a coagulant is added to perform aggregation treatment (aggregation treatment step), and the aggregate is solid-liquid separated (solid-liquid separation step). Then, the pre-treated water produced by solid-liquid separation is transported to the reverse osmosis membrane treatment device 12 through the pre-treated water pipe 18 .
被處理水包含硬度成分,且藉由樹脂軟化法進行硬度成分之去除時,前處理裝置10具有例如使用離子交換樹脂等進行離子交換處理之離子交換處理設備。前處理裝置10中,例如將被處理水通至填充離子交換樹脂作為離子交換處理設備之離子交換塔,並吸附去除硬度成分(離子交換步驟)。接著將藉由離子交換處理製得之前處理水通過前處理水配管18輸送至逆滲透膜處理裝置12。離子交換樹脂需要再生時,藉由通過再生劑再生離子交換樹脂。 When the water to be treated contains hardness components and the hardness components are removed by a resin softening method, the pre-treatment device 10 has an ion exchange treatment device for ion exchange treatment using, for example, an ion exchange resin. In the pre-treatment device 10, for example, the water to be treated is passed to an ion exchange tower filled with an ion exchange resin as an ion exchange treatment device, and the hardness components are removed by adsorption (ion exchange step). The pre-treated water obtained by the ion exchange treatment is then transported to the reverse osmosis membrane treatment device 12 through the pre-treatment water pipe 18. When the ion exchange resin needs to be regenerated, the ion exchange resin is regenerated by passing a regeneration agent.
接著,在逆滲透膜處理裝置12中濃縮處理藉由前處理步驟製得之前處理水(第一濃縮處理步驟)。藉由第一濃縮處理(逆滲透膜處理)製得之濃縮水(RO濃縮水)通過濃縮水配管20輸送至正滲透膜處理裝置14,接著通過透過水配管22排出透過水(RO透過水)。 Next, a concentration process is performed in the reverse osmosis membrane treatment device 12 to obtain pre-treated water through a pre-treatment step (first concentration process step). The concentrated water (RO concentrated water) produced by the first concentration treatment (reverse osmosis membrane treatment) is transported to the forward osmosis membrane treatment device 14 through the concentrated water pipe 20, and then the permeated water (RO permeated water) is discharged through the permeated water pipe 22. .
在正滲透膜處理裝置14中正滲透膜處理藉由第一濃縮處理(逆滲透膜處理)製得之濃縮水(正滲透膜處理步驟)。在正滲透膜處理裝置14中,吸引溶液通過吸引溶液配管24輸送至正滲透膜之二次側,接著透過正滲透膜,使濃縮水及吸引溶液存在,藉此利用滲透壓使水移動至吸引溶液。 In the forward osmosis membrane treatment device 14, the concentrated water obtained by the first concentration treatment (reverse osmosis membrane treatment) is treated by the forward osmosis membrane (forward osmosis membrane treatment step). In the forward osmosis membrane treatment device 14, the draw solution is transported to the secondary side of the forward osmosis membrane through the draw solution piping 24, and then passes through the forward osmosis membrane, so that the concentrated water and the draw solution exist, thereby using the osmotic pressure to move the water to the draw solution.
正滲透膜處理步驟中使用之稀薄吸引溶液的一部份通過稀薄吸引溶液配管26輸送至前處理裝置10,接著在前處理裝置10中在前處理步驟中使用。藉由正滲透膜處理步驟製得之FO濃縮水通過FO濃縮水配管28排出。FO濃縮水亦可依需要藉由濃縮裝置及結晶裝置等進一步濃縮、固形化處理。 A portion of the dilute draw solution used in the forward osmosis membrane treatment step is transported to the pre-treatment device 10 through the dilute draw solution piping 26, and then used in the pre-treatment step in the pre-treatment device 10. The FO concentrated water obtained by the forward osmosis membrane treatment step is discharged through the FO concentrated water piping 28. The FO concentrated water can also be further concentrated and solidified by a concentration device and a crystallization device as needed.
正滲透膜處理步驟中使用之稀薄吸引溶液的一部份由稀薄吸引溶液配管26分歧並通過稀薄吸引溶液配管36輸送至濃縮裝置34,接著在濃縮裝置34中濃縮處理(第二濃縮處理步驟)。藉由第二濃縮處理製得之濃縮吸引溶液通過濃縮吸引溶液配管38供給至吸引溶液配管24之中途,接著作為正滲透膜處理裝置14中之吸引溶液再度使用。藉由第二濃縮處理製得之稀釋液通過稀釋液配管40排出。稀釋液亦可依需要實施超過濾膜(UF膜)處理、逆滲透膜(RO膜)處理、離子交換處理等後,回收、再利用。 A part of the dilute suction solution used in the forward osmosis membrane treatment step is branched from the dilute suction solution pipe 26 and transported to the concentration device 34 through the dilute suction solution pipe 36, and is then concentrated in the concentration device 34 (second concentration step) . The concentrated suction solution obtained by the second concentration treatment is supplied to the middle of the suction solution pipe 24 through the concentrated suction solution pipe 38, and is then reused as the suction solution in the forward osmosis membrane treatment device 14. The diluted liquid obtained by the second concentration process is discharged through the diluent pipe 40 . The diluted liquid can also be recycled and reused after ultrafiltration membrane (UF membrane) treatment, reverse osmosis membrane (RO membrane) treatment, ion exchange treatment, etc. as needed.
前處理裝置10包含進行溶解性二氧化矽去除之裝置時,例如,可使用鎂鹽水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(鎂鹽稀薄水溶液)的一部份可作為在前處理裝置10中添加之鎂鹽使用。此外,正滲透膜處理裝置14中使用之稀薄吸引溶液(鎂鹽稀薄水溶液)的一部份可在濃縮裝置34中濃縮處理並作為正滲透膜處理裝置14中之吸引溶液再度使用。 When the pretreatment device 10 includes a device for removing soluble silica, for example, a magnesium salt aqueous solution can be used as the suction solution in the forward osmosis membrane treatment device 14, and the dilute suction solution (magnesium) used in the forward osmosis membrane treatment device 14 A part of the salt dilute aqueous solution) can be used as the magnesium salt added to the pretreatment device 10. In addition, part of the dilute suction solution (magnesium salt dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be concentrated in the concentration device 34 and reused as the suction solution in the forward osmosis membrane treatment device 14 .
前處理裝置10包含藉由石灰軟化法進行硬度成分之去除的裝置時,可使用例如鹼劑水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(鹼劑稀薄水溶液)的一部份可作為在前處理裝置10中添加之鹼劑使用。此外,正滲透膜處理裝置14中使用之稀薄吸引溶液(鹼劑稀薄水溶液)的一部份可在濃縮裝置34中濃縮處理並作為正滲透膜處理裝置14中之吸引溶液再度使用。 When the pretreatment device 10 includes a device for removing hardness components by lime softening, an alkaline aqueous solution, for example, can be used as the draw solution in the forward osmosis membrane treatment device 14, and a portion of the dilute draw solution (alkaline dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be used as the alkali added to the pretreatment device 10. In addition, a portion of the dilute draw solution (alkaline dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be concentrated in the concentration device 34 and reused as the draw solution in the forward osmosis membrane treatment device 14.
前處理裝置10包含藉由樹脂軟化法進行硬度成分之去除的裝置時,例如,可使用酸水溶液或氯化鈉水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(酸稀薄水溶液或氯化鈉稀薄水溶液)的一部份可在前處理裝置10中作為離子交換樹脂之再生劑使用。此外,正滲透膜處理裝置14中使用之稀薄吸引溶液(酸稀薄水溶液或氯化鈉稀薄水溶液)的一部份可在濃縮裝置34中濃縮處理並作為正滲透膜處理裝置14中之吸引溶液再度使用。 When the pretreatment device 10 includes a device for removing hardness components by a resin softening method, for example, an acid aqueous solution or a sodium chloride aqueous solution can be used as an attracting solution in the forward osmosis membrane treatment device 14, and a portion of the dilute attracting solution (acid dilute aqueous solution or sodium chloride dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be used as a regeneration agent for the ion exchange resin in the pretreatment device 10. In addition, a portion of the dilute attracting solution (acid dilute aqueous solution or sodium chloride dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be concentrated in the concentration device 34 and reused as the attracting solution in the forward osmosis membrane treatment device 14.
藉由本實施形態之水處理方法及水處理裝置,可用低成本處理包含溶解性二氧化矽及硬度成分中之至少一者的被處理水。 By using the water treatment method and water treatment device of this embodiment, water to be treated containing at least one of soluble silica and hardness components can be treated at low cost.
因為在前處理步驟中使用藉由正滲透膜處理稀釋之稀薄吸引溶液,所以可減少本來需要之再利用吸引溶液的必要成本且不需要再生設備。因為稀薄吸引溶液只是稀釋前處理步驟中本來使用之吸引溶液,所以幾乎不產生追加之成本。 Because the thin suction solution diluted by forward osmosis membrane treatment is used in the pretreatment step, the necessary cost of reusing the suction solution can be reduced and no regeneration equipment is required. Because the dilute suction solution is just the suction solution originally used in the dilution pre-treatment step, there is almost no additional cost.
藉由正滲透膜處理稀釋之稀薄吸引溶液比在前處理步驟中所需之使用量多時,在前處理步驟中使用正滲透膜處理中使用之稀薄吸引溶液的一部份,接著濃縮未在前處理步驟中使用之稀薄吸引溶液的一部份,並在正滲透膜處理步驟中再度使用作為吸引溶液,藉此可減少稀薄吸引溶液之損失。因為此時濃縮之稀薄吸引溶液係一部份,所以相較於濃縮稀薄吸引溶液之全量再利用,成本可顯著地降低。 When the amount of dilute attracting solution diluted by the forward osmosis membrane treatment is more than the amount required in the pre-treatment step, a portion of the dilute attracting solution used in the forward osmosis membrane treatment is used in the pre-treatment step, and then a portion of the dilute attracting solution not used in the pre-treatment step is concentrated and reused as the attracting solution in the forward osmosis membrane treatment step, thereby reducing the loss of the dilute attracting solution. Since the concentrated dilute attracting solution is only a portion at this time, the cost can be significantly reduced compared to reusing the entire amount of the concentrated dilute attracting solution.
作為本實施形態之水處理方法及水處理裝置之處理對象的被處理水只要是包含溶解性二氧化矽及硬度成分中之至少一者的水即可,沒有特別限制,但可舉例如:工業用水、表層水、自來水、地下水、海水、藉由逆滲透法或蒸發法使海水脫鹽之海水淡化處理水、例如在半導體製程中排出之排水等的各種排水。 The water to be treated as the treatment object of the water treatment method and the water treatment device of this embodiment is not particularly limited as long as it contains at least one of soluble silica and hardness components, but examples include: industrial Water, surface water, tap water, groundwater, seawater, desalinated seawater desalinated by reverse osmosis or evaporation, and various wastewaters such as wastewater discharged from semiconductor manufacturing processes.
被處理水中含有溶解性二氧化矽時,溶解性二氧化矽之濃度係在例如5至400mg/L之範圍內。被處理水中含有硬度成分時,鈣硬度成分之濃度係在例如5至600mg/L之範圍內。被處理水中之全蒸發殘留物(TDS:全部溶解固體量(Total Dissolved Solid)係在例如100至50000mg/L之範圍內。 When the treated water contains dissolved silica, the concentration of dissolved silica is, for example, in the range of 5 to 400 mg/L. When the treated water contains hardness components, the concentration of calcium hardness components is, for example, in the range of 5 to 600 mg/L. The total evaporation residue (TDS: Total Dissolved Solid) in the treated water is, for example, in the range of 100 to 50,000 mg/L.
在本實施形態之水處理方法及水處理裝置中,被處理水包含溶解性二氧化矽及硬度成分兩者時,前處理設備(前處理步驟)可具有溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)及硬度成分去除設備(硬度成分去除步驟)兩者。溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)及硬度成分去除設備(硬度成分去除步驟)之順序可第一是溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟),第二是硬度成分去除設備(硬度成分去除步驟),或第一是硬度成分去除設備(硬度成分去除步驟),第二是溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)。 In the water treatment method and water treatment device of the present embodiment, when the water to be treated contains both soluble silica and hardness components, the pretreatment equipment (pretreatment step) may include a soluble silica removal equipment (soluble silica removal equipment). Both silica removal step) and hardness component removal equipment (hardness component removal step). The order of the soluble silica removal equipment (soluble silica removal step) and the hardness component removal equipment (hardness component removal step) may be the soluble silica removal equipment (soluble silica removal step) first. The second is a hardness component removal device (hardness component removal step), or the first is a hardness component removal device (hardness component removal step), and the second is a soluble silica removal device (soluble silica removal step).
此時,使用鎂鹽水溶液、鹼劑水溶液、酸水溶液及氯化鈉水溶液中之至少一者作為正滲透膜處理裝置14(正滲透膜處理步驟)中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(鎂鹽稀薄水溶液、鹼劑稀薄水溶液、酸稀薄水溶液及氯化鈉稀薄水溶液中之至少一者)可使用在前處理裝置10(前處理步驟)之溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)及硬度成分去除設備(硬度成分去除步驟)中適合的方面。 At this time, at least one of a magnesium salt solution, an alkali aqueous solution, an acid aqueous solution, and a sodium chloride aqueous solution is used as the suction solution in the forward osmosis membrane treatment device 14 (forward osmosis membrane treatment step), and the forward osmosis membrane treatment device 14 The dilute suction solution (at least one of magnesium salt dilute aqueous solution, alkaline agent dilute aqueous solution, acid dilute aqueous solution and sodium chloride dilute aqueous solution) used in the pretreatment device 10 (pretreatment step) can be used for soluble silica Aspects suitable for removal equipment (soluble silica removal step) and hardness component removal equipment (hardness component removal step).
在本實施形態之水處理方法及水處理裝置中,可更具有去除被處理水中之濁質成分等的濁質去除設備。濁質去除設備可舉例如:砂過濾裝置、超過濾(UF)膜等之膜過濾裝置、加壓浮選裝置等。濁質去除設備之設置位置沒有特別限制,但濁質去除設備為砂過濾裝置時係例如前處理裝置10(前處理步驟)之前段,且濁質去除設備為膜過濾裝置及加壓浮選裝置等時係在前處理裝置10(前處理步驟)與逆滲透膜處理裝置12(濃縮處理步驟)之間。 In the water treatment method and water treatment device of the present embodiment, there may be a turbidity removal device for removing turbidity components in the treated water. The turbidity removal device may be, for example, a sand filter device, a membrane filter device such as an ultrafiltration (UF) membrane, a pressurized flotation device, etc. There is no particular restriction on the location of the turbidity removal device, but when the turbidity removal device is a sand filter device, it is, for example, in front of the pre-treatment device 10 (pre-treatment step), and when the turbidity removal device is a membrane filter device and a pressurized flotation device, it is between the pre-treatment device 10 (pre-treatment step) and the reverse osmosis membrane treatment device 12 (concentration treatment step).
[前處理步驟:去除溶解性二氧化矽] [Pretreatment step: removal of soluble silica]
在被處理水包含溶解性二氧化矽時之前處理步驟中,在例如鹼條件下添加鎂鹽至被處理水中,使溶解性二氧化矽不溶化(鎂反應步驟)。 When the water to be treated contains soluble silica, in the previous treatment step, a magnesium salt is added to the water to be treated, for example, under alkaline conditions to insolubilize the soluble silica (magnesium reaction step).
使用之鎂鹽可為氯化鎂(MgCl2)、硫酸鎂(MgSO4)等之鎂鹽或其水和物,沒有特別限制,但由抑制因添加硫酸鹽而產生難溶性物質等之觀點來看,以氯化鎂為佳。 The magnesium salt used may be magnesium chloride (MgCl 2 ), magnesium sulfate (MgSO 4 ), or a magnesium salt thereof, without particular limitation. However, magnesium chloride is preferred from the viewpoint of suppressing the generation of insoluble substances due to the addition of sulfate.
鎂反應步驟中之pH只要是鹼性條件即可,沒有特別限制,但可在例如pH10至12之範圍內,在10.5至11.5之範圍內較佳,且在11至11.5之範圍內更佳。鎂反應步驟中之pH小於10或超過12時,二氧化矽去除率會降低。 The pH in the magnesium reaction step is not particularly limited as long as it is an alkaline condition, but can be, for example, in the range of pH 10 to 12, preferably in the range of 10.5 to 11.5, and more preferably in the range of 11 to 11.5. When the pH in the magnesium reaction step is less than 10 or greater than 12, the silicon dioxide removal rate will decrease.
pH調整劑可使用氫氧化鈉、氫氧化鈣等之鹼,亦可依需要使用鹽酸、硫酸等之無機酸。 Alkalis such as sodium hydroxide and calcium hydroxide can be used as pH adjusters, and inorganic acids such as hydrochloric acid and sulfuric acid can also be used as needed.
鎂反應步驟中之溫度只要是進行二氧化矽之不溶化反應的溫度即可,沒有特別限制,但可在例如1℃至小於50℃之範圍內,且在10℃至小於50℃之範圍內更佳。鎂反應步驟中之溫度小於1℃時,二氧化矽之不溶化反應會不充分,且50℃以上時,處理成本會升高。 The temperature in the magnesium reaction step is not particularly limited as long as it is the temperature at which the insolubilization reaction of silicon dioxide is carried out, but it can be, for example, in the range of 1°C to less than 50°C, and more in the range of 10°C to less than 50°C. good. When the temperature in the magnesium reaction step is less than 1°C, the insolubilization reaction of silicon dioxide will be insufficient, and when it is above 50°C, the treatment cost will increase.
鎂反應步驟中之反應時間只要可進行二氧化矽之不溶化反應即可,沒有特別限制,但可在例如1分至60分之範圍內,且在5至30分之範圍內更佳。鎂反應步驟中之反應時間小於1分時,二氧化矽之不溶化反應會不充分,且超過60分時,反應槽會過大。 The reaction time in the magnesium reaction step is not particularly limited as long as the insolubilization reaction of silicon dioxide can be carried out, but it can be, for example, in the range of 1 minute to 60 minutes, and preferably in the range of 5 to 30 minutes. If the reaction time in the magnesium reaction step is less than 1 minute, the insolubilization reaction of silicon dioxide will be insufficient, and if it exceeds 60 minutes, the reaction tank will be too large.
鎂鹽之添加量相對被處理水中之二氧化矽的重量濃度按鎂濃度計宜在0.1至10倍量之範圍內,且在0.5至5倍量之範圍內更佳。鎂鹽之添加量相對被處理水中之二氧化矽的重量濃度小於0.1倍量時,二氧化矽之不溶化反應會不充分,且超過10倍量時,污泥產生量會過多。 The amount of magnesium salt added relative to the weight concentration of silicon dioxide in the treated water should be in the range of 0.1 to 10 times, and preferably in the range of 0.5 to 5 times. When the amount of magnesium salt added relative to the weight concentration of silicon dioxide in the treated water is less than 0.1 times, the insolubilization reaction of silicon dioxide will be insufficient, and when it exceeds 10 times, the amount of sludge generated will be excessive.
為了使溶解性二氧化矽不溶化,除了鎂鹽以外,亦可使用多氯化鋁(PAC)、硫酸鋁等之鋁鹽;氯化鐵、硫酸鐵等之鐵鹽等。由二氧化矽去除率等方面來看,使用鎂鹽較佳。 In order to insolubilize soluble silica, in addition to magnesium salts, aluminum salts such as polyaluminum chloride (PAC) and aluminum sulfate; iron salts such as ferric chloride and ferric sulfate can also be used. From the perspective of silica removal rate and other aspects, it is better to use magnesium salt.
凝集處理步驟係例如在凝集槽中,將無機凝集劑添加至鎂反應後之被處理水中,使不溶化物凝集(凝集步驟)。然後,在凝絮形成槽中,添加高分子凝集劑,接著形成凝絮(凝絮形成步驟)。 The coagulation treatment step is, for example, adding an inorganic coagulant to the treated water after the magnesium reaction in a coagulation tank to agglomerate the insoluble matter (agglomeration step). Then, a polymer flocculant is added to the flocculation forming tank, and then flocculation is formed (flocculation forming step).
凝集步驟中使用之無機凝集劑可舉氯化鐵等之鐵系無機凝集劑、多氯化鋁(PAC)等之鋁系無機凝集劑等為例,且由藥品成本及凝集pH範圍等方面來看,鐵系無機凝集劑較佳。 Inorganic coagulants used in the agglomeration step include iron-based inorganic coagulants such as ferric chloride, aluminum-based inorganic coagulants such as polyaluminum chloride (PAC), etc., and are determined by the cost of the drug and the agglutination pH range. Look, iron-based inorganic coagulants are better.
無機凝集劑之添加量相對添加之鎂鹽量按重量比宜在0.1至10倍量之範圍內,且在1至5倍量之範圍內更佳。無機凝集劑之添加量相對添加之鎂鹽量按重量比計小於0.1倍量時,凝集會不充分,且超過10倍量時,污泥產生量會過多。 The weight ratio of the added amount of the inorganic flocculant to the added magnesium salt should be in the range of 0.1 to 10 times, and more preferably in the range of 1 to 5 times the amount. If the added amount of inorganic coagulant is less than 0.1 times the weight ratio of the added magnesium salt, the aggregation will be insufficient, and if it exceeds 10 times, the amount of sludge will be excessive.
凝集步驟中之pH係在例如3至11之範圍內。凝集步驟中之pH小於3或超過11時,會產生凝集不良。此外,凝集步驟中之pH小於9時,會由凝絮溶出二氧化矽,因此最好在pH9至11之範圍內進行凝集步驟。 The pH in the agglutination step is, for example, in the range of 3 to 11. When the pH in the agglutination step is less than 3 or exceeds 11, poor agglutination will occur. In addition, when the pH in the coagulation step is less than 9, silica will be eluted from the flocculation, so it is best to conduct the coagulation step within the pH range of 9 to 11.
凝集步驟中之溫度係在例如1℃至80℃之範圍內。凝集步驟中之溫度小於1℃或超過80℃時,會產生凝集不良。 The temperature in the coagulation step is, for example, in the range of 1°C to 80°C. When the temperature in the coagulation step is less than 1°C or exceeds 80°C, poor coagulation will occur.
凝絮形成步驟中使用之高分子凝集劑可舉例如:聚丙烯醯胺系、聚丙烯酸酯系等之陽離子系高分子凝集劑;陰離子系高分子凝集劑;非離子系高分子凝集劑等,由凝集性等方面來看,陰離子系高分子凝集劑較佳。 Examples of polymer flocculants used in the flocculation formation step include: cationic polymer flocculants such as polyacrylamide series and polyacrylate series; anionic polymer flocculants; nonionic polymer flocculants, etc. In terms of coagulation properties, anionic polymer flocculants are preferred.
市售之高分子凝集劑可舉ORFLOCK OA-3H(ORGANO公司(股)製)等之陰離子系高分子凝集劑為例。 Examples of commercially available polymer flocculants include anionic polymer flocculants such as ORFLOCK OA-3H (manufactured by ORGANO Co., Ltd.).
高分子凝集劑之添加量相對原水之水量宜在0.1至10mg/L之範圍內,且在1至5mg/L之範圍內更佳。高分子凝集劑之添加量相對原水之水量小於0.1mg/L時,會無法促使凝絮形成,且超過10mg/L時,溶存於處理水中之高分子凝集劑會殘留。 The amount of polymer coagulant added relative to the amount of raw water should be in the range of 0.1 to 10 mg/L, and preferably in the range of 1 to 5 mg/L. When the amount of polymer coagulant added relative to the amount of raw water is less than 0.1 mg/L, it will not promote the formation of flocculation, and when it exceeds 10 mg/L, the polymer coagulant dissolved in the treated water will remain.
凝絮形成步驟中之pH係在例如3至11之範圍內。凝絮形成步驟中之pH小於3或超過11時,會產生凝集不良。此外,凝絮形成步驟中之pH小於9時會由凝絮溶出二氧化矽,因此最好在pH9至11之範圍內進行凝絮形成步驟。 The pH in the flocculant formation step is, for example, in the range of 3 to 11. When the pH in the flocculant formation step is less than 3 or exceeds 11, poor coagulation will occur. In addition, when the pH in the flocculant formation step is less than 9, silicon dioxide will be dissolved from the flocculants, so it is best to perform the flocculant formation step in the range of pH 9 to 11.
凝絮形成步驟中之溫度係在例如1℃至80℃之範圍內。凝絮形成步驟中之溫度小於1℃或超過80℃時,會產生凝集不良。 The temperature in the flocculation forming step is, for example, in the range of 1°C to 80°C. When the temperature in the flocculation formation step is less than 1°C or exceeds 80°C, poor coagulation will occur.
上述凝集處理雖然使用無機凝集劑及高分子凝集劑進行凝集步驟及凝絮形成步驟,但可使用無機凝集劑、高分子凝集劑等中之至少一者,且宜使用鐵系無機凝集劑及陰離子系高分子凝集劑中之至少一者。使與鎂鹽反應且不溶化之二氧化矽凝集時,藉由使用鐵系無機凝集劑及陰離子系高分子凝集劑中之至少一者,可提高凝集性及固液分離性。 Although the above-mentioned coagulation treatment uses inorganic coagulants and polymer coagulants for the coagulation step and the flocculant formation step, at least one of inorganic coagulants, polymer coagulants, etc. may be used, and at least one of iron-based inorganic coagulants and anionic polymer coagulants is preferably used. When the silicon dioxide that reacts with magnesium salt and becomes insoluble is coagulated, the coagulation and solid-liquid separation properties can be improved by using at least one of iron-based inorganic coagulants and anionic polymer coagulants.
固液分離步驟係在例如沉澱槽中固液分離凝絮形成之凝集物(固液分離步驟)。接著將藉由固液分離製得之前處理水輸送至逆滲透膜處理裝置12。另一方面,通過污泥配管排出污泥。污泥可回收、再利用。 The solid-liquid separation step is, for example, agglomerates formed by solid-liquid separation and flocculation in a sedimentation tank (solid-liquid separation step). Then, the pre-treated water produced by solid-liquid separation is sent to the reverse osmosis membrane treatment device 12 . On the other hand, the sludge is discharged through the sludge pipe. Sludge can be recycled and reused.
固液分離步驟中之固液分離除了藉由自然沉降來沉降分離以外,可舉加壓浮選處理、膜過濾處理等為例,且由分離性等方面來看,沉降分離較佳。 In addition to sedimentation separation through natural sedimentation, the solid-liquid separation in the solid-liquid separation step can be exemplified by pressurized flotation treatment, membrane filtration treatment, etc., and in terms of separability and other aspects, sedimentation separation is better.
[前處理步驟:藉由石灰軟化法去除硬度成分] [Pre-treatment step: remove hardness components by lime softening method]
被處理水包含硬度成分時,可藉由石灰軟化法去除硬度成分。硬度成分分成一次硬度及永久硬度,且一次硬度係藉由氫氧化鈉(NaOH)等之鹼劑去除,而永久硬度係藉由添加碳酸鈉(NaCO3)等之碳酸鹽去除。在本說明書中,為方便起見,碳酸鹽亦記載為鹼劑。即,在前處理步驟中,添加鹼劑至被處理水中,使硬度成分不溶化(鹼劑反應步驟)。 When the water to be treated contains hardness components, the hardness components can be removed by lime softening. Hardness components are divided into primary hardness and permanent hardness, and primary hardness is removed by alkali such as sodium hydroxide (NaOH), while permanent hardness is removed by adding carbonate such as sodium carbonate (NaCO 3 ). In this specification, for convenience, carbonate is also recorded as alkali. That is, in the pre-treatment step, alkali is added to the water to be treated to make the hardness components insoluble (alkali reaction step).
使用之鹼劑可舉例如:氫氧化鈣(Ca(OH)2)、氫氧化鈉(NaOH)、氫氧化鉀(KOH)、碳酸氫鈣(Ca(HCO3)2)、碳酸氫鎂(Mg(HCO3)2)、碳酸鈉(Na2CO3)、碳酸鉀(K2CO3)等,且可使用其中一者以上。即,亦可依需要分別添加氫氧化鈉及碳酸鈉。由不溶化效率等之觀點來看,碳酸鈉較佳。 The alkali used may be, for example, calcium hydroxide (Ca(OH) 2 ), sodium hydroxide (NaOH), potassium hydroxide (KOH), calcium bicarbonate (Ca(HCO 3 ) 2 ), magnesium bicarbonate (Mg(HCO 3 ) 2 ), sodium carbonate (Na 2 CO 3 ), potassium carbonate (K 2 CO 3 ), etc., and more than one of them may be used. That is, sodium hydroxide and sodium carbonate may be added separately as needed. From the viewpoint of insolubilization efficiency, etc., sodium carbonate is preferred.
鹼劑反應步驟中之pH只要是鹼性條件即可,沒有特別限制,但可在例如pH9至13之範圍內,且在11至12之範圍內較佳。鹼劑反應步驟中之pH小於9時,硬度成分去除率降低,且超過13時,鹼劑之添加量會變多。 The pH in the alkali reaction step is not particularly limited as long as it is an alkaline condition, but it can be in the range of pH 9 to 13, and preferably in the range of 11 to 12. When the pH in the alkali reaction step is less than 9, the hardness component removal rate decreases, and when it exceeds 13, the amount of alkali added will increase.
鹼劑反應步驟中之溫度只要是進行硬度成分之不溶化反應的溫度即可,沒有特別限制,但可在例如1℃至80℃之範圍內。鹼劑反應步驟中之溫度小於1℃ 時,硬度成分之不溶化反應會不充分,且超過80℃時,設備之耐熱溫度會有問題。 The temperature in the alkali reaction step is not particularly limited as long as it is a temperature at which the insolubilization reaction of the hardness component proceeds, but it can be in the range of, for example, 1°C to 80°C. The temperature in the alkali reaction step is less than 1℃ When the temperature exceeds 80°C, the insolubilization reaction of the hardness components will be insufficient, and when the temperature exceeds 80°C, there will be problems with the heat-resistant temperature of the equipment.
鹼劑反應步驟中之只要可進行硬度成分之不溶化反應即可,沒有特別限制,但可在例如10分至30分之範圍內。鹼劑反應步驟中之反應時間小於10分時,硬度成分之不溶化反應會不充分,且超過30分時,反應槽會變大而使設備成本升高。 The alkaline agent reaction step is not particularly limited as long as it can carry out the insolubilization reaction of the hardness component, but it can be in the range of 10 to 30 minutes, for example. If the reaction time in the alkali reaction step is less than 10 minutes, the insolubilization reaction of the hardness component will be insufficient, and if it exceeds 30 minutes, the reaction tank will become larger and the equipment cost will increase.
鹼劑之添加量相對被處理水中之硬度成分的莫耳濃度宜在1.0至2.0倍量之範圍內,且在1.0至1.2倍量之範圍內更佳。鹼劑之添加量相對被處理水中之硬度成分的莫耳濃度小於1.0倍量時,硬度成分之不溶化反應會不充分,且超過2.0倍量時,藥品成本會升高。 The amount of alkali added should be in the range of 1.0 to 2.0 times the molar concentration of the hardness components in the treated water, and preferably in the range of 1.0 to 1.2 times. When the amount of alkali added is less than 1.0 times the molar concentration of the hardness components in the treated water, the insolubilization reaction of the hardness components will be insufficient, and when it exceeds 2.0 times, the cost of the drug will increase.
後來之凝集處理步驟及固液分離步驟與上述前處理步驟(藉由鎂鹽去除二氧化矽)相同。接著將藉由固液分離製得之前處理水輸送至逆滲透膜處理裝置12。 The subsequent coagulation treatment step and solid-liquid separation step are the same as the above-mentioned pre-treatment step (removal of silicon dioxide by magnesium salt). Then, the previously treated water obtained by solid-liquid separation is transported to the reverse osmosis membrane treatment device 12.
[前處理步驟:藉由樹脂軟化法去除硬度成分] [Pre-treatment step: Removing hardness components by resin softening]
在被處理水包含硬度成分時之樹脂軟化法的前處理步驟中,例如,將被處理水通入填充離子交換樹脂之離子交換塔,吸附去除硬度成分(離子交換步驟)。接著將藉由離子交換處理製得之前處理水輸送至逆滲透膜處理裝置12。 In the pretreatment step of the resin softening method when the water to be treated contains hardness components, for example, the water to be treated is passed into an ion exchange tower filled with ion exchange resin, and the hardness components are adsorbed and removed (ion exchange step). Then, the pre-treated water produced by ion exchange treatment is sent to the reverse osmosis membrane treatment device 12 .
離子交換步驟中使用之離子交換樹脂係陽離子交換樹脂,且可舉Amberrex 100Na,IRC-76(ORGANO公司(股)製)等為例。 The ion exchange resin used in the ion exchange step is a cation exchange resin, and examples thereof include Amberrex 100Na, IRC-76 (manufactured by ORGANO Co., Ltd.), and the like.
離子交換樹脂需要再生時,藉由通過再生劑再生離子交換樹脂。 When the ion exchange resin needs to be regenerated, the ion exchange resin is regenerated by using a regeneration agent.
使用之再生劑可舉例如:鹽酸、硫酸、硝酸等之酸水溶液;氯化鈉水溶液;氯化鉀水溶液等,且可使用其中一者以上。即,亦可依需要藉由酸水溶液再生後,藉由氯化鈉水溶液進行追加再生。由吸引溶液之再利用等的觀點來看,酸水溶液、氯化鈉水溶液較佳。若藉由酸水溶液再生,則離子交換樹脂成為H形,而若藉由氯化鈉水溶液再生,則離子交換樹脂成為Na形。 Examples of the regenerant used include: acid aqueous solutions of hydrochloric acid, sulfuric acid, nitric acid, etc.; sodium chloride aqueous solution; potassium chloride aqueous solution, etc., and one or more of them may be used. That is, after regeneration with an acid aqueous solution, additional regeneration with a sodium chloride aqueous solution may be performed as necessary. From the viewpoint of reusing the suction solution, an acid aqueous solution or a sodium chloride aqueous solution is preferred. If regenerated by an acid aqueous solution, the ion exchange resin becomes the H form, and if regenerated by the sodium chloride aqueous solution, the ion exchange resin becomes the Na form.
[濃縮處理步驟(第一濃縮處理步驟)] [Concentration treatment step (first concentration treatment step)]
濃縮處理設備(第一濃縮處理設備)只要可濃縮前處理水即可,沒有特別限制,但除了逆滲透膜處理裝置以外,亦可使用:使用奈米過濾膜等之膜過濾裝置、蒸餾裝置、電透析裝置等中之一個裝置以上。即,可依需要藉由電透析處理進一步濃縮藉由逆滲透膜處理裝置製得之濃縮水,或藉由第二逆滲透處理進一步濃縮藉由第一逆滲透處理製得之濃縮水。由在前處理水中之TDS低時可有效率地處理等之觀點來看,逆滲透膜處理裝置較佳。 The concentration treatment equipment (first concentration treatment equipment) is not particularly limited as long as it can concentrate the pre-treated water. However, in addition to the reverse osmosis membrane treatment equipment, membrane filtration equipment using nanofiltration membranes, distillation equipment, etc. can also be used. One or more devices such as electrodialysis equipment. That is, the concentrated water obtained by the reverse osmosis membrane treatment device can be further concentrated by electrodialysis treatment, or the concentrated water obtained by the first reverse osmosis treatment can be further concentrated by the second reverse osmosis treatment, as needed. A reverse osmosis membrane treatment device is preferable from the viewpoint of efficient treatment when the TDS of the pre-treatment water is low.
逆滲透膜處理裝置中使用之逆滲透膜,除了使用於純水製造用途及排水回收等之用途的超低壓逆滲透膜、低壓逆滲透膜以外,可舉使用於海水淡化等用途之中壓逆滲透膜及高壓逆滲透膜等為例。超低壓逆滲透膜、低壓逆滲透膜可 舉例如:ES15(日東電工製)、TM720D(TORAY製)、BW30HRLE(Dow Chemical製)、LFC3-LD(Hydranautics製)。高壓逆滲透膜可舉例如:SWC5-LD(Hydranautics製)、TM820V(TORAY製)、XUS180808(Dow Chemical製)等。 The reverse osmosis membrane used in the reverse osmosis membrane treatment device includes ultra-low pressure reverse osmosis membrane and low pressure reverse osmosis membrane used for pure water production and wastewater recovery, as well as medium pressure reverse osmosis membrane and high pressure reverse osmosis membrane used for seawater desalination. Examples of ultra-low pressure reverse osmosis membrane and low pressure reverse osmosis membrane include ES15 (manufactured by Nitto Denko), TM720D (manufactured by TORAY), BW30HRLE (manufactured by Dow Chemical), and LFC3-LD (manufactured by Hydranautics). Examples of high pressure reverse osmosis membrane include SWC5-LD (manufactured by Hydranautics), TM820V (manufactured by TORAY), and XUS180808 (manufactured by Dow Chemical).
在濃縮處理步驟(第一濃縮處理步驟)中,亦可添加pH調整劑、抑制在系內之無機鹽結垢的水垢分散劑及抑制在系內產生微生物之殺菌劑等的藥品。 In the concentration treatment step (first concentration treatment step), chemicals such as a pH adjuster, a scale dispersant that inhibits scaling of inorganic salts in the system, and a bactericide that inhibits the generation of microorganisms in the system may also be added.
[正滲透膜處理步驟] [Forward Osmosis Membrane Treatment Steps]
正滲透膜處理步驟中使用之正滲透膜形狀沒有特別限制,但可使用例如:中空紗膜、螺旋膜、管形膜、板底框構造之膜等。正滲透膜之膜材質可舉芳香族聚醯胺系、乙酸纖維素系等為例。此外,亦可使用在分離膜之基材中組合機能性蛋白質及無機材料等以賦予分離性能及透水性等的膜。正滲透膜可舉例如:HP5230(東洋紡製)、HFFO2(Aquaporin製)、OsmoF20(Fruid Technology Solutions製)。該等正滲透膜可單段地使用或串聯地連接多數段使用。即,可藉由第二正滲透膜處理進一步濃縮藉由第一正滲透膜處理製得之FO濃縮水。 There is no particular limitation on the shape of the forward osmosis membrane used in the forward osmosis membrane treatment step, but for example, hollow yarn membranes, spiral membranes, tubular membranes, membranes with plate-bottom-frame structures, etc. can be used. Examples of the membrane material of the forward osmosis membrane include aromatic polyamide series and cellulose acetate series. In addition, a membrane in which functional proteins and inorganic materials are combined in the base material of the separation membrane to impart separation performance and water permeability can also be used. Examples of the forward osmosis membrane include HP5230 (manufactured by Toyobo), HFFO2 (manufactured by Aquaporin), and OsmoF20 (manufactured by Fruid Technology Solutions). Such forward osmosis membranes can be used in a single segment or in a plurality of segments connected in series. That is, the FO concentrated water obtained by the first forward osmosis membrane treatment can be further concentrated by the second forward osmosis membrane treatment.
正滲透膜處理步驟中使用之吸引溶液,如上所述,可舉例如:鎂鹽水溶液、鹼劑水溶液、酸水溶液、氯化鈉水溶液等。此外,除上述以外,只要是本水處理裝置中使用之藥品即可,可無限制地使用。即,亦可使用凝集步驟中使用之各種凝集劑、濃縮處理步驟中使用水垢分散劑及殺菌劑等作為吸引溶液。 As mentioned above, the attracting solution used in the forward osmosis membrane treatment step can be, for example, a magnesium salt aqueous solution, an alkaline aqueous solution, an acid aqueous solution, a sodium chloride aqueous solution, etc. In addition, in addition to the above, any chemical used in the water treatment device can be used without limitation. That is, various coagulants used in the coagulation step, scale dispersants and disinfectants used in the concentration treatment step, etc. can also be used as the attracting solution.
在正滲透膜處理步驟中進行多數段之正滲透膜處理時,可組合上述吸引溶液使用。例如,使用氯化鈉水溶液作為第一正滲透膜處理步驟之吸引溶液,且使用鎂鹽水溶液作為第二正滲透膜處理步驟之吸引溶液。此外,例如,可使用藉由第一正滲透膜處理步驟製得之稀薄氯化鈉水溶液作為軟化樹脂之再生液,且使用藉由第二正滲透膜處理步驟製得之稀薄鎂鹽水溶液作為溶解性二氧化矽去除步驟之鎂源。 When multiple forward osmosis membrane treatments are performed in the forward osmosis membrane treatment step, the above-mentioned draw solutions can be used in combination. For example, a sodium chloride aqueous solution is used as the draw solution for the first forward osmosis membrane treatment step, and a magnesium salt aqueous solution is used as the draw solution for the second forward osmosis membrane treatment step. In addition, for example, a dilute sodium chloride aqueous solution obtained by the first forward osmosis membrane treatment step can be used as a regeneration solution for softening resin, and a dilute magnesium salt aqueous solution obtained by the second forward osmosis membrane treatment step can be used as a magnesium source for the soluble silica removal step.
[第二濃縮處理步驟] [Second concentration step]
第二濃縮處理設備只要可濃縮正滲透膜處理步驟中使用之稀薄吸引溶液即可,沒有特別限制,但可使用:奈米過濾膜處理裝置、逆滲透膜處理裝置、正滲透膜處理裝置、壓力輔助逆滲透膜處理裝置等之使用半透膜的濃縮裝置;使用奈米過濾膜等之膜過濾裝置;蒸餾裝置;電透析裝置等中之一個裝置以上。由減少濃縮成本等之觀點來看,使用半透膜之濃縮裝置較佳,且特別在被處理水之TDS濃度超過5%時可減少滲透壓影響的壓力輔助逆滲透膜處理裝置更佳。 The second concentration treatment equipment is not particularly limited as long as it can concentrate the dilute attracting solution used in the forward osmosis membrane treatment step, but can use: a concentration device using a semipermeable membrane such as a nanofiltration membrane treatment device, a reverse osmosis membrane treatment device, a forward osmosis membrane treatment device, a pressure-assisted reverse osmosis membrane treatment device, etc.; a membrane filtration device using a nanofiltration membrane, etc.; a distillation device; an electrodialysis device, etc., one or more of the following devices can be used. From the perspective of reducing concentration costs, a concentration device using a semipermeable membrane is preferred, and a pressure-assisted reverse osmosis membrane treatment device that can reduce the impact of osmotic pressure is preferred, especially when the TDS concentration of the treated water exceeds 5%.
圖4顯示本實施形態之水處理裝置中的一濃縮裝置例。 FIG. 4 shows an example of a concentration device in the water treatment device of this embodiment.
圖4所示之濃縮裝置340係一壓力輔助逆滲透膜處理裝置例。濃縮裝置340係一裝置,該裝置具有使用半透膜濃縮處理對象水之2個以上的濃縮設備,且將上述稀薄吸引溶液供給至第一段半透膜之一次側並將稀薄液供給至二次側,由一次側之另一流路製得濃縮液且由二次側之另一流路製得稀釋液,接著 供給該稀釋液至次段半透膜之一次側,並加壓各段半透膜之一次側使該一次側含有之水透過二次側,依序製得濃縮液及稀釋液。 The concentration device 340 shown in Figure 4 is an example of a pressure-assisted reverse osmosis membrane treatment device. The concentration device 340 is a device that has two or more concentration devices that use semipermeable membranes to concentrate water to be processed, and supplies the above-mentioned dilute suction solution to one of the primary sides of the first-stage semipermeable membrane and supplies the dilute liquid to the second stage. On the secondary side, a concentrated liquid is produced from another flow path on the primary side and a diluted liquid is produced from another flow path on the secondary side, and then The diluted liquid is supplied to the primary side of the semipermeable membrane of the secondary stage, and the primary side of the semipermeable membrane of each stage is pressurized to allow the water contained in the primary side to pass through the secondary side, thereby producing a concentrated liquid and a diluted liquid in sequence.
濃縮裝置340具有例如:第一段半透膜處理裝置42、第二段半透膜處理裝置44、第三段半透膜處理裝置46。半透膜處理裝置分別具有被半透膜52分隔之一次側(第一空間)48及二次側(第二空間)50。 The concentration device 340 has, for example, a first-stage semipermeable membrane treatment device 42, a second-stage semipermeable membrane treatment device 44, and a third-stage semipermeable membrane treatment device 46. The semipermeable membrane treatment device has a primary side (first space) 48 and a secondary side (second space) 50 separated by a semipermeable membrane 52.
在圖4所示之濃縮裝置340中,配管54透過泵70連接於第一段半透膜處理裝置42之一次側48的入口,且配管56連接於一次側48的出口。第二段半透膜處理裝置44之一次側48的出口及第一段半透膜處理裝置42之二次側50的入口藉由配管58連接,且第一段半透膜處理裝置42之二次側50的出口及第二段半透膜處理裝置44之一次側48的入口透過泵72藉由配管60連接。第三段半透膜處理裝置46之一次側48的出口及第二段半透膜處理裝置44之二次側50的入口藉由配管62連接,且第二段半透膜處理裝置44之二次側50的出口及第三段半透膜處理裝置46之一次側48的入口透過泵74藉由配管64連接。配管66連接於第三段半透膜處理裝置46之二次側50的入口且配管68連接於二次側50的出口。 In the concentration device 340 shown in FIG4 , the pipe 54 is connected to the inlet of the primary side 48 of the first semipermeable membrane treatment device 42 through the pump 70, and the pipe 56 is connected to the outlet of the primary side 48. The outlet of the primary side 48 of the second semipermeable membrane treatment device 44 and the inlet of the secondary side 50 of the first semipermeable membrane treatment device 42 are connected through the pipe 58, and the outlet of the secondary side 50 of the first semipermeable membrane treatment device 42 and the inlet of the primary side 48 of the second semipermeable membrane treatment device 44 are connected through the pipe 60 through the pump 72. The outlet of the primary side 48 of the third-stage semipermeable membrane treatment device 46 and the inlet of the secondary side 50 of the second-stage semipermeable membrane treatment device 44 are connected by a pipe 62, and the outlet of the secondary side 50 of the second-stage semipermeable membrane treatment device 44 and the inlet of the primary side 48 of the third-stage semipermeable membrane treatment device 46 are connected by a pipe 64 through a pump 74. The pipe 66 is connected to the inlet of the secondary side 50 of the third-stage semipermeable membrane treatment device 46 and the pipe 68 is connected to the outlet of the secondary side 50.
濃縮裝置340係使用多段式半透膜處理裝置之裝置,該多段式半透膜處理裝置具有被半透膜52分隔之一次側48及二次側50。作為被處理水之正滲透膜處理裝置14中使用的稀薄吸引溶液(例如,MgCl2:8質量%)之一部份藉由泵70通過配管54而通至第一段半透膜處理裝置42之一次側48,且後述第二段半透膜處理裝置44中製得之第二濃縮液(例如,MgCl2:10質量%)通過配管58而通至二次側 50,接著加壓一次側48使該一次側48含有之水透過二次側50,製得第一濃縮液(例如,MgCl2:30質量%)及第一稀釋液(例如,MgCl2:5質量%)(濃縮步驟(第一段))。第一濃縮液(濃縮吸引溶液)通過配管56排出並作為正滲透膜處理裝置14中之吸引溶液再度使用。 The concentration device 340 is a device using a multi-stage semipermeable membrane treatment device having a primary side 48 and a secondary side 50 separated by a semipermeable membrane 52. A portion of the dilute draw solution (e.g., MgCl 2 : 8 mass %) used in the forward osmosis membrane treatment device 14 as the water to be treated is passed to the primary side 48 of the first-stage semipermeable membrane treatment device 42 through the pipe 54 by the pump 70, and the second concentrated solution (e.g., MgCl 2 : 10 mass %) prepared in the second-stage semipermeable membrane treatment device 44 described later is passed to the secondary side 50 through the pipe 58, and then the primary side 48 is pressurized to allow the water contained in the primary side 48 to pass through the secondary side 50, thereby preparing a first concentrated solution (e.g., MgCl 2 : 30 mass %) and a first diluted solution (e.g., MgCl 2 : 5 mass %) (concentration step (first stage)). The first concentrated liquid (concentrated suction solution) is discharged through the pipe 56 and reused as the suction solution in the forward osmosis membrane treatment device 14.
第一稀釋液通過配管60並藉由泵72通至第二段半透膜處理裝置44之一次側48,且藉由後述第三段半透膜處理裝置46製得之第三濃縮液(例如,MgCl2:3質量%)通過配管62而通至二次側50,接著加壓一次側48使該一次側48含有之水透過二次側50,製得第二濃縮液(例如,MgCl2:10質量%)及第二稀釋液(例如,MgCl2:1質量%)(濃縮步驟(第二段))。第二濃縮液通過配管58而通至第一段半透膜處理裝置42之二次側50。 The first diluent passes through the pipe 60 and is passed to the primary side 48 of the second-stage semipermeable membrane treatment device 44 through the pump 72, and the third concentrated liquid (for example, produced by the third-stage semipermeable membrane treatment device 46 described later) , MgCl 2 : 3 mass%) is passed to the secondary side 50 through the pipe 62 , and then the primary side 48 is pressurized to allow the water contained in the primary side 48 to pass through the secondary side 50 to obtain a second concentrated liquid (for example, MgCl 2 : 10 mass%) and the second dilution (for example, MgCl 2 : 1 mass%) (concentration step (second stage)). The second concentrated liquid passes through the pipe 58 to the secondary side 50 of the first-stage semipermeable membrane treatment device 42 .
第二稀釋液通過配管64並藉由泵74通至第三段半透膜處理裝置46之一次側48,且稀釋液(例如,MgCl2:1質量%)通過配管66而通至二次側50,接著加壓一次側48使該一次側48含有之水透過二次側50,製得第三濃縮液(例如,MgCl2:3質量%)及第三稀釋液(例如,MgCl2:<1質量%)(濃縮步驟(第三段))。第三濃縮液通過配管62而通至第二段半透膜處理裝置44之二次側50。第三稀釋液通過配管68排出。第二濃縮液、第三濃縮液之一部份可作為正滲透膜處理裝置14中之吸引溶液再度使用。第三稀釋液可依需要在實施超過濾膜(UF膜)處理、逆滲透膜(RO膜)處理、離子交換處理等後回收、再利用。 The second diluent passes through the pipe 64 and is passed to the primary side 48 of the third-stage semipermeable membrane treatment device 46 through the pump 74, and the diluent (for example, MgCl 2 :1 mass %) is passed through the pipe 66 to the secondary side. 50, and then pressurize the primary side 48 to allow the water contained in the primary side 48 to pass through the secondary side 50 to prepare a third concentrated liquid (for example, MgCl 2 : 3 mass%) and a third diluted liquid (for example, MgCl 2 : < 1% by mass) (concentration step (third section)). The third concentrated liquid passes through the pipe 62 to the secondary side 50 of the second-stage semipermeable membrane treatment device 44 . The third diluent is discharged through pipe 68 . Part of the second concentrated liquid and the third concentrated liquid can be reused as the suction solution in the forward osmosis membrane treatment device 14 . The third diluent can be recovered and reused after ultrafiltration membrane (UF membrane) treatment, reverse osmosis membrane (RO membrane) treatment, ion exchange treatment, etc. as needed.
該壓力輔助逆滲透膜處理裝置減少一次側48與二次側50之滲透壓差,可用比一般逆滲透膜處理裝置小之能量運轉,因此可用更低成本進行運轉。 The pressure-assisted reverse osmosis membrane treatment device reduces the osmotic pressure difference between the primary side 48 and the secondary side 50, and can be operated with less energy than a general reverse osmosis membrane treatment device, so it can be operated at a lower cost.
如上所述,由上述稀薄吸引溶液製得之濃縮吸引溶液可作為正滲透膜處理裝置14中之吸引溶液再度使用。 As described above, the concentrated attracting solution prepared from the above-mentioned dilute attracting solution can be reused as the attracting solution in the forward osmosis membrane treatment device 14.
在圖4所示之濃縮裝置340中,通至第一段半透膜處理裝置42之二次側50及第二段以後之半透膜處理裝置的液可為與通至第一段半透膜處理裝置42之一次側48的稀薄吸引溶液不同成分的液。圖5顯示如此之濃縮裝置例。 In the concentration device 340 shown in Figure 4, the liquid flowing to the secondary side 50 of the first-stage semi-permeable membrane treatment device 42 and the semi-permeable membrane treatment devices after the second stage can be the same as the liquid flowing to the first-stage semi-permeable membrane treatment device 42. The dilution of the primary side 48 of the membrane treatment device 42 attracts liquids with different components of the solution. Figure 5 shows an example of such a concentration device.
圖5所示之濃縮裝置342係具有與圖4所示之濃縮裝置340相同結構的裝置。作為被處理水之正滲透膜處理裝置14中使用的稀薄吸引溶液(例如,MgCl2:8質量%)之一部份藉由泵70通過配管54而通至第一段半透膜處理裝置42之一次側48,且後述第二段半透膜處理裝置44中製得之第二濃縮液(例如,葡萄糖:20質量%)通過配管58而通至二次側50,接著加壓一次側48使該一次側48含有之水透過二次側50,製得第一濃縮液(例如,MgCl2:30質量%)及第一稀釋液(例如,葡萄糖:10質量%)(濃縮步驟(第一段))。第一濃縮液(濃縮吸引溶液)通過配管56排出並作為正滲透膜處理裝置14中之吸引溶液再度使用。 The concentrating device 342 shown in FIG. 5 is a device having the same structure as the concentrating device 340 shown in FIG. 4 . A portion of the dilute draw solution (e.g., MgCl 2 : 8 mass %) used in the forward osmosis membrane treatment device 14 as the water to be treated is passed to the primary side 48 of the first-stage semipermeable membrane treatment device 42 through the pipe 54 by the pump 70, and the second concentrated solution (e.g., glucose: 20 mass %) prepared in the second-stage semipermeable membrane treatment device 44 described later is passed to the secondary side 50 through the pipe 58, and then the primary side 48 is pressurized to allow the water contained in the primary side 48 to pass through the secondary side 50, thereby preparing a first concentrated solution (e.g., MgCl 2 : 30 mass %) and a first diluted solution (e.g., glucose: 10 mass %) (concentration step (first stage)). The first concentrated liquid (concentrated suction solution) is discharged through the pipe 56 and reused as the suction solution in the forward osmosis membrane treatment device 14.
第一稀釋液通過配管60並藉由泵72通至第二段半透膜處理裝置44之一次側48,且藉由後述第三段半透膜處理裝置46製得之第三濃縮液(例如,NaCl:3質量%)通過配管62而通至二次側50,接著加壓一次側48使該一次側48含有之水透 過二次側50,製得第二濃縮液(例如,葡萄糖:20質量%)及第二稀釋液(例如,NaCl:1質量%)(濃縮步驟(第二段))。第二濃縮液通過配管58而通至第一段半透膜處理裝置42之二次側50。 The first dilution liquid passes through the pipe 60 and is passed to the primary side 48 of the second-stage semipermeable membrane treatment device 44 by the pump 72, and the third concentrated liquid (e.g., NaCl: 3 mass%) obtained by the third-stage semipermeable membrane treatment device 46 described later passes through the pipe 62 to the secondary side 50, and then the primary side 48 is pressurized to allow the water contained in the primary side 48 to pass through the secondary side 50 to obtain the second concentrated liquid (e.g., glucose: 20 mass%) and the second dilution liquid (e.g., NaCl: 1 mass%) (concentration step (second stage)). The second concentrated liquid passes through the pipe 58 to the secondary side 50 of the first-stage semipermeable membrane treatment device 42.
第二稀釋液通過配管64並藉由泵74通至第三段半透膜處理裝置46之一次側48,且稀釋液(例如,NaCl:1質量%)通過配管66而通至二次側50,接著加壓一次側48使該一次側48含有之水透過二次側50,製得第三濃縮液(例如,NaCl:3質量%)及第三稀釋液(例如,NaCl:<1質量%)(濃縮步驟(第三段))。第三濃縮液通過配管62而通至第二段半透膜處理裝置44之二次側50。第三稀釋液通過配管68排出。第三稀釋液可依需要在實施超過濾膜(UF膜)處理、逆滲透膜(RO膜)處理、離子交換處理等後回收、再利用。 The second dilution liquid passes through the pipe 64 and is passed to the primary side 48 of the third-stage semipermeable membrane treatment device 46 by the pump 74, and the dilution liquid (e.g., NaCl: 1 mass%) passes through the pipe 66 to the secondary side 50, and then the primary side 48 is pressurized to allow the water contained in the primary side 48 to pass through the secondary side 50 to obtain a third concentrated liquid (e.g., NaCl: 3 mass%) and a third dilution liquid (e.g., NaCl: <1 mass%) (concentration step (third stage)). The third concentrated liquid passes through the pipe 62 to the secondary side 50 of the second-stage semipermeable membrane treatment device 44. The third dilution liquid is discharged through the pipe 68. The third dilution liquid can be recovered and reused after ultrafiltration membrane (UF membrane) treatment, reverse osmosis membrane (RO membrane) treatment, ion exchange treatment, etc. as needed.
通至第一段半透膜處理裝置42之二次側50及第二段以後之半透膜處理裝置的液只要是具有滲透壓之液即可,沒有特別限制。可舉例如:包含氯化鈉等之無機鹽類的水溶液、包含葡萄糖等之有機物的水溶液、包含聚合物之水溶液及離子液體等。由減少成分由一次側擴散至二次側之影響的觀點來看,宜使用與通至第一段半透膜處理裝置42之一次側48的稀薄吸引溶液相同成分的液。 The liquid passed to the secondary side 50 of the first-stage semipermeable membrane treatment device 42 and the semipermeable membrane treatment devices after the second stage is not particularly limited as long as it has an osmotic pressure. Examples include aqueous solutions containing inorganic salts such as sodium chloride, aqueous solutions containing organic substances such as glucose, aqueous solutions containing polymers, and ionic liquids. From the perspective of the influence of the diffusion of the reduced component from the primary side to the secondary side, it is advisable to use a liquid with the same composition as the dilute absorption solution passed to the primary side 48 of the first-stage semipermeable membrane treatment device 42.
圖6顯示本實施形態之水處理裝置5中之濃縮裝置34的另一例。 FIG. 6 shows another example of the concentration device 34 in the water treatment device 5 of this embodiment.
圖6所示之濃縮裝置344係一壓力輔助逆滲透膜處理裝置例。濃縮裝置344係一裝置,該裝置具有使用半透膜濃縮處理對象水並進一步使用半透膜濃縮該 濃縮液之一個以上的濃縮設備,且將前述稀薄吸引溶液供給至第一段半透膜之一次側,接著將該濃縮液依序供給至各段半透膜之一次側並將前述稀薄吸引溶液之一部份或任一段濃縮液之一部份供給至各段半透膜之二次側,並加壓各段半透膜之一次側使該一次側含有之水透過二次側。 The concentration device 344 shown in Figure 6 is an example of a pressure-assisted reverse osmosis membrane treatment device. The concentration device 344 is a device that uses a semipermeable membrane to concentrate the treatment target water and further uses a semipermeable membrane to concentrate the water. One or more concentration equipment for concentrated liquid, and the aforementioned thin suction solution is supplied to the primary side of the first semipermeable membrane, and then the concentrated liquid is sequentially supplied to the primary side of each semipermeable membrane, and the aforementioned thin suction solution is A part or part of the concentrated liquid in any section is supplied to the secondary side of each section of semipermeable membrane, and the primary side of each section of semipermeable membrane is pressurized to allow the water contained in the primary side to pass through the secondary side.
濃縮裝置344具有例如:第一段半透膜處理裝置78、第二段半透膜處理裝置80、第三段半透膜處理裝置82。各半透膜處理裝置具有被半透膜88分隔之一次側(第一空間)84及二次側(第二空間)86。 The concentration device 344 has, for example, a first-stage semipermeable membrane treatment device 78, a second-stage semipermeable membrane treatment device 80, and a third-stage semipermeable membrane treatment device 82. Each semipermeable membrane treatment device has a primary side (first space) 84 and a secondary side (second space) 86 separated by a semipermeable membrane 88.
在圖6所示之濃縮裝置344中,配管90透過泵106連接於第一段半透膜處理裝置78之一次側84的入口。第一段半透膜處理裝置78之一次側84的出口及第二段半透膜處理裝置80之一次側84的入口藉由配管92連接。第二段半透膜處理裝置80之一次側84的出口及第三段半透膜處理裝置82之一次側84的入口藉由配管94連接。配管96連接於第三段半透膜處理裝置82之一次側84的出口。由配管96分歧之配管98連接於第三段半透膜處理裝置82之二次側86的入口。第三段半透膜處理裝置82之二次側86的出口及第二段半透膜處理裝置80之二次側86的入口藉由配管100連接。第二段半透膜處理裝置80之二次側86的出口及第一段半透膜處理裝置78之二次側86的入口藉由配管102連接。配管104連接於第一段半透膜處理裝置78之二次側86的出口。依據需要,配管92、94、96、98、100、102中可具有:加壓、送液用之泵;用以調整施加在半透膜上之壓力的閥等壓力調整機構;用以暫時貯存處理水之槽等。 In the concentration device 344 shown in FIG6 , the piping 90 is connected to the inlet of the primary side 84 of the first-stage semipermeable membrane treatment device 78 through the pump 106. The outlet of the primary side 84 of the first-stage semipermeable membrane treatment device 78 and the inlet of the primary side 84 of the second-stage semipermeable membrane treatment device 80 are connected by the piping 92. The outlet of the primary side 84 of the second-stage semipermeable membrane treatment device 80 and the inlet of the primary side 84 of the third-stage semipermeable membrane treatment device 82 are connected by the piping 94. The piping 96 is connected to the outlet of the primary side 84 of the third-stage semipermeable membrane treatment device 82. The piping 98 branched from the piping 96 is connected to the inlet of the secondary side 86 of the third-stage semipermeable membrane treatment device 82. The outlet of the secondary side 86 of the third-stage semipermeable membrane treatment device 82 and the inlet of the secondary side 86 of the second-stage semipermeable membrane treatment device 80 are connected by a pipe 100. The outlet of the secondary side 86 of the second-stage semipermeable membrane treatment device 80 and the inlet of the secondary side 86 of the first-stage semipermeable membrane treatment device 78 are connected by a pipe 102. The pipe 104 is connected to the outlet of the secondary side 86 of the first-stage semipermeable membrane treatment device 78. As needed, the pipes 92, 94, 96, 98, 100, and 102 may have: a pump for pressurization and liquid delivery; a pressure adjustment mechanism such as a valve for adjusting the pressure applied to the semipermeable membrane; a tank for temporarily storing treated water, etc.
在濃縮裝置344中,作為被處理水之正滲透膜處理裝置14中使用的稀薄吸引溶液(例如,MgCl2:10質量%)之一部份藉由泵106通過配管90,接著輸送至第一段半透膜處理裝置78之一次側84。另一方面,由後述最終段之第三段半透膜處理裝置82經由第二段半透膜處理裝置80之二次側86送回的稀釋液(二次側處理水)(例如,MgCl2:6質量%)通過配管102,接著輸送至第一段半透膜處理裝置78之二次側86。在第一段半透膜處理裝置78中,加壓半透膜之一次側84使該一次側84含有之水透過二次側86(濃縮步驟(第一段))。 In the concentrator 344, a portion of the dilute draw solution (e.g., MgCl 2 : 10 mass %) used in the forward osmosis membrane treatment device 14 as the treated water is transported to the primary side 84 of the first semipermeable membrane treatment device 78 through the pipe 90 by the pump 106. On the other hand, the dilute solution (secondary side treated water) (e.g., MgCl 2 : 6 mass %) returned from the third semipermeable membrane treatment device 82 as the final stage described later via the secondary side 86 of the second semipermeable membrane treatment device 80 is transported to the secondary side 86 of the first semipermeable membrane treatment device 78 through the pipe 102. In the first-stage semipermeable membrane treatment device 78, the primary side 84 of the semipermeable membrane is pressurized to allow water contained in the primary side 84 to pass through the secondary side 86 (concentration step (first stage)).
第一段半透膜處理裝置78之濃縮液(一次側處理水)(例如,MgCl2:18質量%)通過配管92,接著輸送至第二段半透膜處理裝置80之一次側84。另一方面,由後述最終段之第三段半透膜處理裝置82送回的稀釋液(二次側處理水)(例如,MgCl2:15質量%)通過配管100,接著輸送至第二段半透膜處理裝置80之二次側86。與第一段同樣地,在第二段半透膜處理裝置80中,加壓半透膜之一次側84使該一次側84含有之水透過二次側86(濃縮步驟(第二段))。 The concentrated liquid (primary side treated water) (for example, MgCl 2 :18% by mass) of the first-stage semipermeable membrane treatment device 78 passes through the pipe 92 and is then transported to the primary side 84 of the second-stage semipermeable membrane treatment device 80 . On the other hand, the diluent (secondary side treated water) (for example, MgCl 2 :15% by mass) sent back from the third-stage semipermeable membrane treatment device 82 of the final stage described below passes through the pipe 100 and is then transported to the second stage. The secondary side 86 of the semipermeable membrane processing device 80 . Similar to the first stage, in the second stage semipermeable membrane treatment device 80, the primary side 84 of the semipermeable membrane is pressurized to allow the water contained in the primary side 84 to pass through the secondary side 86 (concentration step (second stage)) .
第二段半透膜處理裝置80之濃縮液(一次側處理水)(例如,MgCl2:23質量%)通過配管94,接著輸送至第三段半透膜處理裝置82之一次側84。另一方面,由後述最終段之第三段半透膜處理裝置82送回的濃縮液(例如,MgCl2:30質量%)通過配管98,接著輸送至第三段半透膜處理裝置82之二次側86。與第一、二段同樣地,在第三段半透膜處理裝置82中,加壓半透膜之一次側84使該一次側84含有之水透過二次側86(濃縮步驟(第三段))。 The concentrated liquid (primary side treated water) (for example, MgCl 2 :23% by mass) of the second-stage semipermeable membrane treatment device 80 passes through the pipe 94 and is then transported to the primary side 84 of the third-stage semipermeable membrane treatment device 82 . On the other hand, the concentrated solution (for example, MgCl 2 :30% by mass) returned from the third-stage semipermeable membrane treatment device 82 of the final stage described below passes through the pipe 98 and is then transported to the third-stage semipermeable membrane treatment device 82 Secondary side 86. Similar to the first and second stages, in the third stage semipermeable membrane treatment device 82, the primary side 84 of the semipermeable membrane is pressurized to allow the water contained in the primary side 84 to pass through the secondary side 86 (concentration step (third stage) )).
最終段之第三段半透膜處理裝置82之濃縮液(一次側處理水)(例如,MgCl2:30質量%)的一部份通過配管96排出,作為正滲透膜處理裝置14中之吸引溶液再度使用。第三段半透膜處理裝置82之濃縮液剩餘的一部份通過配管96、98,接著輸送至第三段半透膜處理裝置82之二次側86。如上所述,在第三段半透膜處理裝置82中,加壓半透膜之一次側84使該一次側84含有之水透過二次側86(濃縮步驟(第三段))。 A part of the concentrated liquid (primary side treatment water) (for example, MgCl 2 :30 mass %) of the third-stage semipermeable membrane treatment device 82 in the final stage is discharged through the pipe 96 and serves as the suction in the forward osmosis membrane treatment device 14 The solution is reused. The remaining portion of the concentrated liquid in the third-stage semipermeable membrane treatment device 82 passes through pipes 96 and 98 and is then transported to the secondary side 86 of the third-stage semipermeable membrane treatment device 82 . As described above, in the third-stage semipermeable membrane treatment device 82, the primary side 84 of the semipermeable membrane is pressurized to allow the water contained in the primary side 84 to pass through the secondary side 86 (concentration step (third stage)).
第三段半透膜處理裝置82之稀釋液(二次側處理水)(例如,MgCl2:15質量%)通過配管100,接著輸送至第二段半透膜處理裝置80之二次側86。如上所述,在第二段半透膜處理裝置80中,加壓半透膜之一次側84使該一次側84含有之水透過二次側86(濃縮步驟(第二段))。 The dilute liquid (secondary side treated water) (e.g., MgCl 2 : 15 mass%) of the third stage semipermeable membrane treatment device 82 is transported to the secondary side 86 of the second stage semipermeable membrane treatment device 80 through the pipe 100. As described above, in the second stage semipermeable membrane treatment device 80, the primary side 84 of the semipermeable membrane is pressurized to allow the water contained in the primary side 84 to pass through the secondary side 86 (concentration step (second stage)).
第二段半透膜處理裝置80之稀釋液(二次側處理水)(例如,MgCl2:6質量%)通過配管102,接著輸送至第一段半透膜處理裝置78之二次側86。如上所述,在第一段半透膜處理裝置78中,加壓半透膜之一次側84使該一次側84含有之水透過二次側86(濃縮步驟(第一段))。第一段半透膜處理裝置78之稀釋液(二次側處理水)(例如,MgCl2:<1質量%)通過配管104排出。稀釋液可依需要在實施超過濾膜(UF膜)處理、逆滲透膜(RO膜)處理、離子交換處理等後回收、再利用。 The dilute liquid (secondary side treated water) (e.g., MgCl 2 : 6 mass%) of the second stage semipermeable membrane treatment device 80 passes through the pipe 102 and is then transported to the secondary side 86 of the first stage semipermeable membrane treatment device 78. As described above, in the first stage semipermeable membrane treatment device 78, the primary side 84 of the semipermeable membrane is pressurized so that the water contained in the primary side 84 passes through the secondary side 86 (concentration step (first stage)). The dilute liquid (secondary side treated water) (e.g., MgCl 2 : <1 mass%) of the first stage semipermeable membrane treatment device 78 is discharged through the pipe 104. The dilute liquid can be recovered and reused after ultrafiltration membrane (UF membrane) treatment, reverse osmosis membrane (RO membrane) treatment, ion exchange treatment, etc. as needed.
因為該濃縮裝置344之如此壓力輔助逆滲透膜處理裝置使用被處理水之一部份作為滲透壓輔助用之稀釋用液,所以可不必另外準備稀釋液,因此裝置結構可比濃縮裝置340之如此壓力輔助逆滲透膜處理裝置簡化。 Because the pressure-assisted reverse osmosis membrane treatment device of the concentration device 344 uses a portion of the treated water as a diluent for osmotic pressure assistance, it is not necessary to prepare a diluent separately, so the device structure can be simplified compared to the pressure-assisted reverse osmosis membrane treatment device of the concentration device 340.
如上所述,由上述稀薄吸引溶液製得之濃縮吸引溶液作為正滲透膜處理裝置14中之吸引溶液再度使用。 As described above, the concentrated attracting solution prepared from the above-mentioned dilute attracting solution is reused as the attracting solution in the forward osmosis membrane treatment device 14.
可在該濃縮裝置344之如此壓力輔助逆滲透膜處理裝置中,供給正滲透膜處理裝置14中使用之稀薄吸引溶液之一部份或任一段濃縮液之一部份至各段半透膜之二次側,該方法沒有特別限制。 In such a pressure-assisted reverse osmosis membrane treatment device of the concentration device 344, a portion of the dilute suction solution used in the forward osmosis membrane treatment device 14 or a portion of the concentrated solution of any section can be supplied to the secondary side of each section of the semipermeable membrane. The method is not particularly limited.
例如,如圖7之濃縮裝置346所示地,可分配作為被處理水之正滲透膜處理裝置14中使用的稀薄吸引溶液,並分別供給至第一段半透膜處理裝置78之一次側84、二次側86,接著分別依序供給該濃縮液及透過液至各段半透膜之一次側84及二次側86,然後加壓各段半透膜之一次側使該一次側含有之水透過二次側。 For example, as shown in the concentration device 346 in FIG. 7 , the thin suction solution used in the forward osmosis membrane treatment device 14 as the water to be treated can be distributed and supplied to the primary side 84 of the first-stage semipermeable membrane treatment device 78 respectively. , the secondary side 86, and then supply the concentrated liquid and permeate sequentially to the primary side 84 and the secondary side 86 of each section of semipermeable membrane, and then pressurize the primary side of each section of semipermeable membrane to make the primary side contain Water passes through the secondary side.
如圖8之濃縮裝置348所示地,可供給作為被處理水之正滲透膜處理裝置14中使用的稀薄吸引溶液至第一段半透膜處理裝置78之一次側84,並依序供給該濃縮液至各段半透膜之一次側,接著供給最終段之第三段半透膜處理裝置82之濃縮液的一部份至第一段半透膜處理裝置78之二次側86並依序供給該透過液至各段半透膜之二次側,然後加壓各段半透膜之一次側使該一次側含有之水透過二次側。 As shown in the concentration device 348 of FIG8 , the dilute draw solution used in the forward osmosis membrane treatment device 14 as the treated water can be supplied to the primary side 84 of the first semipermeable membrane treatment device 78, and the concentrated liquid is sequentially supplied to the primary side of each semipermeable membrane, and then a portion of the concentrated liquid of the final third semipermeable membrane treatment device 82 is supplied to the secondary side 86 of the first semipermeable membrane treatment device 78 and the permeate is sequentially supplied to the secondary side of each semipermeable membrane, and then the primary side of each semipermeable membrane is pressurized to allow the water contained in the primary side to pass through the secondary side.
如圖9之濃縮裝置350所示地,可供給作為被處理水之正滲透膜處理裝置14中使用的稀薄吸引溶液至第一段半透膜處理裝置78之一次側84,並依序供給該 濃縮液至各段半透膜之一次側,接著供給各段之半透膜處理裝置之濃縮液的一部份至該半透膜處理裝置本身之二次側86,然後加壓各段半透膜之一次側使該一次側含有之水透過二次側。 As shown in the concentration device 350 of FIG. 9 , the dilute draw solution used in the forward osmosis membrane treatment device 14 as the treated water can be supplied to the primary side 84 of the first semipermeable membrane treatment device 78, and the concentrated solution is sequentially supplied to the primary side of each semipermeable membrane, and then a portion of the concentrated solution of each semipermeable membrane treatment device is supplied to the secondary side 86 of the semipermeable membrane treatment device itself, and then the primary side of each semipermeable membrane is pressurized to allow the water contained in the primary side to pass through the secondary side.
在上述濃縮裝置340、342、344、346、348、350中,半透膜處理裝置之段數可依據目的之處理水濃度等來決定。例如,在濃縮裝置344、346、348、350中,欲由較稀濃度之稀薄吸引溶液製得較濃濃度之處理水(濃縮吸引溶液)時,可增加半透膜處理裝置之段數。 In the above-described concentration devices 340, 342, 344, 346, 348, and 350, the number of stages of the semipermeable membrane treatment device can be determined according to the intended treatment water concentration, etc. For example, in the concentration devices 344, 346, 348, and 350, when it is desired to produce treatment water with a relatively concentrated concentration (concentrated suction solution) from a thin suction solution with a relatively dilute concentration, the number of stages of the semipermeable membrane treatment device can be increased.
在上述濃縮裝置340、342、344、346、348、350中,可使用具有並聯地連接之2個以上膜模組的膜模組單元作為各段之半透膜處理裝置。各膜模組單元中之膜模組條數可依據處理對象之稀薄吸引溶液的流量等來決定。 In the above-mentioned concentration devices 340, 342, 344, 346, 348, 350, a membrane module unit having two or more membrane modules connected in parallel can be used as a semipermeable membrane treatment device for each section. The number of membrane modules in each membrane module unit can be determined according to the flow rate of the dilute suction solution to be treated, etc.
具有半透膜處理裝置之半透膜可舉例如:逆滲透膜(RO膜)、正滲透膜(FO膜)、奈米過濾膜(NF膜)等之半透膜。半透膜宜為逆滲透膜、正滲透膜、奈米過濾膜。此外,使用逆滲透膜或正滲透膜、奈米過濾膜作為半透膜時,一次側之對象溶液的壓力宜為0.5至10.0MPa。 Semipermeable membranes having a semipermeable membrane treatment device include, for example, reverse osmosis membranes (RO membranes), forward osmosis membranes (FO membranes), nanofiltration membranes (NF membranes), and other semipermeable membranes. The semipermeable membrane is preferably a reverse osmosis membrane, a forward osmosis membrane, or a nanofiltration membrane. In addition, when using a reverse osmosis membrane, forward osmosis membrane, or nanofiltration membrane as a semipermeable membrane, the pressure of the target solution on the primary side is preferably 0.5 to 10.0 MPa.
構成半透膜沒有特別限制,但可舉例如:乙酸纖維素系樹脂等之纖維素系樹脂、聚醚碸系樹脂等之聚碸系樹脂、聚醯胺系樹脂等。構成半透膜之材料係乙酸纖維素系樹脂較佳。 The semipermeable membrane is not particularly limited, but examples thereof include cellulose-based resins such as cellulose acetate-based resins, polyether-based resins such as polyether-based resins, and polyamide-based resins. The material constituting the semipermeable membrane is preferably cellulose acetate resin.
半透膜之形狀只要具有可分別地供給溶液至膜之一次側及二次側的構造即可,沒有特別限制,可舉螺旋型、中空紗膜、板底框型等為例。 The shape of the semipermeable membrane is not particularly limited as long as it has a structure that can separately supply the solution to the primary side and the secondary side of the membrane. Examples include spiral type, hollow gauze membrane, plate-bottom frame type, etc.
[水處理裝置之另一例] [Another example of water treatment device]
本發明實施形態之另一水處理裝置例的概略結構顯示於圖2中。圖2所示之水處理裝置3更具有吸引溶液調製槽30,作為混合氫氧化鎂及酸並在pH7以下使其反應以調製作為吸引溶液使用之鎂鹽水溶液的調製設備。 The schematic structure of another water treatment device example of the embodiment of the present invention is shown in FIG2. The water treatment device 3 shown in FIG2 further has an attracting solution preparation tank 30, which is a preparation device for mixing magnesium hydroxide and acid and reacting them at a pH below 7 to prepare a magnesium salt aqueous solution used as an attracting solution.
在圖2之水處理裝置3中,吸引溶液調製槽30之出口及正滲透膜處理裝置14之吸引溶液入口藉由吸引溶液配管32連接。 In the water treatment device 3 of FIG. 2 , the outlet of the suction solution preparation tank 30 and the suction solution inlet of the forward osmosis membrane treatment device 14 are connected by the suction solution piping 32.
與圖1之水處理裝置1同樣地進行:前處理步驟,其包含溶解性二氧化矽去除步驟及硬度成分去除步驟中之任一步驟;及濃縮處理步驟,濃縮處理藉由前處理步驟製得之前處理水。 The same as the water treatment device 1 in Figure 1 is performed: a pre-treatment step, which includes any one of a soluble silica removal step and a hardness component removal step; and a concentration step, wherein the concentration step is performed to obtain previously treated water through the pre-treatment step.
另一方面,在吸引溶液調製槽30中,混合氫氧化鎂及酸並在pH7以下使其反應以調製作為吸引溶液使用之鎂鹽水溶液(調製步驟)。 On the other hand, in the suction solution preparation tank 30, magnesium hydroxide and acid are mixed and reacted at a pH of 7 or less to prepare a magnesium aqueous salt solution used as the suction solution (preparation step).
在正滲透膜處理裝置14中正滲透膜處理藉由逆滲透膜處理製得之濃縮水(正滲透膜處理步驟)。在正滲透膜處理裝置14中,藉由吸引溶液調製槽30調製之吸引溶液通過吸引溶液配管32輸送至正滲透膜之二次側,接著透過正滲透膜使濃縮水及吸引溶液存在,藉此使水利用滲透壓移動至吸引溶液。 In the forward osmosis membrane treatment device 14, the forward osmosis membrane processes the concentrated water produced by the reverse osmosis membrane treatment (forward osmosis membrane treatment step). In the forward osmosis membrane treatment device 14, the suction solution prepared by the suction solution preparation tank 30 is transported to the secondary side of the forward osmosis membrane through the suction solution pipe 32, and then passes through the forward osmosis membrane to allow concentrated water and the suction solution to exist, thereby Water is allowed to move using osmotic pressure to attract the solution.
正滲透膜處理步驟中使用之稀薄吸引溶液通過稀薄吸引溶液配管26輸送至前處理裝置10,接著在前處理裝置10中在前處理步驟中使用。 The dilute suction solution used in the positive osmosis membrane treatment step is transported to the pre-treatment device 10 through the dilute suction solution pipe 26, and then used in the pre-treatment step in the pre-treatment device 10.
在圖3之水處理裝置5中,與圖2之水處理裝置3同樣地,可更具有吸引溶液調製槽,作為混合氫氧化鎂及酸並在pH7以下使其反應以調製作為吸引溶液使用之鎂鹽水溶液的調製設備。在吸引溶液調製槽中,混合氫氧化鎂及酸並在pH7以下使其反應以調製鎂鹽水溶液(調製步驟),且可將調製之鎂鹽水溶液輸送至正滲透膜處理裝置14之二次側作為吸引溶液使用。 In the water treatment device 5 of Fig. 3, like the water treatment device 3 of Fig. 2, it may be further equipped with an suction solution preparation tank for mixing magnesium hydroxide and acid and reacting them at a pH of 7 or less to prepare an suction solution. Equipment for preparing magnesium salt solution. In the suction solution preparation tank, magnesium hydroxide and acid are mixed and reacted at a pH of 7 or below to prepare a magnesium salt solution (preparation step), and the prepared magnesium salt solution can be transported to the secondary side of the forward osmosis membrane treatment device 14 Use as a suction solution.
調製步驟中使用之酸可舉例如:鹽酸、硫酸、硝酸等,且由抑制難溶解性物質生成等之觀點來看,鹽酸或硝酸較佳。 Examples of the acid used in the preparation step include hydrochloric acid, sulfuric acid, nitric acid, etc., and from the viewpoint of suppressing the production of poorly soluble substances, hydrochloric acid or nitric acid is preferred.
調製步驟中之pH只要7以下即可,沒有特別限制,但可在例如pH1至7之範圍內,且宜在2至5之範圍內。調製步驟中之pH超過7時,鎂鹽之溶解會不充分,且小於1時,酸之添加量會過多。 The pH in the preparation step is not particularly limited as long as it is 7 or lower, but it can be in the range of 1 to 7, and preferably in the range of 2 to 5. If the pH in the preparation step exceeds 7, the magnesium salt will not be fully dissolved, and if it is less than 1, the added amount of acid will be too much.
調製步驟中之溫度只要是進行鎂鹽之溶解反應的溫度即可,沒有特別限制,但可在例如1℃至80℃之範圍內。調製步驟中之溫度小於1℃時,鎂鹽之溶解反應會不充分,且超過80℃時,設備之耐熱性等會有問題。 The temperature in the preparation step is not particularly limited as long as the dissolution reaction of the magnesium salt proceeds, but it may be in the range of 1°C to 80°C, for example. If the temperature in the preparation step is less than 1°C, the dissolution reaction of the magnesium salt will be insufficient, and if it exceeds 80°C, there will be problems with the heat resistance of the equipment.
調製步驟中之反應時間只要可進行鎂鹽之溶解反應即可,沒有特別限制,但可在例如5分至120分之範圍內。調製步驟中之反應時間小於5分時,鎂鹽之溶解反應會不充分,且超過120分時,設備會有問題。 The reaction time in the preparation step is not particularly limited as long as the magnesium salt can be dissolved, but it can be in the range of 5 minutes to 120 minutes. If the reaction time in the preparation step is less than 5 minutes, the dissolution reaction of the magnesium salt will be insufficient, and if it exceeds 120 minutes, the equipment will have problems.
<正滲透膜處理方法及正滲透膜處理系統> <Forward osmosis membrane treatment method and forward osmosis membrane treatment system>
以下在圖11中顯示本發明實施形態之一正滲透膜處理系統例的概略,且說明其結構。 The following is a schematic diagram of an example of a forward osmosis membrane treatment system, which is one embodiment of the present invention, and its structure is described in FIG11.
本實施形態之正滲透膜處理系統8具有正滲透膜處理裝置14,且該正滲透膜處理裝置14作為藉由使被處理水(FO被處理水)及濃度比被處理水(FO被處理水)高之吸引溶液透過正滲透膜110接觸來製得濃縮水(FO濃縮水)及稀薄吸引溶液的正滲透膜處理設備。 The forward osmosis membrane treatment system 8 of this embodiment has a forward osmosis membrane treatment device 14, and the forward osmosis membrane treatment device 14 is a forward osmosis membrane treatment device that produces concentrated water (FO concentrated water) and a dilute draw solution by allowing the water to be treated (FO treated water) and a draw solution with a higher concentration than the water to be treated (FO treated water) to contact through a forward osmosis membrane 110.
在圖11之正滲透膜處理系統8中,FO被處理水配管16連接於正滲透膜處理裝置14之FO被處理水入口,且FO濃縮水配管28連接於FO濃縮水出口。吸引溶液配管24連接於正滲透膜處理裝置14之吸引溶液入口,且稀薄吸引溶液配管26連接於稀薄吸引溶液出口。殺菌劑添加配管112連接於FO被處理水配管16作為殺菌劑添加設備。 In the forward osmosis membrane treatment system 8 of FIG. 11 , the FO treated water pipe 16 is connected to the FO treated water inlet of the forward osmosis membrane treatment device 14 , and the FO concentrated water pipe 28 is connected to the FO concentrated water outlet. The suction solution pipe 24 is connected to the suction solution inlet of the forward osmosis membrane treatment device 14, and the dilute suction solution pipe 26 is connected to the dilute suction solution outlet. The sterilant addition pipe 112 is connected to the FO treated water pipe 16 as a sterilant addition device.
以下說明本實施形態之正滲透膜處理方法及正滲透膜處理系統8之動作。 The following describes the forward osmosis membrane treatment method and the operation of the forward osmosis membrane treatment system 8 of this embodiment.
FO被處理水通過FO被處理水配管16輸送至正滲透膜處理裝置14之一次側且在正滲透膜處理裝置14中進行正滲透膜處理(正滲透膜處理步驟)。在正滲透膜處理裝置14中,吸引溶液通過吸引溶液配管24輸送至正滲透膜之二次側且透過正滲透膜110使FO被處理水及吸引溶液存在,藉此使水利用滲透壓移動至吸引溶液。正滲透膜處理步驟中使用之稀薄吸引溶液通過稀薄吸引溶液配管26排出。藉由正滲透膜處理步驟製得之FO濃縮水通過FO濃縮水配管28排出。稀薄吸引溶液及FO濃縮水中之至少一者可回收、再利用。 The FO treated water is transported to the primary side of the forward osmosis membrane treatment device 14 through the FO treated water pipe 16 and is subjected to forward osmosis membrane treatment (forward osmosis membrane treatment step) in the forward osmosis membrane treatment device 14 . In the forward osmosis membrane treatment device 14, the suction solution is transported to the secondary side of the forward osmosis membrane through the suction solution pipe 24 and passes through the forward osmosis membrane 110 to allow the FO to be treated water and the suction solution to exist, thereby causing the water to move to the secondary side using osmotic pressure. Attract solution. The dilute suction solution used in the forward osmosis membrane treatment step is discharged through the dilute suction solution pipe 26 . The FO concentrated water produced by the forward osmosis membrane treatment step is discharged through the FO concentrated water pipe 28 . At least one of the dilute suction solution and FO concentrated water can be recovered and reused.
在此,使包含溴系氧化劑或氯系氧化劑及胺磺酸化合物之殺菌劑(以下,有時稱為「正滲透膜用殺菌劑」)存在FO被處理水中。例如,正滲透膜用殺菌劑通過殺菌劑添加配管112在FO被處理水配管16中添加至FO被處理水中。亦可在正滲透膜處理裝置14之前段另外設置貯存FO被處理水之FO被處理水槽,且在FO被處理水槽中添加正滲透膜用殺菌劑。 Here, a bactericide containing a bromine-based oxidizing agent or a chlorine-based oxidizing agent and a sulfamic acid compound (hereinafter, sometimes referred to as a "bactericide for forward osmosis membrane") is present in the FO to-be-treated water. For example, the bactericide for the forward osmosis membrane is added to the FO to be treated water in the FO to be treated water pipe 16 through the bactericide adding pipe 112 . It is also possible to provide an additional FO treated water tank for storing FO treated water in the front stage of the forward osmosis membrane treatment device 14, and add a bactericide for the forward osmosis membrane into the FO treated water tank.
如此,在本實施形態之正滲透膜處理方法及正滲透膜處理系統8中,正滲透膜處理被處理水時,使包含溴系氧化劑或氯系氧化劑及胺磺酸化合物之正滲透膜用殺菌劑存在正滲透膜處理之被處理水(FO被處理水)中。本發明人發現包含溴系氧化劑或氯系氧化劑及胺磺酸化合物之正滲透膜用殺菌劑幾乎未透過正滲透膜。該正滲透膜用殺菌劑對正滲透膜發揮比習知之氯系殺菌劑、氧化劑、有機系殺菌劑更充分之殺菌效果。此外,因為殺菌劑幾乎未洩漏至吸引溶液中,所以可再利用稀薄吸引溶液。 Thus, in the forward osmosis membrane treatment method and the forward osmosis membrane treatment system 8 of this embodiment, when the forward osmosis membrane treats the water to be treated, the forward osmosis membrane containing the bromine-based oxidizing agent or the chlorine-based oxidizing agent and the sulfamic acid compound is sterilized. The agent exists in the treated water (FO treated water) treated by the forward osmosis membrane. The present inventors discovered that the bactericide for a forward osmosis membrane containing a bromine-based oxidizing agent or a chlorine-based oxidizing agent and a sulfamic acid compound hardly penetrates the forward osmosis membrane. This bactericide for forward osmosis membrane exerts a more sufficient bactericidal effect on the forward osmosis membrane than conventional chlorine-based bactericides, oxidants, and organic bactericides. In addition, since the bactericide hardly leaks into the suction solution, the dilute suction solution can be reused.
因為該正滲透膜用殺菌劑之殺菌有效成分幾乎未透過正滲透膜,所以隨著前進至正滲透膜處理裝置14之出口(FO濃縮水出口)而逐漸濃縮。因此,殺菌劑之殺菌有效成分可充分地擴散到正滲透膜處理裝置14之出口(FO濃縮水出口)側且充分地殺菌到正滲透膜之出口側。 Since the sterilizing active ingredient of the forward osmosis membrane sterilant hardly penetrates the forward osmosis membrane, it is gradually concentrated as it proceeds to the outlet (FO concentrated water outlet) of the forward osmosis membrane treatment device 14 . Therefore, the sterilizing active ingredient of the sterilizing agent can be fully diffused to the outlet (FO concentrated water outlet) side of the forward osmosis membrane treatment device 14 and can be fully sterilized to the outlet side of the forward osmosis membrane.
在習知方法中,在FO被處理水中添加次氯酸、氯胺、過氧化氫、有機系殺菌劑等之殺菌劑時,FO被處理水之一部份因與吸引溶液之滲透壓差而移動至吸引溶液側,同時殺菌劑之一部份移動至吸引溶液側。相對於此,在本實施形態之正滲透膜處理方法及正滲透膜處理系統8中,藉由使用上述正滲透膜用殺菌劑,可抑制殺菌劑透過正滲透膜且再利用稀薄吸引溶液。 In the conventional method, when fungicides such as hypochlorous acid, chloramine, hydrogen peroxide, organic fungicides, etc. are added to the FO treated water, part of the FO treated water will be damaged due to the osmotic pressure difference between the FO treated water and the suction solution. Move to the suction solution side, and at the same time part of the bactericide moves to the suction solution side. On the other hand, in the forward osmosis membrane treatment method and the forward osmosis membrane treatment system 8 of this embodiment, by using the above-described bactericide for forward osmosis membranes, it is possible to suppress the permeation of the bactericide through the forward osmosis membrane and reuse the dilute suction solution.
「包含溴系氧化劑及胺磺酸化合物之殺菌劑」可為含有包含「溴系氧化劑」及「胺磺酸化合物」之混合物的安定化次溴酸組成物的殺菌劑,或含有包含「溴系氧化劑及胺磺酸化合物之反應生成物」之安定化次溴酸組成物的殺菌劑。「包含氯系氧化劑及胺磺酸化合物之殺菌劑」可為含有包含「氯系氧化劑」及「胺磺酸化合物」之混合物的安定化次氯酸組成物的殺菌劑,或含有包含「氯系氧化劑及胺磺酸化合物之反應生成物」之安定化次氯酸組成物的殺菌劑。 The "bactericide containing a bromine-based oxidizing agent and a sulfamic acid compound" may be a bactericide containing a stabilized hypobromous acid composition containing a mixture of a "bromine-based oxidizing agent" and a "sulfamic acid compound", or a bactericide containing a "bromine-based oxidizing agent" and a "sulfamic acid compound" A fungicide composed of stabilized hypobromous acid, which is the reaction product of oxidants and amine sulfonic acid compounds. The "bactericide containing a chlorine-based oxidizing agent and a sulfamic acid compound" may be a bactericidal agent containing a stabilized hypochlorous acid composition containing a mixture of a "chlorine-based oxidizing agent" and a "sulfamic acid compound", or a bactericidal agent containing a "chlorine-based oxidizing agent" and a "sulfamic acid compound" A bactericide composed of stabilized hypochlorous acid, which is a reaction product of an oxidizing agent and an amine sulfonic acid compound.
即,本發明實施形態之正滲透膜處理方法係使「溴系氧化劑」及「胺磺酸化合物」之混合物或「氯系氧化劑」及「胺磺酸化合物」之混合物存在被處理水(FO被處理水)中的方法。因此,考慮在被處理水中生成安定化次溴酸組成物或安定化次氯酸組成物。 That is, the forward osmosis membrane treatment method of the embodiment of the present invention is a method of allowing a mixture of a "bromine-based oxidant" and a "sulfonic acid compound" or a mixture of a "chlorine-based oxidant" and a "sulfonic acid compound" to exist in the water to be treated (FO treated water). Therefore, it is considered that a stabilized hypobromous acid composition or a stabilized hypochlorous acid composition is generated in the water to be treated.
此外,本發明實施形態之正滲透膜處理方法係使「溴系氧化劑及胺磺酸化合物之反應生成物」之安定化次溴酸組成物或「氯系氧化劑及胺磺酸化合物之反應生成物」之安定化次氯酸組成物存在被處理水(FO被處理水)中的方法。 In addition, the forward osmosis membrane treatment method according to the embodiment of the present invention is to stabilize the hypobromous acid composition of "the reaction product of the bromine-based oxidizing agent and the sulfamic acid compound" or the "reaction product of the chlorine-based oxidizing agent and the sulfamic acid compound" ” is a method in which a stabilized hypochlorous acid composition is present in the water to be treated (FO water to be treated).
具體而言,本發明實施形態之正滲透膜處理方法係使「溴」、「氯化溴」、「次溴酸」或「溴化鈉及次氯酸之反應物」及「胺磺酸化合物」之混合物存在被處理水中的方法。或者,使「次氯酸」及「胺磺酸化合物」之混合物存在被處理水中的方法。 Specifically, the forward osmosis membrane treatment method according to the embodiment of the present invention uses "bromine", "bromine chloride", "hypobromous acid" or "reactant of sodium bromide and hypochlorous acid" and "sulfamic acid compound". "The mixture is present in the water being treated. Alternatively, a mixture of "hypochlorous acid" and "amine sulfonic acid compound" is present in the water to be treated.
此外,本發明實施形態之正滲透膜處理方法係例如使「溴及胺磺酸化合物之反應生成物」、「氯化溴及胺磺酸化合物之反應生成物」、「次溴酸及胺磺酸化合物之反應生成物」或「溴化鈉與次氯酸之反應物及胺磺酸化合物的反應生成物」之安定化次溴酸組成物存在被處理水中的方法。或者,使「次氯酸及胺磺酸化合物之反應生成物」之安定化次氯酸組成物存在被處理水中的方法。 In addition, the forward osmosis membrane treatment method of the embodiment of the present invention is a method for allowing a stabilized hypobromous acid composition of "reaction product of bromine and sulfamic acid compound", "reaction product of bromine chloride and sulfamic acid compound", "reaction product of hypobromous acid and sulfamic acid compound" or "reaction product of sodium bromide and hypochlorous acid and reaction product of sulfamic acid compound" to exist in the water to be treated. Alternatively, a method for allowing a stabilized hypochlorous acid composition of "reaction product of hypochlorous acid and sulfamic acid compound" to exist in the water to be treated.
在本發明實施形態之正滲透膜處理方法中,雖然安定化次溴酸組成物或安定化次氯酸組成物發揮與次氯酸等氯系氧化劑等之習知殺菌劑同等以上的殺菌效果,但相較於氯系氧化劑等之習知殺菌劑,對正滲透膜之劣化影響低,因此可抑制在正滲透膜之積垢且抑制正滲透膜之氧化劣化。因此,本實施形態之正滲透膜處理方法中使用之安定化次溴酸組成物或安定化次氯酸組成物適合作為在利用正滲透膜處理被處理水之方法中使用的殺菌劑。 In the forward osmosis membrane treatment method of the embodiment of the present invention, although the stabilized hypobromous acid composition or the stabilized hypochlorous acid composition exerts a bactericidal effect equal to or higher than that of conventional bactericides such as chlorine-based oxidants such as hypochlorous acid, it has less effect on the deterioration of the forward osmosis membrane than conventional bactericides such as chlorine-based oxidants, and thus can inhibit the fouling of the forward osmosis membrane and inhibit the oxidative degradation of the forward osmosis membrane. Therefore, the stabilized hypobromous acid composition or the stabilized hypochlorous acid composition used in the forward osmosis membrane treatment method of the present embodiment is suitable as a bactericide used in the method of treating the water to be treated using a forward osmosis membrane.
本實施形態之正滲透膜處理方法中,「包含溴系氧化劑及胺磺酸化合物之殺菌劑」時,氯系氧化劑不存在,因此對正滲透膜之劣化影響更低。包含氯系氧化劑時有生成氯酸之虞。 In the forward osmosis membrane treatment method of this embodiment, when "a bactericide containing a bromine-based oxidizing agent and a sulfamic acid compound" is used, the chlorine-based oxidizing agent does not exist, so the influence on the deterioration of the forward osmosis membrane is smaller. When chlorine-based oxidants are included, there is a risk of generating chloric acid.
本實施形態之正滲透膜處理方法中,「溴系氧化劑」係溴時,氯系氧化劑不存在,因此對正滲透膜之劣化影響顯著地低。 In the forward osmosis membrane treatment method of this embodiment, when the "bromine-based oxidant" is bromine, the chlorine-based oxidant does not exist, so the effect on the deterioration of the forward osmosis membrane is significantly low.
在本實施形態之正滲透膜處理方法中,可例如藉由注藥泵等將「溴系氧化劑」或「氯系氧化劑」及「胺磺酸化合物」注入被處理水中。「溴系氧化劑」或「氯系氧化劑」及「胺磺酸化合物」可分別地添加在被處理水中或用原液混合後添加在被處理水中。 In the forward osmosis membrane treatment method of this embodiment, the "bromine-based oxidant" or "chlorine-based oxidant" and "sulfonamic acid compound" can be injected into the water to be treated, for example, by an injection pump. The "bromine-based oxidant" or "chlorine-based oxidant" and "sulfonamic acid compound" can be added to the water to be treated separately or mixed with the original solution and added to the water to be treated.
此外,可例如藉由注藥泵等將「溴系氧化劑及胺磺酸化合物之反應生成物」或「氯系氧化劑及胺磺酸化合物之反應生成物」注入被處理水中。 In addition, the "reaction product of a bromine-based oxidant and an amine sulfonic acid compound" or "reaction product of a chlorine-based oxidant and an amine sulfonic acid compound" can be injected into the treated water, for example, by using an injection pump.
在本實施形態之正滲透膜處理方法中,「胺磺酸化合物」之當量對「溴系氧化劑」或「氯系氧化劑」之當量的比宜為1以上,且在1以上2以下之範圍內更佳。「胺磺酸化合物」之當量對「溴系氧化劑」或「氯系氧化劑」之當量的比小於1時可能使膜劣化,且超過2時製造成本會增加。 In the forward osmosis membrane treatment method of this embodiment, the ratio of the equivalent of the "amine sulfonic acid compound" to the equivalent of the "bromine-based oxidizing agent" or "chlorine-based oxidizing agent" is preferably 1 or more and within the range of 1 or more and 2 or less. Better. If the ratio of the equivalent of the "amine sulfonic acid compound" to the equivalent of the "bromine-based oxidizing agent" or "chlorine-based oxidizing agent" is less than 1, the membrane may deteriorate, and if it exceeds 2, the manufacturing cost will increase.
按有效氯濃度換算,接觸正滲透膜之全氯濃度宜為0.01至100mg/L。小於0.01mg/L時無法獲得充分之殺菌效果,且大於100mg/L時可能引起正滲透膜之劣化、配管等之腐蝕。 Calculated by effective chlorine concentration, the total chlorine concentration in contact with the positive osmosis membrane should be between 0.01 and 100 mg/L. If it is less than 0.01 mg/L, it will not achieve a sufficient sterilization effect, and if it is greater than 100 mg/L, it may cause deterioration of the positive osmosis membrane and corrosion of the piping, etc.
溴系氧化劑可舉例如:溴(液體溴)、氯化溴、溴酸、溴酸鹽、次溴酸等。次溴酸可為使溴化鈉等之溴化物與次氯酸等氯系氧化劑反應而生成者。 Bromine-based oxidants include, for example, bromine (liquid bromine), bromine chloride, bromic acid, bromate, hypobromous acid, etc. Hypobromous acid can be produced by reacting bromides such as sodium bromide with chlorine-based oxidants such as hypochlorous acid.
其中,使用溴之「溴及胺磺酸化合物(溴及胺磺酸化合物之混合物)」或「溴及胺磺酸化合物之反應生成物」的製劑,相較於「次氯酸、溴化合物及胺磺酸」之製劑及「氯化溴及胺磺酸」之製劑等,溴酸之副產物少且不會使正滲透膜更劣化,因此作為正滲透膜用之殺菌劑更理想。 Among them, the preparations using bromine, "bromine and amine sulfonic acid compound (mixture of bromine and amine sulfonic acid compound)" or "reaction product of bromine and amine sulfonic acid compound" have less byproducts of bromic acid and will not further deteriorate the forward osmosis membrane, compared with the preparations of "hypochlorous acid, bromine compound and amine sulfonic acid" and "bromine chloride and amine sulfonic acid". Therefore, they are more ideal as disinfectants for forward osmosis membranes.
即,本發明實施形態之正滲透膜處理方法宜使溴及胺磺酸化合物存在(使溴及胺磺酸化合物之混合物存在)被處理水中。此外,宜使溴及胺磺酸化合物之反應生成物存在被處理水中。 That is, in the forward osmosis membrane treatment method according to the embodiment of the present invention, it is preferable that bromine and a sulfamic acid compound be present in the water to be treated (a mixture of bromine and a sulfamic acid compound be present). In addition, it is preferable to allow the reaction product of bromine and sulfamic acid compound to exist in the water to be treated.
溴化合物可舉例如:溴化鈉、溴化鉀、溴化鋰、溴化銨及溴化氫酸等。其中,由製劑成本等之方面來看,溴化鈉較佳。 Bromine compounds include, for example, sodium bromide, potassium bromide, lithium bromide, ammonium bromide, and hydrobromic acid. Among them, sodium bromide is preferred in terms of the cost of the preparation.
氯系氧化劑可舉例如:氯氣、二氧化氯、次氯酸或其鹽、亞氯酸或其鹽、氯酸或其鹽、過氯酸或其鹽、氯化異氰酸或其鹽等。其中,鹽可舉例如:次氯酸鈉、次氯酸鉀等之次氯酸鹼金屬鹽;次氯酸鈣、次氯酸鋇等之次氯酸鹼土金 屬鹽;亞氯酸鈉、亞氯酸鉀等之亞氯酸鹼金屬鹽;亞氯酸鋇等之亞氯酸鹼土金屬鹽;亞氯酸鎳等之其他亞氯酸金屬鹽;氯酸銨、氯酸鈉、氯酸鉀等之氯酸鹼金屬鹽;氯酸鈣、氯酸鋇等之氯酸鹼土金屬鹽等。該等氯系氧化劑可單獨地使用一種或組合2種以上使用。由操作性等方面來看,氯系氧化劑宜使用次氯酸鈉。 Examples of the chlorine-based oxidizing agent include chlorine gas, chlorine dioxide, hypochlorous acid or its salts, chlorous acid or its salts, chloric acid or its salts, perchloric acid or its salts, chlorinated isocyanic acid or its salts, and the like. Examples of the salt include: alkali metal hypochlorite salts such as sodium hypochlorite and potassium hypochlorite; alkaline earth gold hypochlorite salts such as calcium hypochlorite and barium hypochlorite Salts; alkali metal chlorite salts such as sodium chlorite and potassium chlorite; alkaline earth metal chlorite salts such as barium chlorite; other metal chlorite salts such as nickel chlorite; ammonium chlorate, Alkali metal chlorate salts such as sodium chlorate and potassium chlorate; alkaline earth metal chlorate salts such as calcium chlorate and barium chlorate. These chlorine-based oxidizing agents can be used singly or in combination of two or more. From the perspective of operability and other aspects, sodium hypochlorite is suitable for chlorine-based oxidants.
胺磺酸化合物係用以下通式(1)表示之化合物。 The sulfamic acid compound is a compound represented by the following general formula (1).
R2NSO3H (1) R 2 NSO 3 H (1)
(式中,R係獨立地為氫原子或碳數1至8之烷基。) (In the formula, R is independently a hydrogen atom or an alkyl group having 1 to 8 carbon atoms.)
胺磺酸化合物可舉例如:除了2個R基兩者均係氫原子之胺磺酸(醯胺硫酸)以外,N-甲基胺磺酸、N-乙基胺磺酸、N-丙基胺磺酸、N-異丙基胺磺酸、N-丁基胺磺酸等之2個R基中之一R基係氫原子且另一R基係碳數1至8之烷基的胺磺酸化合物;N,N-二甲基胺磺酸、N,N-二乙基胺磺酸、N,N-二丙基胺磺酸、N,N-二丁基胺磺酸、N-甲基-N-乙基胺磺酸、N-甲基-N-丙基胺磺酸等之2個R基兩者均係碳數1至8之烷基的胺磺酸化合物;N-苯胺磺酸等之2個R基中之一R基係氫原子且另一R基係碳數6至10之芳基的胺磺酸化合物;或其鹽等。胺磺酸鹽可舉例如:鈉鹽、鉀鹽等之鹼金屬鹽;鈣鹽、鍶鹽、鋇鹽等之鹼土金屬鹽;錳鹽、銅鹽、鋅鹽、鐵鹽、鈷鹽、鎳鹽等之其他金屬鹽;銨鹽及胍鹽等。胺磺酸化合物及其鹽可單獨地使用一種或組合2種以上使用。由環境負荷等方面來看,胺磺酸化合物使用胺磺酸(醯胺硫酸)較佳。 Examples of sulfamic acid compounds include: sulfamic acid (amide sulfonic acid) in which both of the two R groups are hydrogen atoms, N-methyl sulfamic acid, N-ethyl sulfamic acid, and N-propyl sulfonic acid. Amines in which one of the two R groups is a hydrogen atom and the other R group is an alkyl group with 1 to 8 carbon atoms, such as amine sulfonic acid, N-isopropyl amine sulfonic acid, and N-butyl amine sulfonic acid. Sulfonic acid compounds; N,N-dimethylaminesulfonic acid, N,N-diethylaminesulfonic acid, N,N-dipropylaminesulfonic acid, N,N-dibutylaminesulfonic acid, N- Methyl-N-ethylamine sulfonic acid, N-methyl-N-propylamine sulfonic acid, etc. are amine sulfonic acid compounds in which both R groups are alkyl groups with 1 to 8 carbon atoms; N-aniline An amine sulfonic acid compound in which one of the two R groups of sulfonic acid is a hydrogen atom and the other R group is an aryl group having 6 to 10 carbon atoms; or a salt thereof, etc. Examples of amine sulfonates include alkali metal salts such as sodium salt and potassium salt; alkaline earth metal salts such as calcium salt, strontium salt, and barium salt; manganese salt, copper salt, zinc salt, iron salt, cobalt salt, and nickel salt. Other metal salts; ammonium salts and guanidinium salts, etc. A sulfamic acid compound and its salt can be used individually by 1 type or in combination of 2 or more types. From the viewpoint of environmental load, etc., it is preferable to use amide sulfonic acid (amide sulfate) as the sulfamic acid compound.
在本實施形態之正滲透膜處理方法中,可進一步使鹼存在。鹼可舉例如:氫氧化鈉、氫氧化鉀等之氫氧化鹼等。由低溫之製品安定性等方面來看,可併用氫氧化鈉及氫氧化鉀。此外,鹼可非固形而是形成水溶液來使用。 In the forward osmosis membrane treatment method of this embodiment, a base may be further present. Examples of the base include alkali hydroxides such as sodium hydroxide and potassium hydroxide. From the perspective of product stability at low temperatures, sodium hydroxide and potassium hydroxide can be used together. Furthermore, the base may be used not in solid form but in the form of an aqueous solution.
正滲透膜處理步驟中使用之正滲透膜的形狀沒有特別限制,但可使用例如中空紗膜、螺旋膜、管形膜、板底框構造之膜等。正滲透膜之膜材質可舉芳香族聚醯胺系、乙酸纖維素系、多酮系等為例。此外,亦可使用在分離膜之基材中組合機能性蛋白質及無機材料等以賦予分離性能及透水性等的膜。本實施形態之正滲透膜處理方法可理想地使用在芳香族聚醯胺系、醯胺系之基材中組合機能性蛋白質及無機材料等以賦予分離性能及透水性等的膜作為正滲透膜。已知的是該等膜特別容易受到因習知使用之氯系氧化劑造成的劣化影響。 The shape of the forward osmosis membrane used in the forward osmosis membrane treatment step is not particularly limited, but for example, hollow yarn membranes, spiral membranes, tubular membranes, membranes with plate-bottom frame structures, etc. can be used. Examples of the membrane material of the forward osmosis membrane include aromatic polyamide series, cellulose acetate series, polyketone series, etc. In addition, a membrane in which functional proteins and inorganic materials are combined in the base material of the separation membrane to impart separation performance and water permeability can also be used. The forward osmosis membrane treatment method of this embodiment can ideally use a membrane in which functional proteins and inorganic materials are combined in the base material of the aromatic polyamide series and amide series to impart separation performance and water permeability as a forward osmosis membrane. It is known that such membranes are particularly susceptible to deterioration caused by the chlorine-based oxidants commonly used.
正滲透膜可舉例如:HP5230(東洋紡製)、HFFO2(Aquaporin製)、OsmoF20(Fruid Technology Solutions製)。該等正滲透膜可單段地使用或串聯地連接多數段使用。即,可藉由第二正滲透膜處理進一步濃縮藉由第一正滲透膜處理製得之濃縮水。 Examples of the forward osmosis membrane include HP5230 (manufactured by Toyobo), HFFO2 (manufactured by Aquaporin), and OsmoF20 (manufactured by Fruid Technology Solutions). These forward osmosis membranes can be used in a single section or multiple sections connected in series. That is, the concentrated water obtained by the first forward osmosis membrane treatment can be further concentrated by the second forward osmosis membrane treatment.
但是,正滲透膜及逆滲透膜因其運轉方法不同,膜之構造、性質不同。逆滲透膜對膜之一次側施加高壓力,因此使膜厚為厚以保持可耐壓力之機械強度。另一方面,因為正滲透膜之施加於膜的壓力比逆滲透膜低,所以可沒有逆滲透膜情形之機械強度,且必須進一步抑制膜內部之濃度極化,因此需要使膜厚為薄。使膜最適合要求之運轉條件,結果逆滲透膜及正滲透膜雖然膜材質相 同,但具有不同膜構造,因此透過性能、阻止性能不同。因此,將逆滲透膜處理中使用之逆滲透膜用於正滲透用途時,無法獲得充分之性能。 However, the forward osmosis membrane and reverse osmosis membrane have different membrane structures and properties due to their different operating methods. The reverse osmosis membrane applies high pressure to the primary side of the membrane, so the membrane thickness is made thick to maintain mechanical strength that can withstand the pressure. On the other hand, because the pressure applied to the forward osmosis membrane is lower than that of the reverse osmosis membrane, the mechanical strength of the reverse osmosis membrane is not as good as that of the reverse osmosis membrane, and the concentration polarization inside the membrane must be further suppressed, so the membrane thickness needs to be made thin. The membrane is made to best suit the required operating conditions. As a result, although the reverse osmosis membrane and the forward osmosis membrane have the same membrane material, they have different membrane structures, so the permeation performance and blocking performance are different. Therefore, when the reverse osmosis membrane used in reverse osmosis membrane treatment is used for forward osmosis purposes, sufficient performance cannot be obtained.
正滲透膜處理步驟中使用之吸引溶液可舉例如:碳酸銨水溶液、鎂鹽水溶液、鈉鹽水溶液等之無機鹽水溶液;蔗糖、葡萄糖、有機性聚合物等之有機物水溶液;離子液體等。正滲透膜處理步驟中使用之稀薄吸引溶液可原封不動地使用在另一步驟中,或藉由對稀薄吸引溶液施加加熱、膜分離等之操作而由稀薄吸引溶液分離水,接著再利用製得之水及濃縮吸引溶液。在正滲透膜處理步驟中進行多數段正滲透膜處理時,可組合使用上述吸引溶液。 Examples of the suction solution used in the forward osmosis membrane treatment step include inorganic aqueous solutions such as ammonium carbonate aqueous solution, magnesium aqueous solution, and sodium aqueous solution; organic aqueous solutions of sucrose, glucose, organic polymers, etc.; ionic liquids, etc. The dilute suction solution used in the forward osmosis membrane treatment step can be used unchanged in another step, or the water can be separated from the dilute suction solution by heating, membrane separation, etc., and then reused. water and concentrated suction solution. When performing multiple stages of forward osmosis membrane treatment in the forward osmosis membrane treatment step, the above-mentioned suction solutions can be used in combination.
被處理水(FO被處理水)沒有特別限制,但可舉例如:工業用水、表層水、自來水、地下水、海水、藉由逆滲透法或蒸發法使海水脫鹽之海水淡化處理水、例如在半導體製程等中排出之排水等的各種排水。 The water to be treated (FO to be treated) is not particularly limited, but examples include: industrial water, surface water, tap water, groundwater, seawater, seawater desalination water desalinated by reverse osmosis or evaporation, for example, in semiconductors Various types of drainage such as drainage discharged from manufacturing processes, etc.
被處理水之pH係在例如2至12之範圍內,且在4至11之範圍內較佳。被處理水之pH小於2或超過12時,正滲透膜會劣化。 The pH of the treated water is, for example, in the range of 2 to 12, and preferably in the range of 4 to 11. When the pH of the treated water is less than 2 or exceeds 12, the positive osmosis membrane will deteriorate.
在正滲透膜處理裝置中,被處理水為pH5.5以上且產生水垢時,可與上述殺菌劑併用分散劑以抑制水垢。分散劑可舉例如:聚丙烯酸、聚順丁烯二酸、膦酸等。分散劑對被處理水之添加量係例如按FO濃縮水中之濃度計在0.1至1,000mg/L之範圍內。 In a forward osmosis membrane treatment device, when the pH of the water to be treated is 5.5 or higher and scale occurs, a dispersant can be used together with the above-mentioned bactericide to inhibit scale. Examples of dispersants include polyacrylic acid, polymaleic acid, phosphonic acid, and the like. The amount of dispersant added to the water to be treated is, for example, in the range of 0.1 to 1,000 mg/L based on the concentration in FO concentrated water.
此外,為了在未使用分散劑之情形下控制水垢之發生,例如,可調整正滲透膜處理裝置之回收率、水溫、pH等之運轉條件,使FO濃縮水中之二氧化矽濃度在溶解度以下且使作為鈣水垢之指標的藍氏(Langelier)指數為0以下。 In addition, in order to control the occurrence of scale without using a dispersant, for example, the recovery rate, water temperature, pH and other operating conditions of the forward osmosis membrane treatment device can be adjusted so that the concentration of silica in the FO concentrated water is below the solubility and the Langelier index, which is an indicator of calcium scale, is below 0.
正滲透膜處理系統之用途可舉例如:海水淡化、排水減容化、有價物之濃縮、食品及飲料之濃縮等。 For example, the use of positive osmosis membrane treatment systems includes seawater desalination, wastewater volume reduction, concentration of valuables, concentration of food and beverages, etc.
<水處理方法、水處理系統> <Water treatment method, water treatment system>
接著,說明使用上述正滲透膜處理方法、正滲透膜處理系統之水處理方法、水處理系統。 Next, a water treatment method and a water treatment system using the above-mentioned forward osmosis membrane treatment method and forward osmosis membrane treatment system will be described.
本發明實施形態之水處理方法係包含上述正滲透膜處理方法,且在正滲透膜處理步驟之前段中包含前處理步驟及逆滲透膜處理步驟,並且在前處理步驟中使用藉由正滲透膜處理步驟製得之稀薄吸引溶液的水處理方法。此外,本發明實施形態之水處理系統係具有上述正滲透膜處理系統,且在正滲透膜處理設備之前段中具有前處理設備及逆滲透膜處理設備,並且在前處理設備中使用藉由正滲透膜處理設備製得之稀薄吸引溶液的水處理系統。 The water treatment method according to the embodiment of the present invention includes the above-mentioned forward osmosis membrane treatment method, and includes a pre-treatment step and a reverse osmosis membrane treatment step before the forward osmosis membrane treatment step, and in the pre-treatment step, a forward osmosis membrane treatment method is used. A water treatment method for the thin suction solution prepared in the treatment step. In addition, the water treatment system according to the embodiment of the present invention has the above-mentioned forward osmosis membrane treatment system, and has a pre-treatment device and a reverse osmosis membrane treatment device in the front stage of the forward osmosis membrane treatment device, and uses a forward osmosis membrane treatment device in the pre-treatment device. Water treatment system for thin suction solutions produced by permeable membrane treatment equipment.
以下在圖12中顯示本發明實施形態之一水處理系統例的概略,且說明其結構。 Next, an outline of an example of a water treatment system according to an embodiment of the present invention is shown in FIG. 12 and its structure is explained.
本實施形態之水處理系統9具有:前處理裝置114,其作為進行被處理水之前處理的前處理設備;逆滲透膜處理裝置118,其作為進行藉由前處理製得之前處理水的逆滲透膜處理且製得RO濃縮水及RO透過水的逆滲透膜處理設備;及正滲透膜處理裝置14,其作為進行藉由逆滲透膜處理製得之RO濃縮水的正滲透膜處理的正滲透膜處理設備。水處理系統9可具有濁質去除裝置116,作為進行藉由前處理製得之前處理水的濁質去除處理的濁質去除設備。 The water treatment system 9 of this embodiment has: a pretreatment device 114, which is a pretreatment device for pre-treating the treated water; a reverse osmosis membrane treatment device 118, which is a reverse osmosis membrane treatment device for performing reverse osmosis membrane treatment to obtain pre-treated water by pre-treatment and producing RO concentrated water and RO permeated water; and a forward osmosis membrane treatment device 14, which is a forward osmosis membrane treatment device for performing forward osmosis membrane treatment of RO concentrated water obtained by reverse osmosis membrane treatment. The water treatment system 9 may have a turbidity removal device 116, which is a turbidity removal device for performing turbidity removal treatment to obtain pre-treated water by pre-treatment.
在圖12之水處理系統9中,被處理水配管120連接於前處理裝置114之前處理水入口,且前處理裝置114之出口及濁質去除裝置116之入口藉由配管122連接,並且濁質去除裝置116之出口及逆滲透膜處理裝置118之入口藉由配管124連接。逆滲透膜處理裝置118之RO濃縮水出口及正滲透膜處理裝置14之FO前處理水入口藉由FO被處理水配管16連接,且RO透過水配管126連接於逆滲透膜處理裝置118之RO透過水出口。吸引溶液配管24連接於正滲透膜處理裝置14之吸引溶液入口,且正滲透膜處理裝置14之稀薄吸引溶液出口及前處理裝置114之稀薄吸引溶液入口藉由稀薄吸引溶液配管26連接,並且FO濃縮水配管28連接於正滲透膜處理裝置14之FO濃縮水出口。逆洗排水配管128亦可連接於濁質去除裝置116之逆洗排水出口。 In the water treatment system 9 of FIG. 12 , the treated water pipe 120 is connected to the pre-treated water inlet of the pre-treatment device 114, and the outlet of the pre-treatment device 114 and the inlet of the filth removal device 116 are connected by a pipe 122, and the outlet of the filth removal device 116 and the inlet of the reverse osmosis membrane treatment device 118 are connected by a pipe 124. The RO concentrated water outlet of the reverse osmosis membrane treatment device 118 and the FO pre-treated water inlet of the forward osmosis membrane treatment device 14 are connected by the FO treated water pipe 16, and the RO permeate water pipe 126 is connected to the RO permeate water outlet of the reverse osmosis membrane treatment device 118. The suction solution piping 24 is connected to the suction solution inlet of the forward osmosis membrane treatment device 14, and the dilute suction solution outlet of the forward osmosis membrane treatment device 14 and the dilute suction solution inlet of the pre-treatment device 114 are connected by the dilute suction solution piping 26, and the FO concentrated water piping 28 is connected to the FO concentrated water outlet of the forward osmosis membrane treatment device 14. The backwash drainage piping 128 can also be connected to the backwash drainage outlet of the filth removal device 116.
以下說明本實施形態之水處理方法及水處理系統9的動作。 The following describes the water treatment method and the operation of the water treatment system 9 of this embodiment.
被處理水通過被處理水配管120輸送至前處理裝置114。在前處理裝置114中,進行被處理水含有之溶解性二氧化矽、硬度成分等的去除處理(前處理步驟)。 The water to be treated is transported to the pre-treatment device 114 through the water to be treated pipe 120 . In the pretreatment device 114, a removal process (pretreatment step) of soluble silica, hardness components, etc. contained in the water to be treated is performed.
被處理水包含溶解性二氧化矽時,前處理裝置114具有例如:鎂反應設備,其將鎂鹽添加至被處理水中使其反應,使溶解性二氧化矽不溶化;凝集處理設備,其將凝集劑添加至反應後之被處理水中使其凝集;及固液分離設備,其由凝集處理後之被處理水分離凝集物。前處理裝置114中,在例如鹼條件(例如,pH10至12)下將鎂鹽添加至被處理水中,使溶解性二氧化矽不溶化(鎂反應步驟)。然後,依需要添加凝集劑以進行凝集處理(凝集處理步驟),使凝集物固液分離(固液分離步驟)。藉由固液分離製得之固液分離處理水作為前處理水通過配管122輸送至濁質去除裝置116,接著藉由UF膜等進行濁質去除處理,並在去除濁質成分等後(濁質去除步驟),輸送至逆滲透膜處理裝置118。 When the water to be treated contains soluble silica, the pretreatment device 114 has, for example, a magnesium reaction device that adds magnesium salt to the water to be treated and reacts it to insolubilize the soluble silica; and an agglomeration treatment device that agglomerates the water. The agent is added to the treated water after the reaction to cause it to agglomerate; and the solid-liquid separation equipment separates the agglomerates from the treated water after the agglutination treatment. In the pretreatment device 114, a magnesium salt is added to the water to be treated under, for example, alkaline conditions (for example, pH 10 to 12) to insolubilize soluble silica (magnesium reaction step). Then, if necessary, a coagulant is added to perform aggregation treatment (aggregation treatment step), and the aggregated product is solid-liquid separated (solid-liquid separation step). The solid-liquid separation treated water produced by solid-liquid separation is transported to the turbidity removal device 116 through the pipe 122 as pre-treatment water, and is then subjected to turbidity removal treatment by a UF membrane or the like, and after the turbidity components and the like are removed (turbidity (mass removal step) and transported to the reverse osmosis membrane treatment device 118.
被處理水包含硬度成分,且藉由石灰軟化法進行硬度成分之去除時,前處理裝置114具有例如:鹼劑反應設備,其將鹼劑添加至被處理水中使其反應,使硬度成分不溶化;凝集處理設備,其依需要將凝集劑添加至反應後之被處理水中使其凝集;及固液分離設備,其由凝集處理後之被處理水分離凝集物。前處理裝置114中,例如將鹼劑添加至被處理水中,使硬度成分不溶化(鹼劑反應步驟)。然後,依需要添加凝集劑以進行凝集處理(凝集處理步驟),使凝集物固液分離(固液分離步驟)。藉由固液分離製得之固液分離處理水作為前處理水通過配管122輸送至濁質去除裝置116,接著藉由UF膜等進行濁質去除處理,並在去除濁質成分等後(濁質去除步驟),輸送至逆滲透膜處理裝置118。 When the water to be treated contains a hardness component and the hardness component is removed by lime softening, the pretreatment device 114 has, for example, an alkali reaction device that adds an alkali agent to the water to be treated to react and insolubilize the hardness component; A coagulation treatment equipment, which adds a coagulant to the water to be treated after the reaction to agglomerate it as necessary; and a solid-liquid separation equipment, which separates agglomerates from the water to be treated after the coagulation treatment. In the pretreatment device 114, for example, an alkali agent is added to the water to be treated to insolubilize the hardness component (alkali agent reaction step). Then, if necessary, a coagulant is added to perform aggregation treatment (aggregation treatment step), and the aggregated product is solid-liquid separated (solid-liquid separation step). The solid-liquid separation treated water produced by solid-liquid separation is transported to the turbidity removal device 116 through the pipe 122 as pre-treatment water, and is then subjected to turbidity removal treatment by a UF membrane or the like, and after the turbidity components and the like are removed (turbidity (mass removal step) and transported to the reverse osmosis membrane treatment device 118.
被處理水包含硬度成分,且藉由樹脂軟化法進行硬度成分之去除時,前處理裝置114具有例如使用離子交換樹脂等進行離子交換處理之離子交換處理設備。前處理裝置114中,例如將被處理水通至填充離子交換樹脂作為離子交換處理設備之離子交換塔,並吸附去除硬度成分(離子交換步驟)。將藉由離子交換處理製得之前處理水通過配管122輸送至濁質去除裝置116,接著藉由UF膜等進行濁質去除處理,並在去除濁質成分等後(濁質去除步驟),輸送至逆滲透膜處理裝置118。離子交換樹脂需要再生時,藉由通過再生劑再生離子交換樹脂。 When the water to be treated contains hardness components and the hardness components are removed by a resin softening method, the pre-treatment device 114 has an ion exchange treatment device that performs ion exchange treatment using, for example, an ion exchange resin. In the pre-treatment device 114, for example, the water to be treated is passed to an ion exchange tower filled with an ion exchange resin as an ion exchange treatment device, and the hardness components are removed by adsorption (ion exchange step). The pre-treated water obtained by the ion exchange treatment is transported to the turbidity removal device 116 through the pipe 122, and then turbidity removal treatment is performed by a UF membrane, etc., and after the turbidity components are removed (turbidity removal step), it is transported to the reverse osmosis membrane treatment device 118. When the ion exchange resin needs to be regenerated, the ion exchange resin is regenerated by using a regeneration agent.
接著,在逆滲透膜處理裝置118中逆滲透膜處理濁質去除處理後之前處理水,製得RO濃縮水及RO透過水(逆滲透膜處理步驟)。藉由逆滲透膜處理製得之RO濃縮水作為FO被處理水通過FO被處理水配管16輸送至正滲透膜處理裝置14之一次側,且RO透過水通過RO透過水配管126排出。此外,在濁質去除裝置116中,可每隔預定時間進行膜之逆洗。例如,供給RO透過水等至濁質去除裝置116作為逆洗水,且逆洗排水通過逆洗排水配管128排出。 Next, the reverse osmosis membrane treatment device 118 processes the pre-treated water after the turbidity removal treatment to produce RO concentrated water and RO permeated water (reverse osmosis membrane treatment step). The RO concentrated water produced by the reverse osmosis membrane treatment is transported to the primary side of the forward osmosis membrane treatment device 14 as FO treated water through the FO treated water pipe 16 , and the RO permeated water is discharged through the RO permeated water pipe 126 . In addition, in the turbidity removal device 116, the membrane can be backwashed every predetermined time. For example, RO permeated water or the like is supplied to the turbidity removal device 116 as backwash water, and the backwash drainage water is discharged through the backwash drainage pipe 128 .
在正滲透膜處理裝置14中正滲透膜處理藉由逆滲透膜處理製得之RO濃縮水(正滲透膜處理步驟)。在正滲透膜處理裝置14中,吸引溶液通過吸引溶液配管24輸送至正滲透膜之二次側,接著透過正滲透膜,使RO濃縮水及吸引溶液存在,藉此利用滲透壓使水移動至吸引溶液。 In the forward osmosis membrane treatment device 14, the forward osmosis membrane processes the RO concentrated water produced by the reverse osmosis membrane treatment (forward osmosis membrane treatment step). In the forward osmosis membrane treatment device 14, the suction solution is transported to the secondary side of the forward osmosis membrane through the suction solution pipe 24, and then passes through the forward osmosis membrane to allow the RO concentrated water and the suction solution to exist, whereby the water is moved to the secondary side by osmotic pressure. Attract solution.
在此,使包含溴系氧化劑或氯系氧化劑及胺磺酸化合物之正滲透膜用殺菌劑存在RO濃縮水(FO被處理水)中。例如,正滲透膜用殺菌劑通過殺菌劑添加配 管112在FO被處理水配管16中添加至RO濃縮水(FO被處理水)中。亦可在正滲透膜處理裝置14之前段,例如逆滲透膜處理裝置118與正滲透膜處理裝置14之間另外設置貯存RO濃縮水(FO被處理水)之FO被處理水槽,且在FO被處理水槽中添加正滲透膜用殺菌劑。 Here, a forward osmosis membrane bactericide containing a bromine-based oxidant or a chlorine-based oxidant and an amine sulfonic acid compound is allowed to exist in RO concentrated water (FO treated water). For example, the forward osmosis membrane bactericide is added to the RO concentrated water (FO treated water) in the FO treated water pipe 16 through the bactericide addition pipe 112. It is also possible to set up a FO treated water tank for storing RO concentrated water (FO treated water) in the front section of the forward osmosis membrane treatment device 14, for example, between the reverse osmosis membrane treatment device 118 and the forward osmosis membrane treatment device 14, and add the forward osmosis membrane bactericide to the FO treated water tank.
該正滲透膜用殺菌劑對正滲透膜發揮比習知之氯系殺菌劑、氧化劑、有機系殺菌劑更充分之殺菌效果。藉由在本實施形態之水處理方法中使用上述正滲透膜用殺菌劑,殺菌有效成分幾乎未透過正滲透膜,因此可在前處理中使用藉由正滲透膜處理稀釋之稀薄吸引溶液且可再利用稀薄吸引溶液。稀薄吸引溶液中含有有機系殺菌劑時,在濁質去除裝置116之逆洗排水及逆滲透膜處理裝置118之RO透過水中包含殺菌有效成分。稀薄吸引溶液中含有氯系殺菌劑或氧化劑時,氯系殺菌劑或氧化劑流入濁質去除裝置116或逆滲透膜處理裝置118時使膜劣化。使用上述正滲透膜用殺菌劑時,因為殺菌有效成分幾乎未透過正滲透膜,所以可抑制如此之風險。 This bactericide for forward osmosis membrane exerts a more sufficient bactericidal effect on the forward osmosis membrane than conventional chlorine-based bactericides, oxidants, and organic bactericides. By using the above-mentioned bactericide for forward osmosis membranes in the water treatment method of this embodiment, the bactericidal active ingredients hardly penetrate the forward osmosis membrane. Therefore, a thin suction solution diluted by the forward osmosis membrane treatment can be used in the pretreatment and can Reuse dilute suction solution. When the thin suction solution contains an organic bactericide, the backwash drainage of the turbidity removal device 116 and the RO permeated water of the reverse osmosis membrane treatment device 118 contain bactericidal active ingredients. When the dilute suction solution contains a chlorine-based bactericide or an oxidizing agent, the chlorine-based bactericide or oxidizing agent flows into the turbidity removal device 116 or the reverse osmosis membrane treatment device 118 and causes membrane degradation. When using the above-mentioned bactericide for forward osmosis membranes, the active bactericidal ingredients hardly penetrate the forward osmosis membrane, so such risks can be suppressed.
正滲透膜處理步驟中使用之稀薄吸引溶液通過稀薄吸引溶液配管26輸送至前處理裝置114,並在前處理裝置114中在前處理步驟中使用。藉由正滲透膜處理步驟製得之FO濃縮水通過FO濃縮水配管28排出。FO濃縮水可回收、再利用。 The dilute draw solution used in the forward osmosis membrane treatment step is transported to the pre-treatment device 114 through the dilute draw solution piping 26 and used in the pre-treatment step in the pre-treatment device 114. The FO concentrated water obtained by the forward osmosis membrane treatment step is discharged through the FO concentrated water piping 28. The FO concentrated water can be recovered and reused.
前處理裝置114包含進行溶解性二氧化矽去除之裝置時,例如,可使用鎂鹽水溶液作為正滲透膜處理裝置14中之吸引溶液,且可使用正滲透膜處理裝置14中使用之稀薄吸引溶液(鎂鹽稀薄水溶液)作為在前處理裝置114中添加之鎂鹽。 When the pretreatment device 114 includes a device for removing soluble silica, for example, a magnesium salt aqueous solution can be used as the suction solution in the forward osmosis membrane treatment device 14, and a dilute suction solution used in the forward osmosis membrane treatment device 14 can be used. (magnesium salt dilute aqueous solution) as the magnesium salt added to the pretreatment device 114.
前處理裝置114包含藉由石灰軟化法進行硬度成分之去除的裝置時,例如,可使用例如鹼劑水溶液作為正滲透膜處理裝置14中之吸引溶液,且可使用正滲透膜處理裝置14中使用之稀薄吸引溶液(鹼劑稀薄水溶液)作為在前處理裝置114中添加之鹼劑。 When the pretreatment device 114 includes a device for removing hardness components by lime softening, for example, an alkaline aqueous solution can be used as the draw solution in the forward osmosis membrane treatment device 14, and the dilute draw solution (alkaline dilute aqueous solution) used in the forward osmosis membrane treatment device 14 can be used as the alkali added to the pretreatment device 114.
前處理裝置114包含藉由樹脂軟化法進行硬度成分之去除的裝置時,例如,可使用酸水溶液或氯化鈉水溶液作為正滲透膜處理裝置14中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(酸稀薄水溶液或氯化鈉稀薄水溶液)可在前處理裝置114中作為離子交換樹脂之再生劑使用。 When the pretreatment device 114 includes a device for removing hardness components by a resin softening method, for example, an acid aqueous solution or a sodium chloride aqueous solution can be used as the suction solution in the forward osmosis membrane treatment device 14, and the forward osmosis membrane treatment device 14 The dilute suction solution (a dilute aqueous acid solution or a dilute sodium chloride aqueous solution) used can be used as a regeneration agent for the ion exchange resin in the pretreatment device 114 .
藉由本實施形態之水處理方法及水處理裝置,可用低成本處理例如包含溶解性二氧化矽及硬度成分中之至少一者的被處理水。 By using the water treatment method and water treatment device of this embodiment, water to be treated, for example, containing at least one of soluble silica and hardness components, can be treated at low cost.
因為在前處理步驟中使用藉由正滲透膜處理稀釋之稀薄吸引溶液,所以可減少本來需要之再利用吸引溶液的必要成本且不需要再生設備。因為稀薄吸引溶液只是稀釋前處理步驟中本來使用之吸引溶液,所以幾乎不產生追加之成本。 Because the thin suction solution diluted by forward osmosis membrane treatment is used in the pretreatment step, the necessary cost of reusing the suction solution can be reduced and no regeneration equipment is required. Because the dilute suction solution is just the suction solution originally used in the dilution pre-treatment step, there is almost no additional cost.
作為本實施形態之水處理方法及水處理裝置之處理對象的被處理水沒有特別限制,但可為例如包含溶解性二氧化矽及硬度成分中之至少一者的水,且可舉例如:工業用水、表層水、自來水、地下水、海水、藉由逆滲透法或蒸發法使海水脫鹽之海水淡化處理水、例如在半導體製程中排出之排水等的各種排水。 The water to be treated by the water treatment method and the water treatment device of this embodiment is not particularly limited, but may be water containing at least one of soluble silica and hardness components, and may include, for example, industrial water, surface water, tap water, groundwater, seawater, desalinated water obtained by desalinating seawater by reverse osmosis or evaporation, and various types of wastewater such as wastewater discharged in semiconductor manufacturing processes.
被處理水中含有溶解性二氧化矽時,溶解性二氧化矽之濃度係在例如5至400mg/L之範圍內。被處理水中含有硬度成分時,鈣硬度成分之濃度係在例如5至600mg/L之範圍內。被處理水中之全蒸發殘留物(TDS:全部溶解固體量(Total Dissolved Solid)係在例如100至50000mg/L之範圍內。 When the water to be treated contains soluble silica, the concentration of soluble silica is in the range of, for example, 5 to 400 mg/L. When the water to be treated contains a hardness component, the concentration of the calcium hardness component is, for example, in the range of 5 to 600 mg/L. The pervaporation residue (TDS: Total Dissolved Solid) in the treated water is in the range of, for example, 100 to 50000 mg/L.
在本實施形態之水處理方法及水處理裝置中,被處理水包含溶解性二氧化矽及硬度成分兩者時,前處理設備(前處理步驟)可具有溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)及硬度成分去除設備(硬度成分去除步驟)兩者。溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)及硬度成分去除設備(硬度成分去除步驟)之順序可第一是溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟),第二是硬度成分去除設備(硬度成分去除步驟),或第一是硬度成分去除設備(硬度成分去除步驟),第二是溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)。 In the water treatment method and water treatment device of the present embodiment, when the treated water contains both soluble silica and hardness components, the pretreatment device (pretreatment step) may have both a soluble silica removal device (soluble silica removal step) and a hardness component removal device (hardness component removal step). The order of the soluble silica removal device (soluble silica removal step) and the hardness component removal device (hardness component removal step) may be the first soluble silica removal device (soluble silica removal step) and the second hardness component removal device (hardness component removal step), or the first hardness component removal device (hardness component removal step) and the second soluble silica removal device (soluble silica removal step).
此時,使用鎂鹽水溶液、鹼劑水溶液、酸水溶液及氯化鈉水溶液中之至少一者作為正滲透膜處理裝置14(正滲透膜處理步驟)中之吸引溶液,且正滲透膜處理裝置14中使用之稀薄吸引溶液(鎂鹽稀薄水溶液、鹼劑稀薄水溶液、酸稀薄 水溶液及氯化鈉稀薄水溶液中之至少一者)可使用在前處理裝置114(前處理步驟)之溶解性二氧化矽去除設備(溶解性二氧化矽去除步驟)及硬度成分去除設備(硬度成分去除步驟)中適合的方面。 At this time, at least one of a magnesium salt solution, an alkali aqueous solution, an acid aqueous solution, and a sodium chloride aqueous solution is used as the suction solution in the forward osmosis membrane treatment device 14 (forward osmosis membrane treatment step), and the forward osmosis membrane treatment device 14 Thin suction solutions (magnesium salt aqueous solution, alkaline aqueous solution, acid aqueous solution) used in At least one of aqueous solution and sodium chloride dilute aqueous solution) can be used in the soluble silica removal equipment (soluble silica removal step) and the hardness component removal equipment (hardness component) of the pretreatment device 114 (pretreatment step) Remove appropriate aspects from step).
濁質去除設備可舉例如:砂過濾裝置、超過濾(UF)膜等之膜過濾裝置、加壓浮選裝置等。濁質去除設備之設置位置沒有特別限制,例如前處理裝置114(前處理步驟)之前段或前處理裝置114(前處理步驟)與逆滲透膜處理裝置118(逆滲透膜處理步驟)之間。 The turbidity removal equipment may include, for example, a sand filter, a membrane filter such as an ultrafiltration (UF) membrane, a pressurized flotation device, etc. There is no particular restriction on the location of the turbidity removal equipment, such as the front section of the pre-treatment device 114 (pre-treatment step) or between the pre-treatment device 114 (pre-treatment step) and the reverse osmosis membrane treatment device 118 (reverse osmosis membrane treatment step).
前處理步驟之細節係如前所述。在溶解性二氧化矽去除及石灰軟化法之硬度成分去除中,藉由固液分離製得之前處理水可輸送至逆滲透膜處理裝置118或通過濁質去除裝置116輸送至逆滲透膜處理裝置118。在樹脂軟化法之硬度成分去除中,藉由離子交換處理製得之前處理水可輸送至逆滲透膜處理裝置118或通過濁質去除裝置116輸送至逆滲透膜處理裝置118。 The details of the pre-processing steps are as described above. In the removal of soluble silica and hardness components in the lime softening method, the pre-treated water obtained by solid-liquid separation can be transported to the reverse osmosis membrane treatment device 118 or transported to the reverse osmosis membrane treatment device through the turbidity removal device 116 118. In the hardness component removal by the resin softening method, the pre-treated water obtained by ion exchange treatment can be sent to the reverse osmosis membrane treatment device 118 or sent to the reverse osmosis membrane treatment device 118 through the turbidity removal device 116 .
可使包含溴系氧化劑或氯系氧化劑及胺磺酸化合物之殺菌劑(「正滲透膜用殺菌劑」)存在圖1至3之水處理裝置1、3、5中作為FO被處理水的濃縮水中。例如,正滲透膜用殺菌劑通過殺菌劑添加配管在濃縮水配管20中添加至FO被處理水(濃縮水)中。亦可在正滲透膜處理裝置14之前段,例如逆滲透膜處理裝置12與正滲透膜處理裝置14之間另外設置貯存FO被處理水(濃縮水)之濃縮水槽,且在濃縮水槽中添加正滲透膜用殺菌劑。 A bactericide ("bactericide for forward osmosis membrane") containing a bromine-based oxidizing agent or a chlorine-based oxidizing agent and a sulfamic acid compound can be stored in the water treatment devices 1, 3, and 5 in Figures 1 to 3 as a concentration of the FO treated water. in water. For example, the bactericide for the forward osmosis membrane is added to the FO treated water (concentrated water) in the concentrated water pipe 20 through the bactericide addition pipe. It is also possible to set up a concentration tank for storing FO treated water (concentrated water) before the forward osmosis membrane treatment device 14, for example between the reverse osmosis membrane treatment device 12 and the forward osmosis membrane treatment device 14, and add positive water to the concentration tank. Permeable membranes with biocides.
[逆滲透膜處理步驟] [Reverse osmosis membrane treatment steps]
近來作為主流之聚醯胺系高分子膜可理想地作為逆滲透膜處理步驟中使用之逆滲透膜使用。聚醯胺系高分子膜對氧化劑之耐性比較低,因此使游離氯等連續地接觸聚醯胺系高分子膜時膜性能顯著地降低。但是,藉由在本實施形態之水處理方法中使用上述正滲透膜用殺菌劑,殺菌有效成分幾乎未透過正滲透膜,因此即使聚醯胺系高分子膜亦幾乎不產生如此顯著之膜性能降低。 Polyamide-based polymer membranes, which have become mainstream recently, can be ideally used as reverse osmosis membranes used in reverse osmosis membrane treatment steps. Polyamide-based polymer membranes have relatively low resistance to oxidants. Therefore, when free chlorine, etc. are continuously contacted with the polyamide-based polymer membrane, the membrane performance is significantly reduced. However, by using the above-mentioned bactericide for forward osmosis membranes in the water treatment method of this embodiment, the bactericidal active ingredients hardly penetrate the forward osmosis membrane, so even the polyamide-based polymer membrane hardly produces such remarkable membrane performance. reduce.
逆滲透膜處理可串聯或並聯多數逆滲透膜處理來使用。可藉由第二、第三逆滲透膜處理進一步濃縮藉由第一逆滲透膜處理製得之濃縮水,或可藉由對藉由第一逆滲透膜處理製得之透過水實施另外之逆滲透膜處理,進一步提高水質。 Reverse osmosis membrane treatment can be used by connecting multiple reverse osmosis membrane treatments in series or in parallel. The concentrated water obtained by the first reverse osmosis membrane treatment can be further concentrated by the second and third reverse osmosis membrane treatments, or the permeate obtained by the first reverse osmosis membrane treatment can be subjected to another reverse osmosis membrane treatment to further improve the water quality.
逆滲透膜處理步驟中使用之逆滲透膜,除了使用於純水製造用途及排水回收等之用途的超低壓逆滲透膜、低壓逆滲透膜以外,可舉使用於海水淡化等用途之中壓逆滲透膜及高壓逆滲透膜等為例。超低壓逆滲透膜、低壓逆滲透膜可舉例如:ES15(日東電工製)、TM720D(TORAY製)、BW30HRLE(Dow Chemical製)、LFC3-LD(Hydranautics製)。高壓逆滲透膜可舉例如:SWC5-LD(Hydranautics製)、TM820V(TORAY製)、XUS180808(Dow Chemical製)等。使用多數段逆滲透膜步驟時,可依據各段之被處理水的TDS、pH、水溫等之條件來選擇不同種類之膜。 The reverse osmosis membrane used in the reverse osmosis membrane treatment step includes ultra-low pressure reverse osmosis membrane and low pressure reverse osmosis membrane used for pure water production and wastewater recovery, as well as medium pressure reverse osmosis membrane and high pressure reverse osmosis membrane used for seawater desalination. Examples of ultra-low pressure reverse osmosis membrane and low pressure reverse osmosis membrane include ES15 (manufactured by Nitto Denko), TM720D (manufactured by TORAY), BW30HRLE (manufactured by Dow Chemical), and LFC3-LD (manufactured by Hydranautics). Examples of high pressure reverse osmosis membrane include SWC5-LD (manufactured by Hydranautics), TM820V (manufactured by TORAY), and XUS180808 (manufactured by Dow Chemical). When using multiple reverse osmosis membrane steps, different types of membranes can be selected based on the TDS, pH, water temperature and other conditions of the water being treated in each stage.
在濃縮處理步驟中,亦可添加pH調整劑、抑制在系內之無機鹽結垢的水垢分散劑、抑制在系內產生微生物之殺菌劑等的藥品。 In the concentration treatment step, chemicals such as pH adjusters, scale dispersants that inhibit the scaling of inorganic salts in the system, and bactericides that inhibit the generation of microorganisms in the system can also be added.
<正滲透膜用殺菌劑> <Bactericide for positive osmosis membrane>
本實施形態之正滲透膜用殺菌劑含有包含「溴系氧化劑或氯系氧化劑」及「胺磺酸化合物」之混合物的安定化次溴酸組成物的殺菌劑或安定化次氯酸組成物,且可進一步含有鹼。 The bactericide for positive osmosis membrane of this embodiment contains a bactericide of a stabilized hypobromous acid composition containing a mixture of a "bromine-based oxidant or a chlorine-based oxidant" and a "sulfonic acid compound" or a stabilized hypochlorous acid composition, and may further contain an alkali.
本實施形態之正滲透膜用殺菌劑含有包含「溴系氧化劑及胺磺酸化合物之反應生成物」之安定化次溴酸組成物或包含「氯系氧化劑及胺磺酸化合物之反應生成物」之安定化次氯酸組成物,且可進一步含有鹼。 The positive osmotic membrane disinfectant of this embodiment contains a stabilized hypobromous acid composition comprising "a reaction product of a bromine-based oxidant and an amide sulfonic acid compound" or a stabilized hypochlorous acid composition comprising "a reaction product of a chlorine-based oxidant and an amide sulfonic acid compound", and may further contain an alkali.
溴系氧化劑、溴化合物、氯系氧化劑及胺磺酸化合物係如上所述。 The bromine-based oxidizing agent, bromine compound, chlorine-based oxidizing agent and sulfamic acid compound are as described above.
包含氯系氧化劑及胺磺酸化合物之安定化次氯酸組成物的市售品可舉栗田工業公司(股)製之「KURIVERTER IK-110」為例。 An example of a commercially available product of a stabilized hypochlorous acid composition containing a chlorine-based oxidizing agent and a sulfamic acid compound is "KURIVERTER IK-110" manufactured by Kurita Industrial Co., Ltd.
為了不使正滲透膜進一步劣化,本實施形態之正滲透膜用殺菌劑宜為含有溴及胺磺酸化合物者(含有溴及胺磺酸化合物之混合物者),例如含有溴、胺磺酸化合物、鹼及水之混合物,或溴及胺磺酸化合物之反應生成物者,例如溴與胺磺酸化合物之反應生成物、鹼及水的混合物。 In order to prevent further deterioration of the forward osmosis membrane, the bactericide for the forward osmosis membrane in this embodiment is preferably one containing bromine and a sulfamic acid compound (a mixture containing a bromine and a sulfamic acid compound), for example, one containing a bromine and a sulfamic acid compound. , a mixture of alkali and water, or a reaction product of bromine and a sulfamic acid compound, such as a reaction product of bromine and a sulfamic acid compound, a mixture of alkali and water.
本實施形態之正滲透膜用殺菌劑中,含有包含溴系氧化劑及胺磺酸化合物之安定化次溴酸組成物的殺菌劑,特別是含有包含溴及胺磺酸化合物之安定化 次溴酸組成物的殺菌劑,相較於包含氯系氧化劑及胺磺酸化合物之殺菌劑(氯胺磺酸等),雖然氧化力高且污泥抑制力、污泥剝離力顯著地高,但幾乎未引起如相同氧化力高之次氯酸的顯著膜劣化。在通常之使用濃度下,可實質地忽視對膜劣化之影響。因此,作為殺菌劑最適當。 The disinfectant for positive osmosis membrane of this embodiment includes a disinfectant containing a stabilized hypobromous acid composition containing a bromine-based oxidant and an amine sulfonic acid compound, and in particular, a disinfectant containing a stabilized hypobromous acid composition containing bromine and an amine sulfonic acid compound. Compared with disinfectants containing chlorine-based oxidants and amine sulfonic acid compounds (chloramine sulfonic acid, etc.), although the oxidizing power is high and the sludge inhibition power and sludge stripping power are significantly high, it hardly causes significant membrane degradation like hypochlorous acid with the same high oxidizing power. At normal usage concentrations, the effect on membrane degradation can be substantially ignored. Therefore, it is most suitable as a disinfectant.
本實施形態之正滲透膜用殺菌劑與次氯酸等之殺菌劑不同,因為幾乎未透過正滲透膜,所以幾乎不會影響稀薄吸引溶液。此外,可與次氯酸等同樣地在現場測量濃度,因此可進行更正確之濃度管理。 The bactericide for the forward osmosis membrane of this embodiment is different from bactericides such as hypochlorous acid in that it hardly permeates the forward osmosis membrane and therefore hardly affects the dilute suction solution. In addition, the concentration can be measured on site in the same way as hypochlorous acid, etc., so more accurate concentration management can be performed.
正滲透膜用殺菌劑之pH係例如超過13.0,且超過13.2更佳。正滲透膜用殺菌劑之pH係13.0以下時,正滲透膜用殺菌劑中之有效鹵素會不安定。 The pH of the positive osmotic membrane disinfectant is, for example, higher than 13.0, and preferably higher than 13.2. When the pH of the positive osmotic membrane disinfectant is lower than 13.0, the effective halogen in the positive osmotic membrane disinfectant will be unstable.
正滲透膜用殺菌劑中之溴酸濃度宜小於5mg/kg。正滲透膜用殺菌劑中之溴酸濃度係5mg/kg以上時,稀薄吸引溶液之溴酸離子濃度會升高。 The concentration of bromic acid in the positive osmotic membrane disinfectant should be less than 5 mg/kg. When the concentration of bromic acid in the positive osmotic membrane disinfectant is above 5 mg/kg, the concentration of bromic acid ions in the dilute attracting solution will increase.
<正滲透膜用殺菌劑之製造方法> <Manufacturing method of disinfectant for positive osmosis membrane>
本實施形態之正滲透膜用殺菌劑係藉由混合溴系氧化劑或氯系氧化劑及胺磺酸化合物製得,且可進一步混合鹼。 The bactericide for forward osmosis membranes in this embodiment is prepared by mixing a bromine-based oxidant or a chlorine-based oxidant and a sulfamic acid compound, and an alkali may be further mixed.
含有包含溴及胺磺酸化合物之安定化次溴酸組成物的正滲透膜用殺菌劑製造方法宜包含以下步驟:在惰性氣體環境下將溴添加至包含水、鹼及胺磺酸化合物之混合液中使其反應,或在惰性氣體環境下將溴添加至包含水、鹼及胺 磺酸化合物之混合液中。藉由在惰性氣體環境下添加使其反應或在惰性氣體環境下添加,正滲透膜用殺菌劑中之溴酸離子濃度降低,因此稀薄吸引溶液中之溴酸離子濃度降低。 The method for manufacturing a bactericide for forward osmosis membranes containing a stabilized hypobromous acid composition containing bromine and a sulfamic acid compound preferably includes the following steps: adding bromine to a mixture containing water, an alkali and a sulfamic acid compound under an inert gas environment to react in a liquid, or add bromine to a solution containing water, alkali and amine under an inert gas environment. in a mixture of sulfonic acid compounds. By adding and reacting in an inert gas environment or adding in an inert gas environment, the bromate ion concentration in the forward osmosis membrane bactericide decreases, and therefore the bromate ion concentration in the dilute suction solution decreases.
使用之惰性氣體沒有特別限制,但由製造等方面來看宜為氮及氬中之至少一者,且由製造成本方面來看氮特別好。 There is no particular restriction on the inert gas used, but from the perspective of manufacturing and other aspects, it is preferably at least one of nitrogen and argon, and nitrogen is particularly preferred from the perspective of manufacturing cost.
溴添加時之反應器內的氧濃度宜為6%以下,但4%以下較佳,2%以下更佳,且1%以下特佳。溴反應時之反應器內的氧濃度超過6%時,反應系內之溴酸生成量會增加。 The oxygen concentration in the reactor when adding bromine is preferably below 6%, but preferably below 4%, more preferably below 2%, and particularly preferably below 1%. When the oxygen concentration in the reactor exceeds 6% during the bromine reaction, the amount of bromic acid generated in the reaction system will increase.
相對正滲透膜用殺菌劑全體之量的溴添加率宜為25重量%以下,且1重量%以上20重量%以下更佳。相對正滲透膜用殺菌劑全體之量的溴添加率超過25重量%時,反應系內之溴酸生成量會增加。小於1重量%時,殺菌力會很差。 The bromine addition rate relative to the total amount of the bactericide for the forward osmosis membrane is preferably 25% by weight or less, and more preferably 1% by weight or more and 20% by weight or less. When the bromine addition rate exceeds 25% by weight relative to the total amount of bactericide for forward osmosis membranes, the amount of bromic acid generated in the reaction system will increase. When the content is less than 1% by weight, the bactericidal effect will be poor.
溴添加時之反應溫度宜控制在0℃以上25℃以下之範圍內,但由製造成本等方面來看,控制在0℃以上15℃以下之範圍內更佳。溴添加時之反應溫度超過25℃時,反應系內之溴酸生成量會增加,且小於0℃時會凍結。 The reaction temperature when adding bromine should be controlled within the range of 0°C to 25°C. However, from the perspective of manufacturing cost, it is better to control the reaction temperature to be within the range of 0°C to 15°C. When the reaction temperature when adding bromine exceeds 25°C, the amount of bromic acid generated in the reaction system will increase, and when it is lower than 0°C, it will freeze.
實施例 Example
以下,列舉實施例及比較例,更具體地詳細說明本發明,但本發明不限於以下實施例。 Hereinafter, examples and comparative examples will be given to explain the present invention in more detail. However, the present invention is not limited to the following examples.
<實施例1> <Implementation Example 1>
對包含TDS100ppm、溶解性二氧化矽15ppm之工業用水使用圖1記載之水處理裝置實施濃縮處理。藉由逆滲透膜處理裝置,濃縮到TDS8%為止。將該濃縮水供給至正滲透膜處理裝置(正滲透膜:HP5230(東洋紡製)),接著供給30重量%氯化鎂溶液作為吸引溶液,製得TDS20%之FO濃縮水。藉由正滲透膜處理稀釋之稀薄氯化鎂溶液原封不動地添加至溶解性二氧化矽去除裝置中。算出用於正滲透膜處理之能量成本。結果顯示於表1中。 Industrial water containing TDS 100ppm and dissolved silica 15ppm was concentrated using the water treatment device shown in Figure 1. The water was concentrated to TDS 8% using a reverse osmosis membrane treatment device. The concentrated water was supplied to a forward osmosis membrane treatment device (forward osmosis membrane: HP5230 (manufactured by Toyobo)), and then a 30 wt% magnesium chloride solution was supplied as an attracting solution to produce FO concentrated water with TDS 20%. The diluted magnesium chloride solution diluted by the forward osmosis membrane treatment was added intact to the dissolved silica removal device. The energy cost for the forward osmosis membrane treatment was calculated. The results are shown in Table 1.
<比較例1> <Comparative example 1>
在實施例1使用之水處理裝置中,實施用蒸發器取代正滲透膜處理裝置之濃縮操作,同樣地製得TDS20%之濃縮水。算出用於蒸發器之能量成本並與實施例1比較。結果顯示於表1中。 In the water treatment device used in Example 1, an evaporator is used to replace the concentration operation of the forward osmosis membrane treatment device to produce concentrated water with TDS 20%. The energy cost used for the evaporator is calculated and compared with Example 1. The results are shown in Table 1.
<比較例2> <Comparative example 2>
在實施例1使用之水處理裝置中,使用30重量%碳酸銨溶液作為正滲透膜處理裝置之吸引溶液,同樣地製得TDS20%之濃縮水。將藉由正滲透膜處理稀釋之稀薄碳酸銨溶液輸送至再生裝置,並藉由熱實施再生(再生步驟)。算出用於正滲透膜處理之能量成本(包含供應至再生步驟之能量)。結果顯示於表1中。 In the water treatment device used in Example 1, a 30 wt% ammonium carbonate solution was used as the draw solution of the forward osmosis membrane treatment device, and concentrated water with a TDS of 20% was similarly produced. The dilute ammonium carbonate solution diluted by the forward osmosis membrane treatment was transported to the regeneration device and regenerated by heat (regeneration step). The energy cost for the forward osmosis membrane treatment (including the energy supplied to the regeneration step) was calculated. The results are shown in Table 1.
[表1]
如此,可了解的是藉由實施例1之處理方法,相較於比較例1、2之處理方法,可用低能量成本濃縮,因此可用低成本處理包含溶解性二氧化矽及硬度成分中之至少一者的被處理水。 In this way, it can be understood that through the processing method of Example 1, compared with the processing methods of Comparative Examples 1 and 2, it is possible to concentrate at a lower energy cost, and therefore it is possible to process at least one of the soluble silica and hardness components at a low cost. One of the treated water.
<實施例2> <Implementation Example 2>
對包含TDS100ppm、溶解性二氧化矽15ppm之工業用水使用圖3記載之水處理裝置實施濃縮處理。藉由逆滲透膜處理裝置,濃縮到TDS8%為止。將該濃縮水供給至正滲透膜處理裝置(正滲透膜:HP5230(東洋紡製)),接著供給30重量%氯化鎂溶液作為吸引溶液,製得TDS20%之FO濃縮水。藉由正滲透膜處理稀釋之稀薄氯化鎂溶液的一部份原封不動地添加至溶解性二氧化矽去除裝置中,且剩餘部份使用圖6之結構的濃縮裝置濃縮到氯化鎂30%為止並作為正滲透膜處理裝置之吸引溶液再利用。算出用於正滲透膜處理之能量成本。結果顯示於表2中。 Industrial water containing TDS 100 ppm and soluble silica 15 ppm was concentrated using the water treatment device shown in Figure 3. Concentrate to TDS8% through reverse osmosis membrane treatment device. This concentrated water was supplied to a forward osmosis membrane treatment device (forward osmosis membrane: HP5230 (Toyobo Co., Ltd.)), and then a 30% by weight magnesium chloride solution was supplied as a suction solution to prepare TDS20% FO concentrated water. A part of the dilute magnesium chloride solution diluted by forward osmosis membrane treatment is added to the soluble silica removal device as it is, and the remaining part is concentrated to 30% of magnesium chloride using the concentration device with the structure of Figure 6 and is used as normal Reuse of suction solution in permeable membrane treatment device. Calculate the energy cost for forward osmosis membrane treatment. The results are shown in Table 2.
<比較例3> <Comparative Example 3>
在實施例2使用之水處理裝置中,實施用蒸發器取代正滲透膜處理裝置之濃縮操作,同樣地製得TDS20%之濃縮水。算出用於蒸發器之能量成本並與實施例2比較。結果顯示於表2中。 In the water treatment device used in Example 2, the evaporator is used to replace the concentration operation of the forward osmosis membrane treatment device to produce concentrated water with TDS 20%. The energy cost used for the evaporator is calculated and compared with Example 2. The results are shown in Table 2.
<比較例4> <Comparative Example 4>
在實施例2使用之水處理裝置中,使用30重量%碳酸銨溶液作為正滲透膜處理裝置之吸引溶液,同樣地製得TDS20%之濃縮水。將藉由正滲透膜處理稀釋之稀薄碳酸銨溶液輸送至再生裝置,並藉由熱實施再生(再生步驟)。算出用於正滲透膜處理之能量成本(包含供應至再生步驟之能量)。結果顯示於表2中。 In the water treatment device used in Example 2, a 30 wt% ammonium carbonate solution was used as the draw solution of the forward osmosis membrane treatment device, and concentrated water with a TDS of 20% was similarly produced. The dilute ammonium carbonate solution diluted by the forward osmosis membrane treatment was transported to the regeneration device and regenerated by heat (regeneration step). The energy cost for the forward osmosis membrane treatment (including the energy supplied to the regeneration step) was calculated. The results are shown in Table 2.
如此,可了解的是藉由實施例2之處理方法,相較於比較例3、4之處理方法,可用低能量成本濃縮,因此可用低成本處理包含溶解性二氧化矽及硬度成分中之至少一者的被處理水。 In this way, it can be understood that through the processing method of Example 2, compared with the processing methods of Comparative Examples 3 and 4, it is possible to concentrate at a lower energy cost, so that at least one of the soluble silica and hardness components can be processed at a low cost. One of the treated water.
[安定化次溴酸組成物(組成物1)之調製] [Preparation of stabilized hypobromous acid composition (composition 1)]
在氮環境下,混合:液體溴:16.9重量%(wt%)、胺磺酸:10.7重量%、氫氧化鈉:12.9重量%、氫氧化鉀:3.94重量%、水:剩餘部份,藉此調製安定化次溴酸組成物(組成物1)。安定化次溴酸組成物之pH為14,且全氯濃度為7.5重量%。全氯濃度係使用HACH公司之多項目水質分析計DR/4000,藉由全氯測量法 (DPD(二乙基對苯二胺)法)測量的值(mg/L相當於Cl2)。安定化次溴酸組成物之詳細調製方法如下。 In a nitrogen environment, the following were mixed: 16.9 wt% liquid bromine, 10.7 wt% sulfamic acid, 12.9 wt% sodium hydroxide, 3.94 wt% potassium hydroxide, and the remainder of water to prepare a stabilized hypobromous acid composition (composition 1). The pH of the stabilized hypobromous acid composition was 14, and the total chlorine concentration was 7.5 wt%. The total chlorine concentration was measured by the total chlorine measurement method (DPD (diethyl-p-phenylenediamine) method) using a multi-item water quality analyzer DR/4000 from HACH (mg/L is equivalent to Cl 2 ). The detailed preparation method of the stabilized hypobromous acid composition is as follows.
一面藉由質量流控制器控制氮氣之流量,使反應容器內之氧濃度維持在1%,一面添加混合1436g之水、361g之氫氧化鈉於藉由連續注入裝入之2L的4個燒瓶中,接著添加混合300g之胺磺酸後,一面維持冷卻使反應液之溫度為0至15℃,一面添加473g之液體溴,接著添加230g之48%氫氧化鉀溶液,製得按對組成物全體之量的重量比計,胺磺酸10.7%、溴16.9%、胺磺酸當量對溴當量之比為1.04的目的安定化次溴酸組成物(組成物1)。生成之溶液的pH用玻璃電極法測量之結果為14。生成之溶液的溴含有率藉由將溴用碘化鉀轉變成碘後,使用硫代硫酸鈉氧化還原滴定之方法測量的結果是16.9%且係理論含有率(16.9%)之100.0%。此外,溴反應時之反應容器內的氧濃度係使用JIKCO公司(股)製之「OXYGEN MONITOR JKO-02 LJDII」測量。另外,溴酸濃度小於5mg/kg。 While controlling the flow rate of nitrogen by a mass flow controller to maintain the oxygen concentration in the reaction container at 1%, 1436 g of water and 361 g of sodium hydroxide were added and mixed into four 2 L flasks filled by continuous injection, and then 300 g of amine sulfonic acid was added and mixed. While cooling the reaction solution to keep the temperature at 0 to 15°C, 473 g of liquid bromine was added, and then 230 g of 48% potassium hydroxide solution was added to obtain the target stabilized hypobromous acid composition (composition 1) with a weight ratio of amine sulfonic acid 10.7%, bromine 16.9%, and a ratio of amine sulfonic acid equivalent to bromine equivalent of 1.04 based on the weight ratio of the total composition. The pH of the resulting solution was measured by a glass electrode method and was 14. The bromine content of the resulting solution was measured by converting bromine into iodine using potassium iodide and then using sodium thiosulfate redox titration. The result was 16.9%, which is 100.0% of the theoretical content (16.9%). In addition, the oxygen concentration in the reaction vessel during the bromine reaction was measured using "OXYGEN MONITOR JKO-02 LJDII" manufactured by JIKCO Co., Ltd. In addition, the bromic acid concentration was less than 5 mg/kg.
此外,pH之測量係在以下條件下進行。 In addition, pH measurements were performed under the following conditions.
電極種類:玻璃電極式 Electrode type: glass electrode type
pH測量計:DKK-TOA公司製,IOL-30型 pH meter: Made by DKK-TOA, model IOL-30
電極之校正:藉由關東化學公司製中性磷酸鹽pH(6.86)標準液(第二種)、同公司製硼酸鹽pH(9.18)標準液(第二種)的2點校正來進行 Electrode calibration: Performed by two-point calibration using neutral phosphate pH (6.86) standard solution (type 2) manufactured by Kanto Chemical Co., Ltd. and borate pH (9.18) standard solution (type 2) manufactured by the same company.
測量溫度:25℃ Measurement temperature: 25℃
測量值:將電極浸漬於測量液中,用安定後之值作為測量值,3次測量之平均值 Measurement value: Immerse the electrode in the measuring liquid, use the value after stabilization as the measurement value, and take the average value of 3 measurements.
[安定化次氯酸組成物(組成物2)之調製] [Preparation of stabilized hypochlorous acid composition (composition 2)]
混合:12%次氯酸鈉水溶液:50重量%、胺磺酸:12重量%、氫氧化鈉:8重量%、水:剩餘部份,藉此調製安定化次氯酸組成物(組成物2)。組成物2之pH為13.7,且全氯濃度為6.2重量%。 Mix: 12% sodium hypochlorite aqueous solution: 50% by weight, sulfamic acid: 12% by weight, sodium hydroxide: 8% by weight, and water: the remainder to prepare a stabilized hypochlorous acid composition (composition 2). The pH of composition 2 was 13.7, and the total chlorine concentration was 6.2% by weight.
<實施例3> <Implementation Example 3>
使用濃縮到全蒸發殘留物(TDS)8重量%為止之工業排水作為FO被處理水,接著用30重量%MgCl2溶液作為吸引溶液,實施正滲透膜處理。調整吸引溶液之流量,使FO濃縮水出口之流量為FO被處理水入口之50%(濃縮倍率2倍)。使用乙酸纖維素製FO膜(HPC3205,東洋紡製)作為正滲透膜(FO膜)。在FO被處理水中添加安定化次溴酸組成物(組成物1)作為正滲透膜用殺菌劑,使在FO被處理水入口之全氯濃度為1ppmCl。總計繼續本運轉200小時,接著評價正滲透膜處理裝置之FO被處理水入口至FO濃縮水出口的壓力損失(通水壓差)及殺菌劑的阻止率。此外,運轉開始後之通水壓差係0.02MPa。結果顯示於表3中。 Industrial wastewater concentrated to 8% by weight of pervaporation residue (TDS) was used as the FO treated water, and then a 30% by weight MgCl2 solution was used as the suction solution to perform forward osmosis membrane treatment. Adjust the flow rate of the suction solution so that the flow rate at the FO concentrated water outlet is 50% of the FO treated water inlet (concentration rate is 2 times). A FO membrane made of cellulose acetate (HPC3205, produced by Toyobo) was used as a forward osmosis membrane (FO membrane). A stabilized hypobromous acid composition (composition 1) was added to the FO treated water as a bactericide for the forward osmosis membrane so that the total chlorine concentration at the FO treated water inlet was 1 ppmCl. This operation was continued for a total of 200 hours, and then the pressure loss (water flow pressure difference) from the FO treated water inlet to the FO concentrated water outlet of the forward osmosis membrane treatment device and the bactericide rejection rate were evaluated. In addition, the water pressure difference after the start of operation is 0.02MPa. The results are shown in Table 3.
殺菌劑之阻止率[%]=(1-(稀薄吸引溶液流量×稀薄吸引溶液全氯濃度/FO被處理水×FO被處理水全氯濃度)) Inhibition rate of fungicides [%] = (1-(Thin suction solution flow rate × dilute suction solution total chlorine concentration/FO treated water × FO treated water total chlorine concentration))
<實施例4> <Implementation Example 4>
在FO被處理水中添加安定化次氯酸組成物(組成物2;氯胺磺酸)取代安定化次溴酸組成物(組成物1)作為正滲透膜用殺菌劑,使在FO被處理水入口之全氯濃 度為1ppmCl,除此以外,與實施例3同樣地實施正滲透膜處理。結果顯示於表3中。 The stabilized hypochlorous acid composition (composition 2; chloramine sulfonic acid) was added to the FO treated water instead of the stabilized hypobromous acid composition (composition 1) as a disinfectant for the forward osmosis membrane, so that the total chlorine concentration at the inlet of the FO treated water was 1ppmCl. The forward osmosis membrane treatment was carried out in the same manner as in Example 3. The results are shown in Table 3.
<比較例5> <Comparison Example 5>
在FO被處理水中添加作為氯系殺菌劑之次氯酸鈉取代安定化次溴酸組成物(組成物1)作為正滲透膜用殺菌劑,使在FO被處理水入口之游離氯濃度為1ppmCl,除此以外,與實施例3同樣地實施正滲透膜處理。結果顯示於表3中。 Add sodium hypochlorite as a chlorine-based bactericide to replace the stabilized hypobromous acid composition (composition 1) as a bactericide for the forward osmosis membrane in the FO treated water, so that the free chlorine concentration at the FO treated water inlet is 1 ppmCl, except that Except for this, forward osmosis membrane treatment was carried out in the same manner as in Example 3. The results are shown in Table 3.
<比較例6> <Comparative Example 6>
在FO被處理水中添加作為有機系殺菌劑之5-氯-2-甲基-4-異噻唑啉-3-酮取代安定化次溴酸組成物(組成物1)作為正滲透膜用殺菌劑,使在FO被處理水入口之TOC為10ppm,除此以外,與實施例3同樣地實施正滲透膜處理。結果顯示於表3中。除此以外,與實施例3同樣地實施正滲透膜處理。結果顯示於表3中。 Add a 5-chloro-2-methyl-4-isothiazolin-3-one-substituted stabilized hypobromous acid composition (composition 1) as an organic bactericide to the FO treated water as a bactericide for forward osmosis membranes , except that the TOC at the FO to be treated water inlet was 10 ppm, forward osmosis membrane treatment was performed in the same manner as in Example 3. The results are shown in Table 3. Except for this, forward osmosis membrane treatment was performed in the same manner as in Example 3. The results are shown in Table 3.
[結果] [result]
在實施例3中,可抑制正滲透膜之通水壓差的上升。殺菌劑亦阻止99%以上。在實施例4中亦有同樣之傾向,但通水壓差稍微上升。在比較例5、6中,通 水壓差>0.2MPa且超過膜之容許通水壓差(0.2MPa)。殺菌劑阻止率亦為85%以下,且確認殺菌有效成分洩漏至稀薄吸引溶液中。 In Example 3, the increase in the water flow pressure difference of the forward osmosis membrane can be suppressed. Fungicides also prevent more than 99%. In Example 4, the same tendency was observed, but the water flow pressure difference increased slightly. In Comparative Examples 5 and 6, through The water pressure difference is >0.2MPa and exceeds the allowable water pressure difference of the membrane (0.2MPa). The bactericide prevention rate was also less than 85%, and it was confirmed that the bactericidal active ingredient leaked into the dilute suction solution.
如此,可了解的是藉由使用安定化次溴酸組成物或安定化次氯酸組成物作為殺菌劑,可抑制殺菌劑透過正滲透膜且可再利用稀薄吸引溶液。 Thus, it can be understood that by using a stabilized hypobromous acid composition or a stabilized hypochlorous acid composition as a bactericide, the bactericide can be inhibited from passing through the positive osmosis membrane and the dilute attracting solution can be reused.
Claims (16)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018190215A JP7212490B2 (en) | 2018-10-05 | 2018-10-05 | Water treatment device and water treatment method |
JP2018-190215 | 2018-10-05 | ||
JP2018190744A JP2020058972A (en) | 2018-10-09 | 2018-10-09 | Positive osmosis membrane treatment method, positive osmosis membrane treatment system, water treatment method, and water treatment system |
JP2018-190744 | 2018-10-09 | ||
JP2019-156729 | 2019-08-29 | ||
JP2019156729A JP7228492B2 (en) | 2019-08-29 | 2019-08-29 | Water treatment device and water treatment method |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202019552A TW202019552A (en) | 2020-06-01 |
TWI835878B true TWI835878B (en) | 2024-03-21 |
Family
ID=70054547
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW108135957A TWI835878B (en) | 2018-10-05 | 2019-10-04 | Water treatment device, and water treatment method |
TW112136510A TWI848823B (en) | 2018-10-05 | 2019-10-04 | Water treatment device, and water treatment method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW112136510A TWI848823B (en) | 2018-10-05 | 2019-10-04 | Water treatment device, and water treatment method |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN112805247B (en) |
TW (2) | TWI835878B (en) |
WO (1) | WO2020071177A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111704268A (en) * | 2020-06-22 | 2020-09-25 | 杭州师范大学附属医院 | Novel medical wastewater treatment and recycling system and method |
JP7521965B2 (en) * | 2020-07-31 | 2024-07-24 | オルガノ株式会社 | Ammonia concentration method and ammonia concentration device |
GB202019662D0 (en) * | 2020-12-14 | 2021-01-27 | Saltwater Holding Aps | Osmotic processes |
US20220204375A1 (en) * | 2020-12-30 | 2022-06-30 | Industrial Technology Research Institute | System and method of treating waste water |
TWI745208B (en) * | 2020-12-30 | 2021-11-01 | 財團法人工業技術研究院 | System and method of treating waste water |
JP2022186382A (en) * | 2021-06-04 | 2022-12-15 | オルガノ株式会社 | Water treatment method and water treatment apparatus |
CN115465978A (en) * | 2021-10-11 | 2022-12-13 | 苏州诺津环保科技有限公司 | Water solution concentration method by combining osmotic membrane and dialysis membrane |
TWI796894B (en) * | 2021-12-23 | 2023-03-21 | 財團法人工業技術研究院 | Forward-osmosis concentration device and concentrating method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100032375A1 (en) * | 2008-08-05 | 2010-02-11 | Venkataraman Jagannathan | Reverse osmosis enhanced recovery hybrid process |
WO2013153587A1 (en) * | 2012-04-11 | 2013-10-17 | Jfeエンジニアリング株式会社 | Method and device for treating accompanying water from well |
CN105026017A (en) * | 2013-02-25 | 2015-11-04 | 水通道蛋白有限公司 | Systems for water extraction |
CN105142762A (en) * | 2013-03-15 | 2015-12-09 | 波里费拉公司 | Improvements in osmotically driven membrane systems containing multi-stage purification |
CN205603387U (en) * | 2016-02-22 | 2016-09-28 | 麦王环境技术股份有限公司 | Strong brine zero release divides membrane concentrator of matter crystallization |
JP2016205242A (en) * | 2015-04-23 | 2016-12-08 | 株式会社ササクラ | Electric power generation/seawater desalination method and system |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014180628A (en) * | 2013-03-19 | 2014-09-29 | Kubota Corp | Water treatment method and system |
JP6401491B2 (en) * | 2013-08-28 | 2018-10-10 | オルガノ株式会社 | Method for inhibiting slime of separation membrane, slime inhibitor composition for reverse osmosis membrane or nanofiltration membrane, and method for producing slime inhibitor composition for separation membrane |
JP6252297B2 (en) * | 2014-03-27 | 2017-12-27 | 東洋紡株式会社 | Forward osmosis treatment method and forward osmosis treatment apparatus |
KR102046581B1 (en) * | 2014-05-08 | 2019-11-19 | 오르가노 코포레이션 | Filtration treatment system and filtration treatment method |
JP6534524B2 (en) * | 2014-12-25 | 2019-06-26 | オルガノ株式会社 | Filtration treatment system and filtration treatment method |
MY188356A (en) * | 2014-12-25 | 2021-12-02 | Organo Corp | Method for controlling slime on separation membrane |
JP2016188823A (en) * | 2015-03-30 | 2016-11-04 | 栗田工業株式会社 | Method and device for processing contaminated water |
WO2016160810A1 (en) * | 2015-03-30 | 2016-10-06 | Oasys Water, Inc. | Osmotic separation systems and methods |
JP6465301B2 (en) * | 2015-08-12 | 2019-02-06 | Jfeエンジニアリング株式会社 | Water desalination equipment |
WO2017038402A1 (en) * | 2015-08-31 | 2017-03-09 | 東洋紡株式会社 | Water treatment method and water treatment system |
JP6727056B2 (en) * | 2016-07-25 | 2020-07-22 | 水ing株式会社 | Wastewater treatment equipment and wastewater treatment method |
KR102291224B1 (en) * | 2016-10-25 | 2021-08-19 | 오르가노 코포레이션 | Water treatment method and water treatment device using reverse osmosis membrane |
-
2019
- 2019-09-24 CN CN201980064798.7A patent/CN112805247B/en active Active
- 2019-09-24 WO PCT/JP2019/037279 patent/WO2020071177A1/en active Application Filing
- 2019-10-04 TW TW108135957A patent/TWI835878B/en active
- 2019-10-04 TW TW112136510A patent/TWI848823B/en active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100032375A1 (en) * | 2008-08-05 | 2010-02-11 | Venkataraman Jagannathan | Reverse osmosis enhanced recovery hybrid process |
WO2013153587A1 (en) * | 2012-04-11 | 2013-10-17 | Jfeエンジニアリング株式会社 | Method and device for treating accompanying water from well |
CN105026017A (en) * | 2013-02-25 | 2015-11-04 | 水通道蛋白有限公司 | Systems for water extraction |
CN105142762A (en) * | 2013-03-15 | 2015-12-09 | 波里费拉公司 | Improvements in osmotically driven membrane systems containing multi-stage purification |
JP2016205242A (en) * | 2015-04-23 | 2016-12-08 | 株式会社ササクラ | Electric power generation/seawater desalination method and system |
CN205603387U (en) * | 2016-02-22 | 2016-09-28 | 麦王环境技术股份有限公司 | Strong brine zero release divides membrane concentrator of matter crystallization |
Also Published As
Publication number | Publication date |
---|---|
CN112805247B (en) | 2023-05-02 |
WO2020071177A1 (en) | 2020-04-09 |
TWI848823B (en) | 2024-07-11 |
CN112805247A (en) | 2021-05-14 |
TW202019552A (en) | 2020-06-01 |
TW202404904A (en) | 2024-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI835878B (en) | Water treatment device, and water treatment method | |
TWI532525B (en) | Combined chlorine agent, preparation method thereof, and use thereof | |
JP5099045B2 (en) | Reverse osmosis membrane separation method | |
TWI633928B (en) | Filtration treatment system and filtration treatment method | |
US7097769B2 (en) | Method of boron removal in presence of magnesium ions | |
WO2003022751A1 (en) | Method of multi-stage reverse osmosis treatment | |
WO2011125764A1 (en) | Treatment method using reverse osmosis membrane | |
JP7013141B2 (en) | Water treatment method using reverse osmosis membrane | |
WO2018078988A1 (en) | Water treatment method using reverse osmosis membrane, and water treatment apparatus | |
JP2009028724A (en) | Method for water treatment and apparatus for water treatment | |
JPWO2016111371A1 (en) | Method of improving semi-permeable membrane blocking performance, semi-permeable membrane, semi-permeable membrane water generator | |
JP2020058972A (en) | Positive osmosis membrane treatment method, positive osmosis membrane treatment system, water treatment method, and water treatment system | |
WO2021192582A1 (en) | Water treatment method, water treatment device and slime inhibitor for membranes | |
WO2018037683A1 (en) | Method and system for processing water containing low-molecular-weight organic matter | |
JP7008470B2 (en) | Reverse osmosis membrane treatment method and reverse osmosis membrane treatment system | |
JP7050414B2 (en) | Water treatment method using reverse osmosis membrane | |
JP7141919B2 (en) | Reverse osmosis membrane treatment method, reverse osmosis membrane treatment system, water treatment method, and water treatment system | |
JP2021030189A (en) | Water treatment apparatus and water treatment method | |
JP7492876B2 (en) | Water treatment method and water treatment device | |
JP2018069120A (en) | Water treatment method and apparatus using reverse osmosis membrane | |
JP2023009864A (en) | Water treatment method, and water treatment device | |
TW201940225A (en) | Water system ORP monitor and/or control method, and water treatment method and device | |
JPS61263607A (en) | Electrodialytic method |